data_2jtx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jtx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.5 mm . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.949 0.404 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.422 ' CG1' HG23 ' A' ' 408' ' ' VAL . 13.8 p -115.57 142.57 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.803 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.6 mmt -90.81 113.83 26.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.808 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 38.1 t -111.75 120.92 63.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.981 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.23 27.34 9.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.439 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.48 23.51 46.99 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.731 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -137.02 152.27 73.61 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.669 0.271 . . . . 0.0 110.738 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 402' ' ' PRO . . . . . 0.402 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 58.3 Cg_endo -71.73 135.84 26.74 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.454 2.103 . . . . 0.0 112.406 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 403' ' ' PHE . . . . . 0.402 ' CD1' ' O ' ' A' ' 402' ' ' PRO . 36.2 m-85 -150.52 172.04 16.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.674 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 24.8 p -98.59 136.9 38.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.552 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 405' ' ' TYR . . . . . 0.484 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 35.1 t80 -56.84 -39.31 74.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.032 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.1 m -64.73 -40.68 95.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -66.61 -29.54 69.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.192 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.422 HG23 ' CG1' ' A' ' 396' ' ' VAL . 48.1 t -68.14 -47.68 77.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.04 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 87.1 p -61.39 -30.39 70.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.941 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -74.07 -26.88 60.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.893 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -125.6 94.89 41.63 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.75 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.31 -23.1 76.36 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.462 2.108 . . . . 0.0 112.367 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.71 -29.05 70.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 30.2 mt -65.09 -38.48 90.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.721 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.4 t -62.61 -39.85 86.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.965 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.1 -27.57 67.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.128 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -80.87 -20.5 42.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.165 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 3.0 mtt -73.64 131.85 42.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.955 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 6.4 p -63.13 167.37 6.43 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.356 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.4 -56.07 3.22 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.31 2.007 . . . . 0.0 112.187 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 54.4 mp0 -59.67 -40.17 86.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.01 0.433 . . . . 0.0 109.946 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -65.3 -33.78 76.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.183 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -65.16 -36.75 85.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.199 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -65.0 -45.45 85.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.528 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.31 -30.37 64.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.147 0.499 . . . . 0.0 110.567 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 426' ' ' TYR . . . . . 0.484 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 58.4 t80 -68.87 -48.05 64.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.223 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.2 mt -75.13 -33.54 29.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.512 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.65 -43.0 99.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.208 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 429' ' ' MET . . . . . 0.4 ' HE2' ' CD1' ' A' ' 405' ' ' TYR . 68.9 mtm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.948 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.9 mm . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.905 0.383 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.403 HG12 ' CG2' ' A' ' 408' ' ' VAL . 12.0 p -127.48 141.07 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.742 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 16.1 mmt -84.26 113.68 21.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.825 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.407 ' HB ' ' CD1' ' A' ' 403' ' ' PHE . 32.8 t -111.76 108.6 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.808 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.76 22.54 7.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.256 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.83 -17.48 49.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.931 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 -100.21 146.04 31.27 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.678 0.275 . . . . 0.0 111.047 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.79 135.92 20.16 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.649 2.233 . . . . 0.0 112.494 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 403' ' ' PHE . . . . . 0.407 ' CD1' ' HB ' ' A' ' 398' ' ' VAL . 57.4 m-85 -148.33 158.75 44.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.751 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 18.0 p -76.92 137.8 39.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.646 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 405' ' ' TYR . . . . . 0.493 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 57.6 t80 -57.58 -40.57 79.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.948 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.0 m -63.49 -39.02 93.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -66.11 -29.39 69.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.403 ' CG2' HG12 ' A' ' 396' ' ' VAL . 57.1 t -67.41 -46.94 82.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.963 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.8 p -64.22 -29.3 70.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.026 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -75.89 -26.2 56.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.919 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 35.9 mtt-85 -124.0 97.2 41.24 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.824 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.72 -25.59 78.95 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.345 2.03 . . . . 0.0 112.272 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -62.84 -28.47 70.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 68.7 mt -66.05 -40.24 90.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.846 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.4 -38.38 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.969 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.88 67.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.073 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -79.07 -19.1 52.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.114 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 3.5 mtt -74.41 129.3 37.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.067 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 419' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 8.7 p -61.69 158.07 43.85 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.208 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 3.0 Cg_endo -45.79 -56.07 3.11 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.661 2.241 . . . . 0.0 112.244 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.1 -38.42 82.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 0.0 109.937 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -66.05 -34.53 78.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.159 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -63.23 -36.22 82.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.116 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -64.84 -43.12 94.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.474 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -59.5 -31.69 69.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.193 0.52 . . . . 0.0 110.473 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 426' ' ' TYR . . . . . 0.493 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 57.2 t80 -67.78 -45.1 75.81 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.282 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . 0.407 HG23 HD13 ' A' ' 427' ' ' ILE . 61.9 mt -79.46 -33.76 15.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.794 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -68.39 -43.26 77.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.336 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 49.4 mtm . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.14 -179.912 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.0 mm . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.878 0.37 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.424 HG13 ' CG2' ' A' ' 408' ' ' VAL . 14.7 p -124.92 142.48 41.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.86 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 15.2 mmt -85.83 113.81 22.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.647 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 12.6 t -118.75 114.56 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.95 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.41 22.67 6.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.268 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.33 -17.36 57.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.872 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -100.69 146.24 31.73 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.722 0.296 . . . . 0.0 111.032 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.77 135.98 16.47 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.661 2.241 . . . . 0.0 112.525 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 403' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -148.18 157.73 43.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.771 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 49.4 m -71.38 139.98 49.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.527 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -58.01 -40.95 82.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.994 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.3 t -65.86 -38.81 89.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.64 -29.9 70.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.424 ' CG2' HG13 ' A' ' 396' ' ' VAL . 60.3 t -68.76 -46.3 79.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.004 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.5 p -63.14 -28.94 70.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -74.31 -26.25 60.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.019 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -124.35 87.18 54.19 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.859 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -51.8 -27.21 26.33 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.6 2.2 . . . . 0.0 112.36 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.24 -28.29 69.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 69.5 mt -66.57 -38.75 87.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.788 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.25 -37.72 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.02 -28.57 68.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.014 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -79.68 -17.63 53.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.141 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 7.6 mtt -72.64 132.21 43.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.199 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 419' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 2.9 p -74.6 173.08 7.27 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.066 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.4 Cg_exo -52.94 -55.98 3.23 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.169 1.912 . . . . 0.0 112.264 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -59.83 -40.19 87.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.01 0.433 . . . . 0.0 109.931 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -65.29 -34.23 77.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.229 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -64.49 -36.84 85.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.148 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -63.63 -47.18 82.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.615 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -59.59 -29.71 68.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.12 0.486 . . . . 0.0 110.578 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 426' ' ' TYR . . . . . 0.417 ' CE1' HG11 ' A' ' 408' ' ' VAL . 85.1 t80 -70.11 -45.14 67.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.162 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 57.7 mt -77.92 -35.55 20.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.695 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.76 83.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.827 0.346 . . . . 0.0 111.082 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 76.3 mtp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.901 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.8 mm . . . . . 0 C--O 1.23 0.07 0 CA-C-O 121.038 0.447 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.416 HG11 ' CG2' ' A' ' 408' ' ' VAL . 12.4 p -129.59 141.94 45.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.906 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 397' ' ' MET . . . . . 0.4 ' N ' HG23 ' A' ' 396' ' ' VAL . 17.8 mmt -82.58 113.76 20.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.817 0.341 . . . . 0.0 110.629 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.412 ' HB ' ' CD1' ' A' ' 403' ' ' PHE . 22.0 t -117.87 112.73 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.965 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.36 23.46 5.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.283 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.11 -15.63 59.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.801 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -103.55 145.82 31.32 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.735 0.303 . . . . 0.0 111.046 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.4 136.03 19.1 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.628 2.219 . . . . 0.0 112.455 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 403' ' ' PHE . . . . . 0.412 ' CD1' ' HB ' ' A' ' 398' ' ' VAL . 64.0 m-85 -147.1 156.9 43.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.751 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 50.0 m -69.04 137.75 53.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.645 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -58.16 -43.3 87.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.958 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.0 t -64.89 -37.44 87.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.19 -29.46 70.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.424 HG13 ' CE1' ' A' ' 426' ' ' TYR . 53.2 t -69.8 -47.36 70.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.999 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.2 p -64.49 -29.04 70.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.022 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -76.76 -26.35 54.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.974 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -124.16 85.29 55.03 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -51.58 -26.77 23.35 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.595 2.197 . . . . 0.0 112.344 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.0 -28.36 69.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 70.0 mt -66.11 -36.75 83.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.797 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 39.7 t -63.92 -38.88 83.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.961 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.76 -28.86 68.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.113 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -76.56 -22.08 54.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.094 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 4.1 mtt -72.72 130.08 39.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.939 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 419' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 3.9 p -65.76 171.49 3.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.072 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 50.2 Cg_exo -53.36 -56.07 3.05 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.196 1.93 . . . . 0.0 112.154 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.01 -37.82 83.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.018 0.437 . . . . 0.0 109.842 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -66.94 -33.38 75.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.249 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -34.08 77.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.203 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -64.5 -45.62 86.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.65 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.07 -30.92 64.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.145 0.498 . . . . 0.0 110.653 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 426' ' ' TYR . . . . . 0.424 ' CE1' HG13 ' A' ' 408' ' ' VAL . 63.8 t80 -68.51 -48.37 64.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.088 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 3.2 mt -73.2 -35.44 47.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.565 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -65.42 -49.14 70.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.173 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 71.5 mtm . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.844 179.91 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.3 mm . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.967 0.413 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.406 HG12 ' CG2' ' A' ' 408' ' ' VAL . 13.9 p -131.43 142.11 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.893 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 17.2 mmt -84.47 113.7 21.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.597 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 22.3 t -118.18 113.6 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.977 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.62 23.17 5.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.295 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.43 -13.82 61.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.956 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 6.8 mtt85 -104.75 146.3 32.37 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.722 0.296 . . . . 0.0 110.991 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.04 136.0 17.85 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.667 2.245 . . . . 0.0 112.526 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 403' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -147.65 158.92 44.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.738 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 63.6 m -71.34 138.76 49.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.694 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -58.25 -43.72 88.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 m -64.69 -38.06 89.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.919 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.73 -29.31 70.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.419 HG11 ' CE1' ' A' ' 426' ' ' TYR . 60.4 t -70.65 -46.79 67.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.012 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.8 t -63.09 -31.28 72.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.026 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -73.87 -26.72 60.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.001 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -123.77 96.75 42.55 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.785 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.22 -25.94 77.21 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.393 2.062 . . . . 0.0 112.299 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -62.75 -28.61 70.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.95 -38.11 85.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.731 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 35.7 t -63.65 -37.81 80.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.847 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.88 -29.05 68.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.993 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -76.24 -22.06 55.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.063 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 3.8 mtt -71.88 129.56 38.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 4.9 p -64.3 169.95 4.2 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.14 -56.05 3.12 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.155 1.904 . . . . 0.0 112.161 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 54.2 mp0 -60.69 -38.31 84.56 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -65.99 -34.61 78.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.288 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -65.26 -34.76 79.11 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.226 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -64.76 -44.7 89.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.76 -30.4 67.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.222 0.534 . . . . 0.0 110.631 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 426' ' ' TYR . . . . . 0.419 ' CE1' HG11 ' A' ' 408' ' ' VAL . 76.4 t80 -69.38 -45.95 68.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.294 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.8 -33.77 19.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.751 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.43 -36.16 77.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.341 . . . . 0.0 111.227 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.942 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.3 mm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.93 0.395 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.417 ' CG1' HG23 ' A' ' 408' ' ' VAL . 13.6 p -114.02 135.52 53.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.751 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 16.8 mmt -83.77 113.86 21.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.845 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.429 ' HB ' ' CD2' ' A' ' 403' ' ' PHE . 15.1 t -117.61 118.21 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.943 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.4 22.7 6.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.259 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.59 -14.01 64.7 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.905 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -100.82 147.79 34.15 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.788 0.328 . . . . 0.0 111.011 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.22 136.01 19.42 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.67 2.247 . . . . 0.0 112.375 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 403' ' ' PHE . . . . . 0.429 ' CD2' ' HB ' ' A' ' 398' ' ' VAL . 77.4 m-85 -147.14 168.41 21.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.72 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 55.5 m -88.66 136.82 32.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.675 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -53.55 -41.67 66.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 0.0 110.988 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 26.4 m -67.96 -34.17 76.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.811 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -67.18 -31.25 71.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.051 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.417 HG23 ' CG1' ' A' ' 396' ' ' VAL . 84.9 t -67.8 -43.19 86.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.829 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.9 p -63.39 -29.79 71.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.073 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -74.44 -27.96 60.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.934 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 11.3 mtt-85 -124.57 92.99 47.08 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.823 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.13 -23.1 75.25 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.451 2.101 . . . . 0.0 112.411 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -62.47 -29.25 70.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.938 0.399 . . . . 0.0 110.982 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 25.7 mt -66.47 -35.98 81.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.722 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.9 t -62.89 -36.23 74.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -64.4 -29.13 70.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.944 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -81.1 -19.76 42.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.076 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 418' ' ' MET . . . . . 0.404 ' HG2' ' HA ' ' A' ' 398' ' ' VAL . 6.3 mtt -70.36 124.41 24.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.025 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 5.3 p -63.65 171.01 2.54 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.115 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.5 -56.14 2.74 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.109 1.872 . . . . 0.0 112.118 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.77 -39.79 90.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.018 0.437 . . . . 0.0 109.844 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -65.49 -33.41 75.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.234 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -65.18 -36.68 84.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.24 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -64.89 -45.87 84.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.597 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.08 -30.18 64.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.151 0.5 . . . . 0.0 110.647 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 426' ' ' TYR . . . . . 0.412 ' CE1' HG12 ' A' ' 408' ' ' VAL . 46.8 t80 -69.17 -48.31 62.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.165 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.2 mt -74.52 -33.69 33.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.434 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.27 -43.97 98.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.121 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.932 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.9 mm . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.948 0.404 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.414 HG12 ' CG2' ' A' ' 408' ' ' VAL . 14.6 p -125.75 141.07 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.69 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 17.9 mmt -82.21 113.89 20.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.88 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.429 ' HA ' ' HG2' ' A' ' 418' ' ' MET . 21.5 t -116.16 111.42 35.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.971 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.94 23.92 5.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.288 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.4 -19.25 51.69 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.752 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -99.61 145.32 29.91 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 111.012 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.06 135.93 19.61 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.679 2.253 . . . . 0.0 112.425 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 403' ' ' PHE . . . . . 0.417 ' CD1' ' HB ' ' A' ' 398' ' ' VAL . 59.1 m-85 -147.04 155.65 42.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.79 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 10.9 p -75.97 137.37 40.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.51 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 405' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 55.2 t80 -55.21 -34.63 64.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.018 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 21.8 m -63.88 -38.13 89.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.985 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -69.84 -29.73 67.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.063 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.437 ' CG1' ' CE1' ' A' ' 426' ' ' TYR . 43.4 t -68.97 -49.33 64.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.02 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.9 p -66.86 -28.99 68.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.98 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -82.14 -23.58 35.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.106 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 21.7 mtt-85 -123.49 84.71 52.72 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -51.76 -25.51 20.97 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.626 2.217 . . . . 0.0 112.33 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -60.98 -36.21 78.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 72.1 mt -60.84 -40.75 94.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.888 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.46 -35.95 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.808 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.47 69.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -81.59 -16.72 50.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.044 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 418' ' ' MET . . . . . 0.429 ' HG2' ' HA ' ' A' ' 398' ' ' VAL . 3.7 mtt -72.01 127.1 31.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.162 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 1.3 p -66.75 166.7 17.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.173 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -50.79 -56.24 3.28 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.26 1.974 . . . . 0.0 112.324 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.25 -39.84 88.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 109.975 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.8 -33.4 75.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.217 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -64.92 -36.42 84.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.142 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -64.72 -46.22 83.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.512 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.55 -30.29 65.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.137 0.494 . . . . 0.0 110.591 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 426' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 50.9 t80 -69.05 -47.75 64.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.275 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.6 mt -75.33 -33.64 28.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.464 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.16 96.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.073 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 71.2 mtm . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.833 179.969 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.4 mm . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.959 0.409 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.4 p -132.75 142.52 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.771 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 5.3 mmt -86.65 113.83 22.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 110.889 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 29.5 t -112.8 118.73 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.95 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.07 23.53 5.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.435 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.33 19.58 41.43 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.853 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -136.97 146.45 54.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.668 0.234 . . . . 0.0 110.89 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 402' ' ' PRO . . . . . 0.441 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 17.1 Cg_exo -66.81 135.62 38.89 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.439 2.093 . . . . 0.0 112.319 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 403' ' ' PHE . . . . . 0.441 ' CD1' ' O ' ' A' ' 402' ' ' PRO . 20.6 m-85 -149.44 156.04 41.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.64 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 56.2 m -76.27 133.79 39.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.704 0.288 . . . . 0.0 110.572 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -56.23 -41.56 75.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.006 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.9 m -64.57 -36.13 83.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.799 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.45 -29.13 68.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.144 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.442 ' CG1' ' CE1' ' A' ' 426' ' ' TYR . 48.7 t -66.49 -47.89 82.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.013 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.1 p -64.14 -29.2 70.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.005 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -81.71 -25.3 35.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.966 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -122.94 91.33 49.87 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.813 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.36 -22.42 74.07 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.5 2.133 . . . . 0.0 112.419 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -61.9 -30.23 70.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.983 0.421 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 20.7 mt -68.67 -36.77 78.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.597 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 22.5 t -64.94 -35.97 76.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.777 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.35 -26.0 66.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.083 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -92.16 -0.5 57.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.358 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -87.47 125.9 34.57 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.74 0.305 . . . . 0.0 111.179 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 419' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 14.5 p -61.38 160.64 22.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.321 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 6.9 Cg_endo -49.11 -53.16 7.45 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.55 2.167 . . . . 0.0 112.246 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -60.02 -42.76 95.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 110.159 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -65.57 -32.91 74.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.162 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -65.03 -37.21 86.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.175 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -64.6 -46.26 83.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.546 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.54 -30.22 65.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.17 0.51 . . . . 0.0 110.585 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 426' ' ' TYR . . . . . 0.442 ' CE1' ' CG1' ' A' ' 408' ' ' VAL . 46.9 t80 -69.0 -47.95 64.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.259 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.7 mt -75.13 -33.67 29.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.452 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -59.75 -42.87 94.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.132 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 69.1 mtm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 41.0 mm . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.973 0.416 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.405 ' CG1' HG21 ' A' ' 408' ' ' VAL . 14.8 p -130.24 143.26 41.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 18.3 mmt -87.18 113.83 23.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.704 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.25 118.66 59.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 51.41 26.41 3.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.478 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 89.15 20.49 45.69 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.823 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -137.06 143.22 41.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.681 0.277 . . . . 0.0 110.693 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.17 135.92 23.61 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.439 2.093 . . . . 0.0 112.611 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 403' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -150.49 154.26 37.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.687 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 13.3 p -69.72 136.02 50.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.59 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -56.2 -39.77 72.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.062 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.6 m -64.3 -36.43 84.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.979 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -66.11 -30.95 71.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.095 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.422 ' CG1' ' CE1' ' A' ' 426' ' ' TYR . 44.6 t -70.9 -48.93 53.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.9 t -62.56 -31.77 72.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.998 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -81.66 -25.7 35.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.053 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . 0.419 ' CB ' HD12 ' A' ' 414' ' ' LEU . 21.4 mtt180 -127.49 99.53 27.0 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.87 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.29 -15.37 42.29 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.446 2.097 . . . . 0.0 112.606 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -58.4 -33.34 69.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.019 0.438 . . . . 0.0 111.206 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . 0.419 HD12 ' CB ' ' A' ' 411' ' ' ARG . 1.1 mt -72.11 -34.11 68.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.494 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 23.4 t -67.28 -32.98 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.612 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -69.45 -25.6 64.18 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.029 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -90.75 -13.17 34.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.282 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 1.7 mtt -74.61 124.54 26.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.802 0.334 . . . . 0.0 111.088 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 419' ' ' THR . . . . . 0.421 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 10.2 p -61.29 158.25 38.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.107 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 2.5 Cg_endo -45.52 -56.0 3.11 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.547 2.165 . . . . 0.0 112.346 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -60.2 -38.89 84.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.004 0.43 . . . . 0.0 110.002 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -66.41 -33.85 76.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.222 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -64.85 -35.07 79.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.214 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -64.22 -46.36 84.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.61 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.04 -30.69 64.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.23 0.538 . . . . 0.0 110.603 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 426' ' ' TYR . . . . . 0.422 ' CE1' ' CG1' ' A' ' 408' ' ' VAL . 42.4 t80 -68.62 -48.37 64.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.254 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.6 mt -74.44 -33.56 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.473 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -58.91 -39.81 82.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.129 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.992 179.882 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.4 mm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.892 0.377 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.407 HG12 ' CG2' ' A' ' 408' ' ' VAL . 11.6 p -121.16 140.1 46.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.719 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 22.3 mmt -83.19 113.81 20.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.748 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.418 ' HB ' ' CD1' ' A' ' 403' ' ' PHE . 31.4 t -110.61 107.17 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.27 22.9 6.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.254 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 104.99 -20.33 38.68 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.919 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -97.18 145.29 29.37 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.612 0.244 . . . . 0.0 111.096 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.79 135.98 18.31 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.677 2.252 . . . . 0.0 112.503 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 403' ' ' PHE . . . . . 0.418 ' CD1' ' HB ' ' A' ' 398' ' ' VAL . 61.8 m-85 -148.52 156.98 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.687 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 51.3 m -73.49 138.46 45.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.605 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -58.04 -42.27 85.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.934 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.8 t -64.76 -37.37 87.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.85 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -64.69 -29.33 70.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.033 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.407 ' CG2' HG12 ' A' ' 396' ' ' VAL . 49.0 t -68.48 -47.67 76.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.054 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.4 t -62.89 -31.04 72.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.997 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -74.01 -27.07 60.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.977 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -124.41 85.34 55.87 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.787 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -51.68 -26.82 24.21 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.585 2.19 . . . . 0.0 112.338 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.2 -29.14 70.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.976 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 59.2 mt -65.98 -37.21 85.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.728 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 25.7 t -63.45 -37.78 80.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.951 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.41 -30.77 71.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.077 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -74.13 -23.61 59.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.074 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 418' ' ' MET . . . . . 0.401 ' CE ' HG23 ' A' ' 398' ' ' VAL . 3.5 mtt -72.65 129.08 37.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.986 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 419' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.5 p -64.08 170.74 3.11 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.258 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 65.5 Cg_exo -51.65 -55.96 3.45 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.256 1.971 . . . . 0.0 112.386 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -58.84 -40.54 84.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.429 . . . . 0.0 110.092 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -65.42 -34.41 78.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.237 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -64.26 -36.58 84.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.187 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -64.92 -45.24 86.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.557 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.88 -30.53 65.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.167 0.508 . . . . 0.0 110.633 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 426' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -69.15 -47.01 66.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.32 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 60.4 mt -76.28 -33.82 24.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.62 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.69 -43.13 94.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.143 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 71.5 mtm . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.972 -179.99 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.5 mm . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.053 0.454 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.41 ' CG1' HG22 ' A' ' 408' ' ' VAL . 14.7 p -120.46 143.34 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.733 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.4 mmt -89.5 113.79 25.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.774 0.321 . . . . 0.0 110.68 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 27.3 t -114.8 125.68 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.915 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.94 24.37 5.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.349 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.81 19.89 55.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.767 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -137.05 154.99 76.36 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.601 0.238 . . . . 0.0 110.843 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 402' ' ' PRO . . . . . 0.413 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 12.8 Cg_exo -69.86 135.77 31.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.6 2.2 . . . . 0.0 112.309 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 403' ' ' PHE . . . . . 0.413 ' CD1' ' O ' ' A' ' 402' ' ' PRO . 31.7 m-85 -150.56 155.71 39.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.461 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 17.2 p -80.32 135.2 36.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.731 0.301 . . . . 0.0 110.588 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 405' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 61.3 t80 -56.0 -39.62 72.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.007 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 m -64.02 -38.3 90.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -66.82 -29.52 69.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.14 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.419 HG11 ' CE1' ' A' ' 426' ' ' TYR . 50.7 t -67.25 -47.51 81.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.991 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.7 t -63.04 -31.93 73.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -73.76 -26.67 60.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.969 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -124.1 95.26 44.15 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.789 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.2 -25.46 80.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.484 2.122 . . . . 0.0 112.21 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -62.95 -28.36 70.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.922 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 62.5 mt -67.07 -40.56 87.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 39.1 t -62.88 -36.27 74.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.722 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.79 -29.28 69.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.929 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -80.35 -19.38 46.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.052 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 6.0 mtt -70.35 128.12 35.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.046 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 419' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 3.2 p -68.65 172.02 5.29 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.143 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.4 Cg_exo -53.04 -56.02 3.17 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.188 1.925 . . . . 0.0 112.233 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.23 -41.55 88.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.0 0.428 . . . . 0.0 109.973 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.77 -33.68 76.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.139 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -64.26 -38.29 90.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.16 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -65.51 -44.76 85.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.577 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.19 -29.92 66.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.136 0.493 . . . . 0.0 110.528 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 426' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 49.8 t80 -69.44 -47.12 65.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.202 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.4 mt -76.42 -33.81 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.53 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -65.86 -45.89 80.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.25 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 69.0 mtm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.929 -179.971 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.417 HD11 HG23 ' A' ' 395' ' ' ILE . 34.5 mm . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.924 0.392 . . . . 0.0 111.028 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.417 ' CG1' HG23 ' A' ' 408' ' ' VAL . 12.5 p -113.96 139.71 38.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.591 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 21.7 mmt -84.11 113.85 21.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.825 0.345 . . . . 0.0 110.815 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.419 ' HA ' ' HG2' ' A' ' 418' ' ' MET . 22.0 t -112.23 112.46 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.838 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.28 22.86 6.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.304 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.97 -16.0 57.67 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.826 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -100.58 148.23 34.69 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.691 0.281 . . . . 0.0 111.052 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.78 136.01 20.3 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.641 2.227 . . . . 0.0 112.472 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 403' ' ' PHE . . . . . 0.408 ' CD1' ' HB ' ' A' ' 398' ' ' VAL . 57.8 m-85 -149.23 156.34 41.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.68 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 15.7 p -79.98 137.6 36.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.504 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 405' ' ' TYR . . . . . 0.498 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 57.5 t80 -55.33 -34.83 64.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.126 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 93.4 p -64.2 -40.67 96.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -67.63 -30.32 69.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.178 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.433 ' CG1' ' CE1' ' A' ' 426' ' ' TYR . 45.7 t -66.08 -48.92 79.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.6 t -64.84 -30.57 71.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.008 0.432 . . . . 0.0 110.978 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -77.46 -26.13 51.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.061 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -124.4 84.16 56.79 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.816 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -51.69 -24.91 18.92 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.65 2.233 . . . . 0.0 112.38 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -61.78 -29.81 70.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.002 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 32.3 mt -67.95 -37.76 81.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.728 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 38.9 t -64.36 -35.6 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.765 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.74 -29.97 70.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.879 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -80.21 -19.41 47.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.935 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 418' ' ' MET . . . . . 0.419 ' HG2' ' HA ' ' A' ' 398' ' ' VAL . 4.3 mtt -70.45 124.95 25.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.037 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 17.3 p -61.04 163.18 10.65 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.348 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.07 -56.06 3.46 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.363 2.042 . . . . 0.0 112.382 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -59.49 -40.03 85.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.008 0.432 . . . . 0.0 110.0 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -65.11 -33.99 77.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.176 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -63.58 -37.96 89.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.158 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -64.93 -46.18 82.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.569 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.78 -29.5 64.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.16 0.505 . . . . 0.0 110.655 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 426' ' ' TYR . . . . . 0.498 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 63.3 t80 -69.72 -47.67 62.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.217 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.5 mt -75.23 -33.98 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.416 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.94 76.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.103 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 59.4 mtp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 179.948 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.9 mm . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.868 0.366 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.4 p -124.05 141.47 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 18.6 mmt -83.36 114.95 21.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.825 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.408 ' CG2' ' HB2' ' A' ' 403' ' ' PHE . 60.0 t -114.25 106.54 20.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.591 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 63.95 16.55 9.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.342 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 109.57 -22.39 24.31 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.073 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -99.0 149.76 36.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.85 0.357 . . . . 0.0 111.129 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.25 135.93 32.99 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.806 2.337 . . . . 0.0 113.012 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 403' ' ' PHE . . . . . 0.408 ' HB2' ' CG2' ' A' ' 398' ' ' VAL . 4.2 m-85 -139.32 172.17 13.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.696 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.89 130.45 39.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.457 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -54.24 -42.93 70.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.172 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 31.1 m -66.75 -34.85 78.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -67.62 -29.72 69.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.159 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.441 ' CG1' ' CE1' ' A' ' 426' ' ' TYR . 55.1 t -70.29 -47.46 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.058 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.9 t -61.6 -31.45 71.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.007 0.432 . . . . 0.0 111.036 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -75.9 -27.49 57.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.948 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -125.87 96.35 37.84 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.832 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.79 -23.94 74.49 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.465 2.11 . . . . 0.0 112.373 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -61.4 -29.25 69.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 110.954 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 16.4 mt -67.38 -36.42 81.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.708 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.2 -37.03 78.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.86 -28.58 68.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.015 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -76.7 -22.88 53.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.053 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 5.0 mtt -71.11 129.29 38.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.944 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 419' ' ' THR . . . . . 0.419 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.3 p -63.91 171.18 2.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.206 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.4 Cg_exo -52.66 -56.09 3.16 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.179 1.919 . . . . 0.0 112.188 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -60.48 -38.69 85.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -65.45 -34.23 77.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.133 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -64.34 -36.63 84.74 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.288 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -65.32 -44.36 88.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.597 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.76 -30.45 65.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.181 0.515 . . . . 0.0 110.528 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 426' ' ' TYR . . . . . 0.441 ' CE1' ' CG1' ' A' ' 408' ' ' VAL . 68.5 t80 -68.78 -47.57 65.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.31 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.2 mt -75.37 -34.03 29.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.532 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.77 -30.1 70.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.239 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 64.0 mtp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.04 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.7 mm . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.904 0.383 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.412 HG12 ' CG2' ' A' ' 408' ' ' VAL . 14.4 p -119.97 141.94 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.759 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 15.1 mmt -84.76 113.85 21.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.417 ' HA ' ' HG2' ' A' ' 418' ' ' MET . 18.7 t -114.81 113.01 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.944 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.86 23.9 5.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.306 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.85 56.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.804 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.61 146.38 31.73 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.732 0.301 . . . . 0.0 111.05 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.13 135.98 19.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.669 2.246 . . . . 0.0 112.529 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 403' ' ' PHE . . . . . 0.409 ' CD1' ' HB ' ' A' ' 398' ' ' VAL . 62.1 m-85 -148.12 156.26 42.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.682 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 17.3 p -74.82 138.59 42.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.58 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -56.88 -39.91 75.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.003 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.3 m -64.55 -38.21 90.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -65.87 -29.72 70.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.182 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.426 HG11 ' CE1' ' A' ' 426' ' ' TYR . 59.8 t -67.12 -46.3 84.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.946 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.7 p -65.02 -29.33 70.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.98 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -76.83 -26.14 53.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.947 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -123.7 95.03 45.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.801 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.02 -25.51 77.72 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.389 2.059 . . . . 0.0 112.252 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.34 -28.47 69.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.951 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 65.7 mt -66.57 -38.84 87.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.703 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.41 -36.17 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.735 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -64.62 -29.97 70.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.936 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -80.77 -18.25 48.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.974 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 418' ' ' MET . . . . . 0.417 ' HG2' ' HA ' ' A' ' 398' ' ' VAL . 5.3 mtt -72.71 126.44 29.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.176 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 2.8 p -69.14 172.57 4.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.049 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.71 -56.09 2.96 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.188 1.925 . . . . 0.0 112.226 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.33 -41.92 90.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.923 0.392 . . . . 0.0 110.028 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.05 -33.35 75.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.34 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -65.97 -36.62 83.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.308 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -65.03 -45.8 83.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.639 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.2 -29.48 65.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.11 0.481 . . . . 0.0 110.57 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 426' ' ' TYR . . . . . 0.426 ' CE1' HG11 ' A' ' 408' ' ' VAL . 43.9 t80 -69.82 -47.05 64.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.263 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.7 mt -76.44 -33.84 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.443 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -63.59 -45.88 88.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.127 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 179.962 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.4 mm . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.919 0.39 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.41 HG11 ' CG2' ' A' ' 408' ' ' VAL . 11.7 p -129.0 140.48 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.725 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 397' ' ' MET . . . . . 0.403 ' N ' HG23 ' A' ' 396' ' ' VAL . 18.2 mmt -81.04 113.72 19.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.669 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.408 ' HB ' ' CD1' ' A' ' 403' ' ' PHE . 23.2 t -115.68 110.44 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.57 23.31 5.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.295 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.19 -17.74 53.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.862 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 35.9 mtp85 -101.54 145.15 29.95 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.737 0.268 . . . . 0.0 111.095 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.29 135.92 19.16 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.689 2.259 . . . . 0.0 112.412 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 403' ' ' PHE . . . . . 0.408 ' CD1' ' HB ' ' A' ' 398' ' ' VAL . 62.0 m-85 -147.4 157.52 43.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.787 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 49.0 m -69.88 138.2 52.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.611 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -58.49 -41.59 85.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.979 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 95.4 p -66.25 -39.89 89.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.14 -29.22 69.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.131 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.423 HG13 ' CE1' ' A' ' 426' ' ' TYR . 49.4 t -68.46 -47.67 76.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.994 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.7 t -64.08 -30.12 71.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -75.71 -26.31 57.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.025 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -124.35 85.09 55.84 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.08 -27.25 28.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.611 2.207 . . . . 0.0 112.291 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -61.07 -29.27 69.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 63.3 mt -66.17 -37.54 85.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.761 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 37.5 t -63.68 -38.06 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.11 -28.48 68.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.066 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -80.05 -17.73 51.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.116 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 3.0 mtt -76.35 132.2 39.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.153 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 419' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 8.3 p -63.79 158.61 59.8 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.065 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 2.0 Cg_endo -45.05 -56.03 3.0 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.617 2.211 . . . . 0.0 112.257 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.25 -38.55 83.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.969 0.414 . . . . 0.0 109.956 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -66.0 -34.25 77.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.158 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -63.52 -36.16 82.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.205 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -64.57 -45.46 86.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.634 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -56.87 -31.04 64.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.131 0.491 . . . . 0.0 110.594 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 426' ' ' TYR . . . . . 0.423 ' CE1' HG13 ' A' ' 408' ' ' VAL . 47.4 t80 -68.45 -48.23 65.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.218 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.1 mt -74.05 -34.03 37.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.519 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.63 83.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.061 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 65.1 mtm . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.826 179.849 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . 0.407 HG21 HD12 ' A' ' 395' ' ' ILE . 33.6 mm . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.916 0.389 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.7 p -115.9 142.24 30.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.769 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.8 mmt -90.13 113.86 25.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.866 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 39.2 t -110.63 119.09 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.011 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.95 27.68 11.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.363 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.88 23.51 45.43 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.785 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 75.8 mtm-85 -137.01 151.68 72.53 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.602 0.239 . . . . 0.0 110.688 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 402' ' ' PRO . . . . . 0.412 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 57.7 Cg_endo -71.28 135.72 27.48 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.406 2.071 . . . . 0.0 112.411 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 403' ' ' PHE . . . . . 0.412 ' CD1' ' O ' ' A' ' 402' ' ' PRO . 35.1 m-85 -150.67 172.09 16.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.668 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 49.4 m -97.84 136.87 37.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.569 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 405' ' ' TYR . . . . . 0.428 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 41.3 t80 -57.11 -41.71 79.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.913 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.4 t -64.4 -39.57 94.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.843 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.86 -29.22 69.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.109 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.4 HG12 ' CE1' ' A' ' 426' ' ' TYR . 51.5 t -66.59 -47.49 83.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.016 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.0 p -64.45 -29.03 70.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.983 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -76.78 -25.65 53.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.01 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 38.7 mtt85 -124.76 85.57 56.89 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.794 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -51.79 -26.7 24.64 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.623 2.215 . . . . 0.0 112.295 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.61 -29.79 70.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.945 0.403 . . . . 0.0 111.009 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 67.7 mt -66.83 -36.86 83.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.74 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 43.2 t -64.71 -37.95 81.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.948 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -68.09 -28.39 67.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -77.3 -22.46 51.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.121 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 2.6 mtt -73.47 130.28 39.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 419' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.1 p -65.97 171.18 4.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.259 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 50.6 Cg_exo -53.91 -56.2 2.81 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.334 2.023 . . . . 0.0 112.418 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -58.33 -42.66 87.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.857 0.36 . . . . 0.0 110.216 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -65.96 -32.82 74.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.079 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -36.69 84.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.168 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -64.6 -45.82 85.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.59 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.11 -30.81 64.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.119 0.485 . . . . 0.0 110.536 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 426' ' ' TYR . . . . . 0.428 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 63.5 t80 -68.46 -48.27 64.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.273 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.4 mt -74.47 -33.82 34.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.434 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.05 87.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.144 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 68.8 mtm . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.891 179.894 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.4 mm . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.923 0.392 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.417 HG11 ' CG2' ' A' ' 408' ' ' VAL . 11.8 p -127.44 139.75 51.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.763 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 19.4 mmt -81.0 113.82 19.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.824 0.345 . . . . 0.0 110.82 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.3 110.27 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.03 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.02 24.38 4.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.28 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.9 -19.68 48.64 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.758 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -98.68 143.6 26.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.651 0.262 . . . . 0.0 110.958 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.56 135.91 16.79 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.651 2.234 . . . . 0.0 112.475 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 403' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -148.47 161.1 42.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.714 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 25.9 p -75.92 141.35 42.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.595 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -58.24 -40.8 82.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.908 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.7 t -63.59 -40.39 96.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -63.97 -28.79 70.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.418 HG11 ' CE1' ' A' ' 426' ' ' TYR . 37.7 t -70.32 -54.02 20.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.051 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 18.2 m -61.04 -30.17 70.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.94 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -76.19 -25.44 55.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.974 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -124.72 86.79 55.52 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.845 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -51.77 -25.51 21.05 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.559 2.173 . . . . 0.0 112.408 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -61.67 -30.7 70.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.934 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 30.5 mt -68.07 -36.94 80.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.679 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.51 -36.49 77.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.813 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.98 -28.07 67.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.035 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -81.47 -17.16 49.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.227 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 2.9 mtt -77.02 130.93 38.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.151 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 419' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.6 p -67.25 159.07 79.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.982 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 1.2 Cg_endo -44.14 -53.35 4.8 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.694 2.263 . . . . 0.0 112.497 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.27 -41.59 93.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 0.0 110.207 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.46 -33.76 76.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.248 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -65.0 -35.13 80.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.115 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -63.24 -46.27 87.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.637 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.42 -31.51 67.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.222 0.534 . . . . 0.0 110.755 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 426' ' ' TYR . . . . . 0.418 ' CE1' HG11 ' A' ' 408' ' ' VAL . 65.0 t80 -68.62 -46.01 70.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.207 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . 0.45 HD13 HG22 ' A' ' 427' ' ' ILE . 58.3 mt -76.42 -35.92 27.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.705 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -65.68 -35.19 80.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.932 0.396 . . . . 0.0 111.176 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 60.2 mtp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 179.943 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 34.4 mm . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.921 0.391 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.401 ' CG1' HG23 ' A' ' 408' ' ' VAL . 12.6 p -125.22 140.34 48.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.686 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.8 mmt -85.55 113.75 22.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.065 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.407 HG23 ' CE ' ' A' ' 418' ' ' MET . 34.6 t -111.03 120.08 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.851 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.73 23.25 6.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.466 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.81 21.02 37.85 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.825 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -137.11 149.67 66.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.563 0.22 . . . . 0.0 110.74 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 402' ' ' PRO . . . . . 0.426 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 18.2 Cg_exo -66.29 135.66 40.76 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.474 2.116 . . . . 0.0 112.338 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 403' ' ' PHE . . . . . 0.426 ' CD1' ' O ' ' A' ' 402' ' ' PRO . 17.3 m-85 -148.42 172.13 14.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 22.3 p -97.71 135.37 39.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.431 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 405' ' ' TYR . . . . . 0.499 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 45.8 t80 -56.98 -39.57 74.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.122 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.1 m -64.44 -39.7 94.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.093 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -68.24 -28.89 67.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.41 HG11 ' CE1' ' A' ' 426' ' ' TYR . 24.3 t -68.25 -55.97 14.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.068 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 1.4 m -59.23 -29.99 67.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -73.74 -26.26 60.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.861 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 41.4 mtt-85 -125.04 87.47 55.41 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.817 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.97 -26.43 18.46 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.535 2.157 . . . . 0.0 112.408 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.52 -28.52 69.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.031 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 68.6 mt -66.56 -39.58 88.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.845 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.5 -37.07 78.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.009 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -68.41 -28.85 67.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.034 0.445 . . . . 0.0 111.158 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -80.11 -19.71 46.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.119 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 418' ' ' MET . . . . . 0.407 ' CE ' HG23 ' A' ' 398' ' ' VAL . 2.8 mtt -75.46 133.33 41.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.055 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 419' ' ' THR . . . . . 0.433 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 6.7 p -62.63 158.41 50.86 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.015 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 2.6 Cg_endo -45.65 -52.85 6.27 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.624 2.216 . . . . 0.0 112.377 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -60.09 -43.38 95.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.925 0.393 . . . . 0.0 110.168 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -65.07 -33.25 75.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.196 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -64.66 -38.07 89.74 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.085 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -65.02 -45.24 86.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.588 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.34 -30.4 64.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.211 0.529 . . . . 0.0 110.712 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 426' ' ' TYR . . . . . 0.499 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 56.1 t80 -69.19 -47.89 63.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.248 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.0 mt -74.69 -33.72 32.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.497 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.66 -39.49 88.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.167 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 429' ' ' MET . . . . . 0.406 ' HE3' ' CD1' ' A' ' 405' ' ' TYR . 71.6 mtm . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.833 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.4 mm . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.933 0.397 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.422 ' CG1' HG21 ' A' ' 408' ' ' VAL . 11.4 p -117.7 139.34 45.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.688 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.3 mmt -86.9 113.85 23.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.95 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . 0.416 ' HB ' ' CD1' ' A' ' 403' ' ' PHE . 39.9 t -110.03 119.58 59.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.816 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 57.2 24.82 10.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.323 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 88.44 22.07 41.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.835 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 29.4 mtt-85 -136.94 150.71 70.51 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.607 0.242 . . . . 0.0 110.813 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 402' ' ' PRO . . . . . 0.434 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 17.7 Cg_exo -66.52 135.64 39.93 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.47 2.113 . . . . 0.0 112.372 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 403' ' ' PHE . . . . . 0.434 ' CD1' ' O ' ' A' ' 402' ' ' PRO . 17.9 m-85 -148.82 171.99 15.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.606 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 53.6 p -100.32 134.81 42.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.559 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 405' ' ' TYR . . . . . 0.481 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 28.3 t80 -56.03 -37.36 69.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 21.7 m -66.46 -41.63 88.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.099 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -66.28 -29.71 69.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 111.256 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.44 ' CG1' ' CE1' ' A' ' 426' ' ' TYR . 44.1 t -65.81 -48.91 80.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.102 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.1 p -64.49 -29.25 70.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -77.91 -25.91 48.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.02 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -124.1 85.76 54.51 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.87 -26.81 18.9 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.569 2.179 . . . . 0.0 112.398 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.31 -28.25 69.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.034 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 71.8 mt -66.48 -39.25 88.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.833 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 38.6 t -63.82 -38.15 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.78 -28.86 67.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.11 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -76.07 -22.88 55.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.053 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 2.8 mtt -74.21 133.68 42.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 419' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 3.8 p -66.69 171.25 4.59 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.11 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 51.1 Cg_exo -53.27 -56.06 3.08 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.247 1.965 . . . . 0.0 112.368 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.0 -41.53 87.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.072 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -65.83 -33.02 74.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.094 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -64.43 -37.21 86.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.1 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -65.4 -45.09 85.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.527 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -56.94 -30.53 64.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.21 0.528 . . . . 0.0 110.537 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 426' ' ' TYR . . . . . 0.481 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 64.3 t80 -68.49 -48.82 63.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.132 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 3.6 mt -73.14 -35.16 46.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.3 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -71.59 -29.23 64.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.065 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 57.7 mtp . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.899 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.9 mm . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.859 0.361 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 396' ' ' VAL . . . . . 0.412 ' CG1' HG21 ' A' ' 408' ' ' VAL . 13.4 p -116.16 137.61 49.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.732 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.1 mmt -85.74 113.94 22.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.04 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 33.2 t -114.92 123.87 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.928 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.66 26.88 11.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.23 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.44 22.63 56.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.647 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -137.07 153.34 75.11 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.665 0.269 . . . . 0.0 110.931 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -68.88 135.97 34.08 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.518 2.145 . . . . 0.0 112.339 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 403' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -146.65 171.54 14.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.686 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 50.8 m -97.48 129.71 44.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.619 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -52.29 -40.31 61.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.027 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 41.6 t -67.61 -35.26 78.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.738 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.87 -30.8 70.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.051 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 408' ' ' VAL . . . . . 0.417 HG12 ' CE1' ' A' ' 426' ' ' TYR . 81.9 t -69.83 -44.55 78.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.869 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 32.9 t -62.95 -30.91 71.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.989 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -75.48 -26.59 58.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.996 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 14.6 mtt85 -125.86 84.89 60.17 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.883 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.37 -24.99 23.0 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.597 2.198 . . . . 0.0 112.371 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -61.23 -29.31 69.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.976 0.417 . . . . 0.0 111.064 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 28.8 mt -66.39 -36.23 82.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.761 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.68 -37.71 80.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.4 70.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.035 0.445 . . . . 0.0 111.008 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -79.57 -21.18 45.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.0 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 418' ' ' MET . . . . . 0.424 ' HE3' ' CD1' ' A' ' 426' ' ' TYR . 7.3 mtt -69.19 123.72 21.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.033 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 419' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 7.0 p -61.53 167.77 3.94 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.172 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 420' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 62.4 Cg_exo -51.47 -56.07 3.36 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.288 1.992 . . . . 0.0 112.155 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -59.98 -39.84 87.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 109.882 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.11 -34.23 77.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.27 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -64.82 -36.66 85.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.197 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -64.27 -46.24 84.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.474 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.42 -30.49 66.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.167 0.508 . . . . 0.0 110.607 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 426' ' ' TYR . . . . . 0.424 ' CD1' ' HE3' ' A' ' 418' ' ' MET . 75.1 t80 -69.37 -46.42 66.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.259 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 427' ' ' ILE . . . . . 0.4 HG23 HD12 ' A' ' 427' ' ' ILE . 58.7 mt -77.19 -33.66 20.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.574 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -63.4 -38.38 90.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.249 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 60.0 mtm . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.935 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 52.0 t0 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.803 0.335 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -109.78 154.03 23.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.92 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -92.2 135.34 34.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -99.69 29.02 4.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.001 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -93.94 16.27 14.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.228 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -95.5 111.97 23.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.787 0.327 . . . . 0.0 110.834 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -132.6 139.89 48.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -114.29 126.51 55.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -143.66 153.96 43.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.98 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -152.13 79.94 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.915 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.2 t -137.27 128.98 41.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.054 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -175.88 147.51 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.162 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -81.16 140.82 34.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.812 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -60.91 139.95 93.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.48 166.05 30.31 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.494 2.129 . . . . 0.0 112.418 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.5 mm -104.41 135.01 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.034 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.422 ' CG1' HG23 ' A' ' 408' ' ' VAL . 13.8 p -115.57 142.57 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.803 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.6 mmt -90.81 113.83 26.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.808 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 38.1 t -111.75 120.92 63.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.981 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.23 27.34 9.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.439 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.48 23.51 46.99 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.731 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -137.02 152.27 73.61 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.669 0.271 . . . . 0.0 110.738 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.402 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 58.3 Cg_endo -71.73 135.84 26.74 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.454 2.103 . . . . 0.0 112.406 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 403' ' ' PHE . . . . . 0.402 ' CD1' ' O ' ' A' ' 402' ' ' PRO . 36.2 m-85 -150.52 172.04 16.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.674 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 24.8 p -98.59 136.9 38.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.552 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 405' ' ' TYR . . . . . 0.484 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 35.1 t80 -56.84 -39.31 74.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.032 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.1 m -64.73 -40.68 95.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -66.61 -29.54 69.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.192 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.422 HG23 ' CG1' ' A' ' 396' ' ' VAL . 48.1 t -68.14 -47.68 77.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.04 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 87.1 p -61.39 -30.39 70.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.941 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -74.07 -26.88 60.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.893 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -125.6 94.89 41.63 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.75 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.31 -23.1 76.36 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.462 2.108 . . . . 0.0 112.367 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.71 -29.05 70.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 30.2 mt -65.09 -38.48 90.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.721 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.4 t -62.61 -39.85 86.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.965 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.1 -27.57 67.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.128 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -80.87 -20.5 42.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.165 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 3.0 mtt -73.64 131.85 42.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.955 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 6.4 p -63.13 167.37 6.43 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.356 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.4 -56.07 3.22 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.31 2.007 . . . . 0.0 112.187 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 54.4 mp0 -59.67 -40.17 86.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.01 0.433 . . . . 0.0 109.946 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -65.3 -33.78 76.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.183 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -65.16 -36.75 85.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.199 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -65.0 -45.45 85.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.528 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.31 -30.37 64.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.147 0.499 . . . . 0.0 110.567 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 426' ' ' TYR . . . . . 0.484 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 58.4 t80 -68.87 -48.05 64.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.223 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.2 mt -75.13 -33.54 29.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.512 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.65 -43.0 99.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.208 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 429' ' ' MET . . . . . 0.4 ' HE2' ' CD1' ' A' ' 405' ' ' TYR . 68.9 mtm -60.43 -37.75 81.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.948 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.66 -44.9 96.49 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.527 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -64.64 -38.6 91.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.777 0.322 . . . . 0.0 110.927 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -60.48 -39.01 86.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.019 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 70.2 mtm -75.08 -25.94 58.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.237 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -99.9 29.8 4.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.017 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -79.87 -21.21 44.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.263 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -145.06 80.51 1.62 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.965 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 3.8 mp -148.51 80.6 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -104.07 132.77 49.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.961 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.939 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.777 0.322 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -103.15 136.38 43.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.958 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.55 143.33 42.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.966 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -97.49 142.39 29.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.885 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -59.69 -38.81 82.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -135.17 164.35 27.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.838 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -133.09 80.01 1.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -121.84 152.3 39.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.821 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -150.82 -65.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -108.39 135.32 49.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.952 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.1 t -125.77 135.07 65.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.135 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -147.65 150.99 35.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.123 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -105.13 154.32 20.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.97 149.86 40.61 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.07 160.75 48.51 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.565 2.177 . . . . 0.0 112.351 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.9 mm -84.83 148.7 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.111 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.403 HG12 ' CG2' ' A' ' 408' ' ' VAL . 12.0 p -127.48 141.07 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.742 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 16.1 mmt -84.26 113.68 21.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.825 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.407 ' HB ' ' CD1' ' A' ' 403' ' ' PHE . 32.8 t -111.76 108.6 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.808 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.76 22.54 7.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.256 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.83 -17.48 49.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.931 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 -100.21 146.04 31.27 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.678 0.275 . . . . 0.0 111.047 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.79 135.92 20.16 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.649 2.233 . . . . 0.0 112.494 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 403' ' ' PHE . . . . . 0.407 ' CD1' ' HB ' ' A' ' 398' ' ' VAL . 57.4 m-85 -148.33 158.75 44.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.751 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 18.0 p -76.92 137.8 39.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.646 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 405' ' ' TYR . . . . . 0.493 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 57.6 t80 -57.58 -40.57 79.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.948 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.0 m -63.49 -39.02 93.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -66.11 -29.39 69.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.403 ' CG2' HG12 ' A' ' 396' ' ' VAL . 57.1 t -67.41 -46.94 82.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.963 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.8 p -64.22 -29.3 70.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.026 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -75.89 -26.2 56.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.919 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 35.9 mtt-85 -124.0 97.2 41.24 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.824 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.72 -25.59 78.95 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.345 2.03 . . . . 0.0 112.272 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -62.84 -28.47 70.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 68.7 mt -66.05 -40.24 90.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.846 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.4 -38.38 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.969 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.88 67.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.073 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -79.07 -19.1 52.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.114 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 3.5 mtt -74.41 129.3 37.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.067 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 419' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 8.7 p -61.69 158.07 43.85 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.208 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 3.0 Cg_endo -45.79 -56.07 3.11 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.661 2.241 . . . . 0.0 112.244 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.1 -38.42 82.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 0.0 109.937 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -66.05 -34.53 78.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.159 179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -63.23 -36.22 82.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.116 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -64.84 -43.12 94.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.474 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -59.5 -31.69 69.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.193 0.52 . . . . 0.0 110.473 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 426' ' ' TYR . . . . . 0.493 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 57.2 t80 -67.78 -45.1 75.81 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.282 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . 0.407 HG23 HD13 ' A' ' 427' ' ' ILE . 61.9 mt -79.46 -33.76 15.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.794 -179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -68.39 -43.26 77.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.336 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 49.4 mtm -56.31 -35.0 67.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.14 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.38 -46.8 93.3 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.489 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -71.13 -36.64 72.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.772 0.32 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -56.23 -32.46 64.48 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.13 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 73.3 mtm -59.27 -25.37 64.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.167 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -117.42 14.73 14.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.423 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -80.01 -23.99 41.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.744 0.307 . . . . 0.0 111.151 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -157.84 86.1 0.91 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.034 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 20.5 mt -158.08 87.07 0.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -103.24 131.73 50.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.883 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.909 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 47.1 p30 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.826 0.346 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -101.69 142.26 33.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -79.98 150.54 30.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -79.81 -37.55 34.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.961 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -175.87 -46.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.984 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -158.02 163.61 37.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -100.64 163.33 12.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -89.6 132.67 35.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -105.13 142.13 35.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -103.16 146.07 28.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 p -126.86 142.17 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.08 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -110.46 156.73 20.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.02 162.11 25.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.813 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -60.92 142.72 92.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.918 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.33 165.19 33.21 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.599 2.199 . . . . 0.0 112.366 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.0 mm -99.66 148.64 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.977 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.424 HG13 ' CG2' ' A' ' 408' ' ' VAL . 14.7 p -124.92 142.48 41.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.86 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 15.2 mmt -85.83 113.81 22.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.647 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 12.6 t -118.75 114.56 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.95 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.41 22.67 6.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.268 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.33 -17.36 57.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.872 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -100.69 146.24 31.73 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.722 0.296 . . . . 0.0 111.032 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.77 135.98 16.47 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.661 2.241 . . . . 0.0 112.525 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 403' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -148.18 157.73 43.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.771 179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 49.4 m -71.38 139.98 49.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.527 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -58.01 -40.95 82.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.994 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.3 t -65.86 -38.81 89.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.64 -29.9 70.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.424 ' CG2' HG13 ' A' ' 396' ' ' VAL . 60.3 t -68.76 -46.3 79.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.004 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.5 p -63.14 -28.94 70.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -74.31 -26.25 60.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.019 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -124.35 87.18 54.19 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.859 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -51.8 -27.21 26.33 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.6 2.2 . . . . 0.0 112.36 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.24 -28.29 69.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 69.5 mt -66.57 -38.75 87.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.788 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.25 -37.72 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.02 -28.57 68.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.014 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -79.68 -17.63 53.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.141 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 7.6 mtt -72.64 132.21 43.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.199 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 419' ' ' THR . . . . . 0.417 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 2.9 p -74.6 173.08 7.27 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.066 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.417 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.4 Cg_exo -52.94 -55.98 3.23 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.169 1.912 . . . . 0.0 112.264 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -59.83 -40.19 87.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.01 0.433 . . . . 0.0 109.931 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -65.29 -34.23 77.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.229 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -64.49 -36.84 85.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.148 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -63.63 -47.18 82.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.615 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -59.59 -29.71 68.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.12 0.486 . . . . 0.0 110.578 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 426' ' ' TYR . . . . . 0.417 ' CE1' HG11 ' A' ' 408' ' ' VAL . 85.1 t80 -70.11 -45.14 67.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.162 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 57.7 mt -77.92 -35.55 20.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.695 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.76 83.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.827 0.346 . . . . 0.0 111.082 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 76.3 mtp -61.86 -37.29 83.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.22 -36.78 90.24 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.42 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.92 -38.83 83.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -64.99 -32.88 74.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.948 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 87.5 mtp -59.02 -25.59 63.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.135 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -79.91 -6.95 58.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.432 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -79.85 -21.97 43.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.709 0.29 . . . . 0.0 111.119 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -153.41 84.72 1.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.942 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.25 83.69 1.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.832 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -109.19 135.98 49.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.887 -179.942 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.809 0.337 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -80.05 141.07 36.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -117.98 150.44 39.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.85 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -102.63 -72.66 0.68 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.009 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.33 -41.3 93.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -92.75 118.02 30.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -124.52 136.21 53.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.838 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -122.61 154.33 38.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -107.16 139.34 41.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -116.31 153.81 31.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.914 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 p -131.78 141.9 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.07 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -63.75 147.65 51.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -79.94 135.82 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.05 157.06 87.41 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.96 163.66 32.88 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.604 2.203 . . . . 0.0 112.284 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.8 mm -95.37 147.65 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.089 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.416 HG11 ' CG2' ' A' ' 408' ' ' VAL . 12.4 p -129.59 141.94 45.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.906 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 397' ' ' MET . . . . . 0.4 ' N ' HG23 ' A' ' 396' ' ' VAL . 17.8 mmt -82.58 113.76 20.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.817 0.341 . . . . 0.0 110.629 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.412 ' HB ' ' CD1' ' A' ' 403' ' ' PHE . 22.0 t -117.87 112.73 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.965 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.36 23.46 5.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.283 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.11 -15.63 59.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.801 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -103.55 145.82 31.32 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.735 0.303 . . . . 0.0 111.046 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.4 136.03 19.1 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.628 2.219 . . . . 0.0 112.455 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 403' ' ' PHE . . . . . 0.412 ' CD1' ' HB ' ' A' ' 398' ' ' VAL . 64.0 m-85 -147.1 156.9 43.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.751 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 50.0 m -69.04 137.75 53.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.645 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -58.16 -43.3 87.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.958 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.0 t -64.89 -37.44 87.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.19 -29.46 70.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.424 HG13 ' CE1' ' A' ' 426' ' ' TYR . 53.2 t -69.8 -47.36 70.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.999 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.2 p -64.49 -29.04 70.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.022 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -76.76 -26.35 54.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.974 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -124.16 85.29 55.03 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -51.58 -26.77 23.35 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.595 2.197 . . . . 0.0 112.344 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.0 -28.36 69.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 70.0 mt -66.11 -36.75 83.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.797 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 39.7 t -63.92 -38.88 83.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.961 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.76 -28.86 68.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.113 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -76.56 -22.08 54.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.094 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 4.1 mtt -72.72 130.08 39.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.939 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 419' ' ' THR . . . . . 0.401 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 3.9 p -65.76 171.49 3.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.072 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.401 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 50.2 Cg_exo -53.36 -56.07 3.05 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.196 1.93 . . . . 0.0 112.154 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.01 -37.82 83.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.018 0.437 . . . . 0.0 109.842 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -66.94 -33.38 75.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.249 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -34.08 77.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.203 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -64.5 -45.62 86.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.65 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.07 -30.92 64.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.145 0.498 . . . . 0.0 110.653 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 426' ' ' TYR . . . . . 0.424 ' CE1' HG13 ' A' ' 408' ' ' VAL . 63.8 t80 -68.51 -48.37 64.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.088 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 3.2 mt -73.2 -35.44 47.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.565 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -65.42 -49.14 70.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.173 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 71.5 mtm -62.12 -36.93 83.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.844 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.43 -35.92 87.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.445 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.02 -40.37 89.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.331 . . . . 0.0 110.843 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -66.24 -32.02 73.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.884 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 94.2 mmm -58.52 -24.2 59.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.139 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 434' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 434' ' ' PHE . 68.2 t80 -94.56 20.58 8.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -79.98 -23.51 41.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.802 0.334 . . . . 0.0 111.023 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -143.21 80.03 1.66 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.787 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.87 82.1 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.823 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -124.69 161.36 26.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 50.2 mp0 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.9 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.804 0.335 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -110.77 158.72 18.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -97.57 154.37 17.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 50.2 mp0 -79.98 85.13 5.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -135.76 160.93 37.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -103.86 154.27 19.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -122.23 153.43 38.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -101.64 125.9 48.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.843 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -132.03 141.15 49.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -99.12 130.61 45.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.926 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.2 133.85 67.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.157 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -109.75 151.55 26.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.993 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -79.99 89.44 5.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.08 163.79 27.71 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.38 152.59 78.75 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.591 2.194 . . . . 0.0 112.284 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.3 mm -71.71 152.27 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.11 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.406 HG12 ' CG2' ' A' ' 408' ' ' VAL . 13.9 p -131.43 142.11 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.893 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 17.2 mmt -84.47 113.7 21.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.597 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 22.3 t -118.18 113.6 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.977 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.62 23.17 5.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.295 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.43 -13.82 61.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.956 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 6.8 mtt85 -104.75 146.3 32.37 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.722 0.296 . . . . 0.0 110.991 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.04 136.0 17.85 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.667 2.245 . . . . 0.0 112.526 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 403' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -147.65 158.92 44.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.738 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 63.6 m -71.34 138.76 49.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.694 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -58.25 -43.72 88.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 m -64.69 -38.06 89.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.919 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.73 -29.31 70.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.419 HG11 ' CE1' ' A' ' 426' ' ' TYR . 60.4 t -70.65 -46.79 67.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.012 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.8 t -63.09 -31.28 72.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.026 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -73.87 -26.72 60.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.001 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -123.77 96.75 42.55 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.785 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.22 -25.94 77.21 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.393 2.062 . . . . 0.0 112.299 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -62.75 -28.61 70.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.95 -38.11 85.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.731 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 35.7 t -63.65 -37.81 80.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.847 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.88 -29.05 68.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.993 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -76.24 -22.06 55.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.063 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 3.8 mtt -71.88 129.56 38.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 4.9 p -64.3 169.95 4.2 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.145 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -53.14 -56.05 3.12 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.155 1.904 . . . . 0.0 112.161 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 54.2 mp0 -60.69 -38.31 84.56 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -65.99 -34.61 78.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.288 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -65.26 -34.76 79.11 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.226 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -64.76 -44.7 89.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.76 -30.4 67.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.222 0.534 . . . . 0.0 110.631 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 426' ' ' TYR . . . . . 0.419 ' CE1' HG11 ' A' ' 408' ' ' VAL . 76.4 t80 -69.38 -45.95 68.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.294 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.8 -33.77 19.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.751 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.43 -36.16 77.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.341 . . . . 0.0 111.227 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 67.4 mtm -59.61 -35.27 74.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.942 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.14 -43.51 95.26 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.428 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -65.39 -36.98 85.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 0.0 110.801 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -61.95 -30.43 70.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 95.9 mmm -57.51 -27.82 62.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.1 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -79.97 -17.97 51.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.172 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -79.89 -18.06 51.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.266 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -143.27 79.95 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.859 0.362 . . . . 0.0 110.948 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 8.1 mt -148.26 79.91 1.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.902 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -123.76 146.29 48.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.299 -0.857 . . . . 0.0 110.881 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.806 0.336 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -110.74 145.7 37.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.942 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -113.53 135.89 53.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -122.56 139.89 53.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -133.15 27.38 4.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.047 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -159.19 162.44 36.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -82.54 122.06 27.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -107.9 132.4 53.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.927 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -111.23 148.75 32.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -113.12 155.64 24.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.934 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 7.7 p -107.13 79.88 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.043 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . 58.4 164.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 48.2 p30 -102.24 173.66 6.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.919 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.01 144.63 90.51 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.897 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.26 161.68 44.87 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.574 2.182 . . . . 0.0 112.307 -179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.3 mm -98.84 137.27 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.088 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.417 ' CG1' HG23 ' A' ' 408' ' ' VAL . 13.6 p -114.02 135.52 53.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.751 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 16.8 mmt -83.77 113.86 21.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.845 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.429 ' HB ' ' CD2' ' A' ' 403' ' ' PHE . 15.1 t -117.61 118.21 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.943 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.4 22.7 6.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.259 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.59 -14.01 64.7 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.905 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -100.82 147.79 34.15 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.788 0.328 . . . . 0.0 111.011 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.22 136.01 19.42 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.67 2.247 . . . . 0.0 112.375 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 403' ' ' PHE . . . . . 0.429 ' CD2' ' HB ' ' A' ' 398' ' ' VAL . 77.4 m-85 -147.14 168.41 21.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.72 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 55.5 m -88.66 136.82 32.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.675 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 405' ' ' TYR . . . . . 0.445 ' CD2' ' CE ' ' A' ' 433' ' ' MET . 42.2 t80 -53.55 -41.67 66.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 0.0 110.988 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 26.4 m -67.96 -34.17 76.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.811 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -67.18 -31.25 71.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.051 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.417 HG23 ' CG1' ' A' ' 396' ' ' VAL . 84.9 t -67.8 -43.19 86.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.829 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.9 p -63.39 -29.79 71.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.073 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -74.44 -27.96 60.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.934 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 11.3 mtt-85 -124.57 92.99 47.08 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.823 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.13 -23.1 75.25 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.451 2.101 . . . . 0.0 112.411 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -62.47 -29.25 70.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.938 0.399 . . . . 0.0 110.982 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 25.7 mt -66.47 -35.98 81.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.722 179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.9 t -62.89 -36.23 74.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -64.4 -29.13 70.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.944 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -81.1 -19.76 42.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.076 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 418' ' ' MET . . . . . 0.404 ' HG2' ' HA ' ' A' ' 398' ' ' VAL . 6.3 mtt -70.36 124.41 24.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.025 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 5.3 p -63.65 171.01 2.54 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.115 179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.5 -56.14 2.74 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.109 1.872 . . . . 0.0 112.118 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.77 -39.79 90.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.018 0.437 . . . . 0.0 109.844 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -65.49 -33.41 75.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.234 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 54.9 tttm -65.18 -36.68 84.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.24 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -64.89 -45.87 84.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.597 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.08 -30.18 64.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.151 0.5 . . . . 0.0 110.647 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 426' ' ' TYR . . . . . 0.412 ' CE1' HG12 ' A' ' 408' ' ' VAL . 46.8 t80 -69.17 -48.31 62.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.165 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.2 mt -74.52 -33.69 33.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.434 -179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.27 -43.97 98.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.121 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 69.8 mtm -62.94 -37.25 86.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.932 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.99 -39.68 94.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.619 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -61.66 -40.72 95.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.961 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -64.44 -38.35 90.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.002 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 433' ' ' MET . . . . . 0.445 ' CE ' ' CD2' ' A' ' 405' ' ' TYR . 65.4 mtt -61.36 -29.01 69.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.066 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 434' ' ' PHE . . . . . 0.4 ' O ' ' CD2' ' A' ' 434' ' ' PHE . 58.2 t80 -99.02 25.02 7.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.044 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -79.93 -23.93 41.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.116 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.7 t0 -159.89 87.81 0.81 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 88.8 mt -143.85 79.97 1.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.931 179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -113.95 139.35 49.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.905 179.919 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.764 0.316 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -108.19 147.13 31.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -153.04 -72.04 0.14 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -154.81 54.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -96.15 21.14 9.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.155 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -104.35 154.2 20.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -79.88 150.75 30.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -119.45 152.21 37.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -127.34 155.95 42.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.99 155.47 20.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.9 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 30.6 t -111.24 136.18 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.089 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -136.88 158.19 45.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -80.65 115.61 20.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.89 163.65 57.0 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.916 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.86 155.26 68.67 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.573 2.182 . . . . 0.0 112.302 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.9 mm -76.25 145.12 10.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.414 HG12 ' CG2' ' A' ' 408' ' ' VAL . 14.6 p -125.75 141.07 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.69 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 17.9 mmt -82.21 113.89 20.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.88 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.429 ' HA ' ' HG2' ' A' ' 418' ' ' MET . 21.5 t -116.16 111.42 35.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.971 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.94 23.92 5.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.288 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.4 -19.25 51.69 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.752 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -99.61 145.32 29.91 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 111.012 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.06 135.93 19.61 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.679 2.253 . . . . 0.0 112.425 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 403' ' ' PHE . . . . . 0.417 ' CD1' ' HB ' ' A' ' 398' ' ' VAL . 59.1 m-85 -147.04 155.65 42.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.79 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 10.9 p -75.97 137.37 40.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.51 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 405' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 55.2 t80 -55.21 -34.63 64.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.018 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 21.8 m -63.88 -38.13 89.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.985 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -69.84 -29.73 67.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.063 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.437 ' CG1' ' CE1' ' A' ' 426' ' ' TYR . 43.4 t -68.97 -49.33 64.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.02 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.9 p -66.86 -28.99 68.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.98 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -82.14 -23.58 35.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.106 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 21.7 mtt-85 -123.49 84.71 52.72 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -51.76 -25.51 20.97 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.626 2.217 . . . . 0.0 112.33 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -60.98 -36.21 78.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 72.1 mt -60.84 -40.75 94.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.888 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.46 -35.95 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.808 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.47 69.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -81.59 -16.72 50.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.044 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 418' ' ' MET . . . . . 0.429 ' HG2' ' HA ' ' A' ' 398' ' ' VAL . 3.7 mtt -72.01 127.1 31.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.162 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 1.3 p -66.75 166.7 17.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.173 179.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -50.79 -56.24 3.28 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.26 1.974 . . . . 0.0 112.324 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.25 -39.84 88.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 109.975 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.8 -33.4 75.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.217 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -64.92 -36.42 84.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.142 179.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -64.72 -46.22 83.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.512 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.55 -30.29 65.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.137 0.494 . . . . 0.0 110.591 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 426' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 50.9 t80 -69.05 -47.75 64.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.275 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.6 mt -75.33 -33.64 28.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.464 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.16 96.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.073 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 71.2 mtm -62.85 -37.66 87.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.833 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.33 95.99 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.447 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.34 -37.94 82.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.84 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 42.0 mmt180 -62.14 -35.09 77.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.969 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.64 -27.61 66.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.061 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -81.0 -2.37 47.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.414 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -79.96 -23.74 41.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.742 0.306 . . . . 0.0 111.195 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -150.4 81.55 1.36 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 21.7 mt -156.89 86.58 0.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.926 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -129.59 161.89 29.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.884 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.827 0.346 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -111.58 147.56 35.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -99.81 28.39 4.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.961 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -99.23 -59.11 1.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.023 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -104.09 22.94 13.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.104 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -90.21 118.47 29.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.904 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -96.07 150.11 20.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -129.28 157.11 42.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -124.43 138.89 54.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.83 132.58 45.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.9 p -137.05 143.29 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.175 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -100.52 141.24 33.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.026 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -82.45 113.51 20.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -71.73 147.52 91.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.948 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.27 155.02 70.84 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.553 2.169 . . . . 0.0 112.292 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.4 mm -97.12 148.82 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.066 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.4 p -132.75 142.52 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.771 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 5.3 mmt -86.65 113.83 22.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 110.889 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 29.5 t -112.8 118.73 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.95 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.07 23.53 5.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.435 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.33 19.58 41.43 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.853 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -136.97 146.45 54.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.668 0.234 . . . . 0.0 110.89 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.441 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 17.1 Cg_exo -66.81 135.62 38.89 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.439 2.093 . . . . 0.0 112.319 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 403' ' ' PHE . . . . . 0.441 ' CD1' ' O ' ' A' ' 402' ' ' PRO . 20.6 m-85 -149.44 156.04 41.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.64 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 56.2 m -76.27 133.79 39.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.704 0.288 . . . . 0.0 110.572 179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -56.23 -41.56 75.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.006 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.9 m -64.57 -36.13 83.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.799 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.45 -29.13 68.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.144 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.442 ' CG1' ' CE1' ' A' ' 426' ' ' TYR . 48.7 t -66.49 -47.89 82.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.013 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.1 p -64.14 -29.2 70.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.005 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -81.71 -25.3 35.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.966 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -122.94 91.33 49.87 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.813 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.36 -22.42 74.07 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.5 2.133 . . . . 0.0 112.419 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -61.9 -30.23 70.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.983 0.421 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 20.7 mt -68.67 -36.77 78.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.597 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 22.5 t -64.94 -35.97 76.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.777 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.35 -26.0 66.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.083 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -92.16 -0.5 57.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.358 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -87.47 125.9 34.57 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.74 0.305 . . . . 0.0 111.179 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 419' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 14.5 p -61.38 160.64 22.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.321 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 6.9 Cg_endo -49.11 -53.16 7.45 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.55 2.167 . . . . 0.0 112.246 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -60.02 -42.76 95.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 110.159 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -65.57 -32.91 74.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.162 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 16.9 tptm -65.03 -37.21 86.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.175 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -64.6 -46.26 83.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.546 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.54 -30.22 65.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.17 0.51 . . . . 0.0 110.585 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 426' ' ' TYR . . . . . 0.442 ' CE1' ' CG1' ' A' ' 408' ' ' VAL . 46.9 t80 -69.0 -47.95 64.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.259 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.7 mt -75.13 -33.67 29.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.452 -179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -59.75 -42.87 94.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.132 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 69.1 mtm -62.03 -38.2 87.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.93 -36.73 91.1 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.479 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -60.31 -37.07 79.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.33 . . . . 0.0 110.952 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -60.38 -40.09 89.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 65.0 mtt -62.96 -28.47 70.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.014 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -116.91 30.56 7.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.957 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -79.78 -23.96 41.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.073 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -143.62 79.93 1.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.56 87.46 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -106.61 132.39 52.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.224 -0.894 . . . . 0.0 110.919 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.867 0.365 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -104.2 147.16 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -97.35 28.65 3.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.05 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.96 -36.06 36.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -59.09 -38.06 78.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.951 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -85.3 112.73 21.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -126.84 143.59 51.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.48 135.51 47.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.848 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.01 -37.57 33.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -128.62 124.75 36.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.4 t -133.2 133.01 58.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -152.12 148.0 27.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.105 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -109.53 152.09 25.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.51 146.46 98.96 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.02 151.8 77.3 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.548 2.166 . . . . 0.0 112.182 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 41.0 mm -95.49 144.73 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.061 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.405 ' CG1' HG21 ' A' ' 408' ' ' VAL . 14.8 p -130.24 143.26 41.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 18.3 mmt -87.18 113.83 23.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.704 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 21.3 t -117.25 118.66 59.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 51.41 26.41 3.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.478 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 89.15 20.49 45.69 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.823 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -137.06 143.22 41.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.681 0.277 . . . . 0.0 110.693 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.17 135.92 23.61 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.439 2.093 . . . . 0.0 112.611 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 403' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -150.49 154.26 37.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.687 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 13.3 p -69.72 136.02 50.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.59 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -56.2 -39.77 72.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.062 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.6 m -64.3 -36.43 84.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.979 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -66.11 -30.95 71.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.095 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.422 ' CG1' ' CE1' ' A' ' 426' ' ' TYR . 44.6 t -70.9 -48.93 53.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.9 t -62.56 -31.77 72.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.998 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -81.66 -25.7 35.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.053 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . 0.419 ' CB ' HD12 ' A' ' 414' ' ' LEU . 21.4 mtt180 -127.49 99.53 27.0 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.87 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.29 -15.37 42.29 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.446 2.097 . . . . 0.0 112.606 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -58.4 -33.34 69.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.019 0.438 . . . . 0.0 111.206 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . 0.419 HD12 ' CB ' ' A' ' 411' ' ' ARG . 1.1 mt -72.11 -34.11 68.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.494 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 23.4 t -67.28 -32.98 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.612 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -69.45 -25.6 64.18 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.029 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -90.75 -13.17 34.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.282 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 1.7 mtt -74.61 124.54 26.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.802 0.334 . . . . 0.0 111.088 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 419' ' ' THR . . . . . 0.421 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 10.2 p -61.29 158.25 38.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.107 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.421 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 2.5 Cg_endo -45.52 -56.0 3.11 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.547 2.165 . . . . 0.0 112.346 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -60.2 -38.89 84.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.004 0.43 . . . . 0.0 110.002 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -66.41 -33.85 76.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.222 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -64.85 -35.07 79.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.214 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -64.22 -46.36 84.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.61 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.04 -30.69 64.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.23 0.538 . . . . 0.0 110.603 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 426' ' ' TYR . . . . . 0.422 ' CE1' ' CG1' ' A' ' 408' ' ' VAL . 42.4 t80 -68.62 -48.37 64.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.254 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.6 mt -74.44 -33.56 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.473 -179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -58.91 -39.81 82.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.129 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 66.9 mtm -63.39 -38.29 90.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.992 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.66 -40.06 94.26 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.645 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.35 -39.34 90.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 110.909 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 26.8 mmt85 -64.18 -36.91 85.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.006 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 97.0 mmm -61.58 -27.54 68.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.146 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 434' ' ' PHE . . . . . 0.419 ' CD2' HD12 ' A' ' 437' ' ' LEU . 2.2 t80 -122.74 31.27 6.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.903 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -79.86 -24.35 41.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.176 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -144.78 80.17 1.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.977 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . 0.419 HD12 ' CD2' ' A' ' 434' ' ' PHE . 93.9 mt -146.65 80.0 1.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.894 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -127.08 155.91 42.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.934 -179.923 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.838 0.351 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -104.55 135.81 45.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -117.33 135.94 53.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -138.71 154.68 48.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -129.59 -66.22 0.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -80.0 134.8 36.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -129.68 148.61 51.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 55.5 p90 -136.03 157.85 45.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -101.24 -53.46 3.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -112.92 154.86 25.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.93 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 31.1 t -110.58 130.38 64.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.051 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -111.2 147.83 34.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -80.0 131.61 35.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -121.03 150.38 53.2 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.926 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.4 164.63 34.47 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.59 2.193 . . . . 0.0 112.352 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.4 mm -100.32 143.17 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.407 HG12 ' CG2' ' A' ' 408' ' ' VAL . 11.6 p -121.16 140.1 46.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.719 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 22.3 mmt -83.19 113.81 20.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.748 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.418 ' HB ' ' CD1' ' A' ' 403' ' ' PHE . 31.4 t -110.61 107.17 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.27 22.9 6.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.254 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 104.99 -20.33 38.68 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.919 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -97.18 145.29 29.37 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.612 0.244 . . . . 0.0 111.096 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.79 135.98 18.31 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.677 2.252 . . . . 0.0 112.503 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 403' ' ' PHE . . . . . 0.418 ' CD1' ' HB ' ' A' ' 398' ' ' VAL . 61.8 m-85 -148.52 156.98 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.687 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 51.3 m -73.49 138.46 45.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.605 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -58.04 -42.27 85.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.934 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.8 t -64.76 -37.37 87.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.85 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -64.69 -29.33 70.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.033 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.407 ' CG2' HG12 ' A' ' 396' ' ' VAL . 49.0 t -68.48 -47.67 76.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.054 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.4 t -62.89 -31.04 72.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.997 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -74.01 -27.07 60.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.977 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -124.41 85.34 55.87 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.787 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -51.68 -26.82 24.21 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.585 2.19 . . . . 0.0 112.338 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.2 -29.14 70.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.976 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 59.2 mt -65.98 -37.21 85.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.728 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 25.7 t -63.45 -37.78 80.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.951 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.41 -30.77 71.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.077 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -74.13 -23.61 59.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.074 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 418' ' ' MET . . . . . 0.401 ' CE ' HG23 ' A' ' 398' ' ' VAL . 3.5 mtt -72.65 129.08 37.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.986 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 419' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.5 p -64.08 170.74 3.11 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.258 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 65.5 Cg_exo -51.65 -55.96 3.45 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.256 1.971 . . . . 0.0 112.386 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -58.84 -40.54 84.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.429 . . . . 0.0 110.092 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -65.42 -34.41 78.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.237 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -64.26 -36.58 84.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.187 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -64.92 -45.24 86.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.557 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.88 -30.53 65.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.167 0.508 . . . . 0.0 110.633 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 426' ' ' TYR . . . . . . . . . . . . . 79.0 t80 -69.15 -47.01 66.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.32 179.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 60.4 mt -76.28 -33.82 24.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.62 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.69 -43.13 94.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.143 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 71.5 mtm -62.27 -40.86 97.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.972 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.83 -42.59 98.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.573 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -62.5 -32.55 73.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.862 0.363 . . . . 0.0 110.958 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -75.23 -28.61 59.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.791 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 62.7 mtt -59.11 -25.47 63.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.219 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.74 27.6 3.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.095 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -80.07 -26.45 39.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.389 . . . . 0.0 111.168 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -160.04 87.82 0.8 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.06 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 58.7 mt -143.61 79.87 1.64 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.899 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -125.31 154.41 41.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.308 -0.854 . . . . 0.0 110.876 179.932 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 51.8 t0 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.882 0.372 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 47.9 mp0 -108.75 150.26 27.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -111.39 149.83 30.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.91 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -116.11 49.74 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.79 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -97.8 25.34 5.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.976 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -135.61 160.45 38.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -112.32 139.79 47.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -117.71 142.22 47.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -120.02 142.51 48.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -119.24 145.5 46.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.9 p -92.71 118.25 37.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.147 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -175.63 150.39 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.103 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -94.52 117.91 30.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -117.09 146.65 38.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.9 159.39 50.56 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.516 2.144 . . . . 0.0 112.321 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.5 mm -99.11 140.64 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.024 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.41 ' CG1' HG22 ' A' ' 408' ' ' VAL . 14.7 p -120.46 143.34 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.733 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.4 mmt -89.5 113.79 25.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.774 0.321 . . . . 0.0 110.68 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 27.3 t -114.8 125.68 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.915 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.94 24.37 5.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.349 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.81 19.89 55.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.767 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -137.05 154.99 76.36 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.601 0.238 . . . . 0.0 110.843 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.413 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 12.8 Cg_exo -69.86 135.77 31.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.6 2.2 . . . . 0.0 112.309 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 403' ' ' PHE . . . . . 0.413 ' CD1' ' O ' ' A' ' 402' ' ' PRO . 31.7 m-85 -150.56 155.71 39.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.461 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 17.2 p -80.32 135.2 36.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.731 0.301 . . . . 0.0 110.588 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 405' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 61.3 t80 -56.0 -39.62 72.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.007 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 m -64.02 -38.3 90.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -66.82 -29.52 69.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.14 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.419 HG11 ' CE1' ' A' ' 426' ' ' TYR . 50.7 t -67.25 -47.51 81.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.991 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.7 t -63.04 -31.93 73.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -73.76 -26.67 60.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.969 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -124.1 95.26 44.15 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.789 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.2 -25.46 80.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.484 2.122 . . . . 0.0 112.21 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -62.95 -28.36 70.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.922 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 62.5 mt -67.07 -40.56 87.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 39.1 t -62.88 -36.27 74.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.722 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.79 -29.28 69.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.929 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -80.35 -19.38 46.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.052 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 6.0 mtt -70.35 128.12 35.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.046 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 419' ' ' THR . . . . . 0.402 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 3.2 p -68.65 172.02 5.29 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.143 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.402 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.4 Cg_exo -53.04 -56.02 3.17 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.188 1.925 . . . . 0.0 112.233 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.23 -41.55 88.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.0 0.428 . . . . 0.0 109.973 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.77 -33.68 76.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.139 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -64.26 -38.29 90.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.16 179.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -65.51 -44.76 85.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.577 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.19 -29.92 66.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.136 0.493 . . . . 0.0 110.528 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 426' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 49.8 t80 -69.44 -47.12 65.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.202 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.4 mt -76.42 -33.81 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.53 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -65.86 -45.89 80.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.25 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 69.0 mtm -59.78 -35.42 74.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.929 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.24 -45.48 94.08 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.535 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -66.8 -36.85 83.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -60.28 -36.49 77.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.957 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 73.0 mtm -59.72 -27.26 66.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.049 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 434' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' A' ' 434' ' ' PHE . 39.5 t80 -101.74 25.28 8.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.998 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -79.98 -22.13 42.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.159 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -143.61 79.94 1.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.904 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.64 79.98 1.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -133.3 162.39 31.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.911 179.965 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.856 0.36 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -110.02 153.71 24.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -100.39 139.14 36.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -80.01 140.8 36.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -167.62 95.54 0.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -84.15 112.34 20.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.796 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -125.21 149.12 48.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.823 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -117.19 144.54 44.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.871 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -108.24 129.93 55.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.967 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -133.09 152.79 51.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.1 t -118.27 130.03 73.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.104 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -158.92 152.22 22.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.051 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -80.43 122.12 26.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -120.97 149.34 50.82 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.972 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.47 160.45 49.73 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.558 2.172 . . . . 0.0 112.131 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.417 HD11 HG23 ' A' ' 395' ' ' ILE . 34.5 mm -97.13 134.62 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.028 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.417 ' CG1' HG23 ' A' ' 408' ' ' VAL . 12.5 p -113.96 139.71 38.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.591 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 21.7 mmt -84.11 113.85 21.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.825 0.345 . . . . 0.0 110.815 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.419 ' HA ' ' HG2' ' A' ' 418' ' ' MET . 22.0 t -112.23 112.46 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.838 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.28 22.86 6.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.304 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.97 -16.0 57.67 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.826 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -100.58 148.23 34.69 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.691 0.281 . . . . 0.0 111.052 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.78 136.01 20.3 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.641 2.227 . . . . 0.0 112.472 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 403' ' ' PHE . . . . . 0.408 ' CD1' ' HB ' ' A' ' 398' ' ' VAL . 57.8 m-85 -149.23 156.34 41.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.68 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 15.7 p -79.98 137.6 36.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.504 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 405' ' ' TYR . . . . . 0.498 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 57.5 t80 -55.33 -34.83 64.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.126 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 93.4 p -64.2 -40.67 96.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -67.63 -30.32 69.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.178 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.433 ' CG1' ' CE1' ' A' ' 426' ' ' TYR . 45.7 t -66.08 -48.92 79.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.6 t -64.84 -30.57 71.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.008 0.432 . . . . 0.0 110.978 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -77.46 -26.13 51.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.061 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -124.4 84.16 56.79 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.816 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -51.69 -24.91 18.92 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.65 2.233 . . . . 0.0 112.38 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -61.78 -29.81 70.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.002 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 32.3 mt -67.95 -37.76 81.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.728 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 38.9 t -64.36 -35.6 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.765 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.74 -29.97 70.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.879 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -80.21 -19.41 47.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.935 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 418' ' ' MET . . . . . 0.419 ' HG2' ' HA ' ' A' ' 398' ' ' VAL . 4.3 mtt -70.45 124.95 25.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.037 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 17.3 p -61.04 163.18 10.65 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.348 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -48.07 -56.06 3.46 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.363 2.042 . . . . 0.0 112.382 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -59.49 -40.03 85.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.008 0.432 . . . . 0.0 110.0 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -65.11 -33.99 77.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.176 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -63.58 -37.96 89.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.158 179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -64.93 -46.18 82.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.569 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.78 -29.5 64.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.16 0.505 . . . . 0.0 110.655 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 426' ' ' TYR . . . . . 0.498 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 63.3 t80 -69.72 -47.67 62.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.217 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.5 mt -75.23 -33.98 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.416 -179.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.94 76.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.103 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 59.4 mtp -59.98 -37.55 79.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.16 -39.7 92.65 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.482 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -61.62 -31.93 72.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.861 0.362 . . . . 0.0 110.884 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -78.21 -29.8 48.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.686 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 96.6 mmm -58.87 -22.69 59.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.217 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -90.96 12.65 18.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.459 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -79.96 -24.99 40.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.762 0.315 . . . . 0.0 111.077 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -147.93 82.01 1.5 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.27 83.06 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.883 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -109.47 138.32 46.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.912 179.996 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.86 0.362 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -109.35 151.27 26.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -111.8 155.77 23.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -79.84 -35.45 38.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -89.05 123.67 33.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -81.96 116.99 21.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.9 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -79.98 137.69 36.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.97 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -124.27 154.6 39.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.89 115.83 19.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -136.85 159.76 40.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.3 t -113.72 130.5 67.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -109.49 140.67 42.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -88.99 130.93 35.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.982 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -97.47 149.19 35.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.802 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.8 150.56 85.88 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.498 2.132 . . . . 0.0 112.274 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.71 139.93 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.062 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.4 p -124.05 141.47 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 18.6 mmt -83.36 114.95 21.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.825 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.408 ' CG2' ' HB2' ' A' ' 403' ' ' PHE . 60.0 t -114.25 106.54 20.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.591 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 63.95 16.55 9.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.342 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 109.57 -22.39 24.31 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.073 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 11.7 ptm180 -99.0 149.76 36.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.85 0.357 . . . . 0.0 111.129 -179.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.25 135.93 32.99 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.806 2.337 . . . . 0.0 113.012 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 403' ' ' PHE . . . . . 0.408 ' HB2' ' CG2' ' A' ' 398' ' ' VAL . 4.2 m-85 -139.32 172.17 13.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.696 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -93.89 130.45 39.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.457 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -54.24 -42.93 70.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.172 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 31.1 m -66.75 -34.85 78.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -67.62 -29.72 69.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.159 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.441 ' CG1' ' CE1' ' A' ' 426' ' ' TYR . 55.1 t -70.29 -47.46 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.058 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.9 t -61.6 -31.45 71.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.007 0.432 . . . . 0.0 111.036 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -75.9 -27.49 57.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.948 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -125.87 96.35 37.84 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.832 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.79 -23.94 74.49 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.465 2.11 . . . . 0.0 112.373 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -61.4 -29.25 69.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 110.954 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 16.4 mt -67.38 -36.42 81.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.708 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.2 -37.03 78.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.86 -28.58 68.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.015 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -76.7 -22.88 53.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.053 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 5.0 mtt -71.11 129.29 38.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.944 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 419' ' ' THR . . . . . 0.419 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.3 p -63.91 171.18 2.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.206 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.419 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.4 Cg_exo -52.66 -56.09 3.16 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.179 1.919 . . . . 0.0 112.188 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -60.48 -38.69 85.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -65.45 -34.23 77.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.133 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 11.3 tptm -64.34 -36.63 84.74 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.288 179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -65.32 -44.36 88.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.597 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.76 -30.45 65.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.181 0.515 . . . . 0.0 110.528 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 426' ' ' TYR . . . . . 0.441 ' CE1' ' CG1' ' A' ' 408' ' ' VAL . 68.5 t80 -68.78 -47.57 65.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.31 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.2 mt -75.37 -34.03 29.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.532 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.77 -30.1 70.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.239 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 64.0 mtp -57.84 -35.14 70.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.04 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . 0.412 ' O ' ' CE1' ' A' ' 434' ' ' PHE . . . -59.21 -48.04 87.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.477 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . 0.445 ' HA ' ' CE1' ' A' ' 434' ' ' PHE . 95.1 mt-30 -63.34 -38.46 91.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.782 0.325 . . . . 0.0 110.89 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -50.62 -31.59 16.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 86.1 mtp -72.99 -29.37 63.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.903 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 434' ' ' PHE . . . . . 0.445 ' CE1' ' HA ' ' A' ' 431' ' ' GLN . 49.9 p90 -131.58 45.37 2.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.164 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -111.64 -18.79 12.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.342 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -154.07 85.31 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.84 0.352 . . . . 0.0 110.958 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 2.4 mp -143.02 79.86 1.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.76 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -120.27 156.26 31.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.952 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 50.7 mp0 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.849 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.796 0.331 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -107.31 145.54 32.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 49.2 mp0 -126.52 147.45 49.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -146.79 141.71 26.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -59.73 -37.47 79.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 48.3 p30 -145.76 164.27 32.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.965 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 50.2 mp0 -121.31 132.36 54.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -111.67 129.78 55.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.817 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -160.09 -47.06 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -125.13 163.77 21.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.6 p -126.43 137.41 57.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.08 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -174.28 145.3 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.052 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -79.99 136.57 36.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -117.69 146.26 38.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.852 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.25 164.54 35.32 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.576 2.184 . . . . 0.0 112.357 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.7 mm -99.01 143.2 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.028 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.412 HG12 ' CG2' ' A' ' 408' ' ' VAL . 14.4 p -119.97 141.94 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.759 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 15.1 mmt -84.76 113.85 21.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.417 ' HA ' ' HG2' ' A' ' 418' ' ' MET . 18.7 t -114.81 113.01 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.944 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.86 23.9 5.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.306 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.85 56.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.804 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.61 146.38 31.73 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.732 0.301 . . . . 0.0 111.05 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.13 135.98 19.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.669 2.246 . . . . 0.0 112.529 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 403' ' ' PHE . . . . . 0.409 ' CD1' ' HB ' ' A' ' 398' ' ' VAL . 62.1 m-85 -148.12 156.26 42.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.682 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 17.3 p -74.82 138.59 42.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.58 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -56.88 -39.91 75.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.003 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.3 m -64.55 -38.21 90.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -65.87 -29.72 70.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.182 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.426 HG11 ' CE1' ' A' ' 426' ' ' TYR . 59.8 t -67.12 -46.3 84.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.946 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.7 p -65.02 -29.33 70.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.98 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -76.83 -26.14 53.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.947 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -123.7 95.03 45.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.801 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.02 -25.51 77.72 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.389 2.059 . . . . 0.0 112.252 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.34 -28.47 69.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.951 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 65.7 mt -66.57 -38.84 87.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.703 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.41 -36.17 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.735 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -64.62 -29.97 70.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.936 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -80.77 -18.25 48.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.974 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 418' ' ' MET . . . . . 0.417 ' HG2' ' HA ' ' A' ' 398' ' ' VAL . 5.3 mtt -72.71 126.44 29.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.176 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 419' ' ' THR . . . . . . . . . . . . . 2.8 p -69.14 172.57 4.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.049 179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -53.71 -56.09 2.96 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.188 1.925 . . . . 0.0 112.226 -179.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.33 -41.92 90.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.923 0.392 . . . . 0.0 110.028 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.05 -33.35 75.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.34 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 48.6 tttm -65.97 -36.62 83.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.308 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -65.03 -45.8 83.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.639 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.2 -29.48 65.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.11 0.481 . . . . 0.0 110.57 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 426' ' ' TYR . . . . . 0.426 ' CE1' HG11 ' A' ' 408' ' ' VAL . 43.9 t80 -69.82 -47.05 64.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.263 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.7 mt -76.44 -33.84 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.443 -179.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -63.59 -45.88 88.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.127 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 66.9 mtm -62.34 -37.29 85.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.5 -37.24 87.93 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.458 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.91 -32.11 71.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.891 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 3.8 ttm105 -80.5 -29.4 37.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.734 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 95.5 mmm -58.32 -27.61 64.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.089 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.27 24.37 10.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.997 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -79.87 -22.9 42.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.189 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 34.7 p30 -152.14 83.96 1.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.038 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 87.4 mt -142.95 79.91 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -120.68 152.72 37.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 50.7 mp0 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.922 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 47.5 p30 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.84 0.352 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -99.66 136.63 39.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -79.83 -36.0 37.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -113.71 150.75 32.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -130.93 -45.63 1.04 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.046 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -160.03 95.49 1.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.043 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -114.31 141.66 47.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.89 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.411 ' CE2' HG21 ' A' ' 390' ' ' VAL . 0.1 OUTLIER -160.04 85.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -79.86 -37.91 33.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.999 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -128.58 148.57 50.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . 0.411 HG21 ' CE2' ' A' ' 387' ' ' PHE . 26.9 t -124.29 132.28 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.979 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -156.08 148.46 23.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -90.47 120.23 31.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -117.87 150.89 48.0 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.75 163.45 37.12 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.613 2.209 . . . . 0.0 112.269 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.4 mm -101.57 146.37 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.174 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.41 HG11 ' CG2' ' A' ' 408' ' ' VAL . 11.7 p -129.0 140.48 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.725 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 397' ' ' MET . . . . . 0.403 ' N ' HG23 ' A' ' 396' ' ' VAL . 18.2 mmt -81.04 113.72 19.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.669 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.408 ' HB ' ' CD1' ' A' ' 403' ' ' PHE . 23.2 t -115.68 110.44 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.57 23.31 5.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.295 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.19 -17.74 53.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.862 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 35.9 mtp85 -101.54 145.15 29.95 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.737 0.268 . . . . 0.0 111.095 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.29 135.92 19.16 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.689 2.259 . . . . 0.0 112.412 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 403' ' ' PHE . . . . . 0.408 ' CD1' ' HB ' ' A' ' 398' ' ' VAL . 62.0 m-85 -147.4 157.52 43.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.787 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 49.0 m -69.88 138.2 52.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.611 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -58.49 -41.59 85.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.979 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 95.4 p -66.25 -39.89 89.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.14 -29.22 69.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.131 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.423 HG13 ' CE1' ' A' ' 426' ' ' TYR . 49.4 t -68.46 -47.67 76.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.994 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.7 t -64.08 -30.12 71.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -75.71 -26.31 57.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.025 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -124.35 85.09 55.84 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.08 -27.25 28.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.611 2.207 . . . . 0.0 112.291 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -61.07 -29.27 69.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 63.3 mt -66.17 -37.54 85.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.761 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 37.5 t -63.68 -38.06 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.11 -28.48 68.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.066 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -80.05 -17.73 51.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.116 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 3.0 mtt -76.35 132.2 39.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.153 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 419' ' ' THR . . . . . 0.423 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 8.3 p -63.79 158.61 59.8 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.065 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.423 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 2.0 Cg_endo -45.05 -56.03 3.0 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.617 2.211 . . . . 0.0 112.257 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.25 -38.55 83.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.969 0.414 . . . . 0.0 109.956 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -66.0 -34.25 77.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.158 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -63.52 -36.16 82.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.205 179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -64.57 -45.46 86.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.634 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -56.87 -31.04 64.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.131 0.491 . . . . 0.0 110.594 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 426' ' ' TYR . . . . . 0.423 ' CE1' HG13 ' A' ' 408' ' ' VAL . 47.4 t80 -68.45 -48.23 65.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.218 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.1 mt -74.05 -34.03 37.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.519 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.63 83.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.061 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 65.1 mtm -62.69 -36.99 84.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.826 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.99 -35.99 86.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.464 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -59.97 -40.01 87.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.797 0.332 . . . . 0.0 110.828 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -69.53 -29.83 67.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.942 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 16.3 mmt -57.48 -22.82 46.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.209 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 434' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 434' ' ' PHE . 55.7 t80 -91.9 45.98 1.25 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.076 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -109.31 -21.14 12.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.12 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -142.9 79.96 1.67 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.854 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -142.58 79.88 1.67 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.724 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -90.98 133.39 35.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.881 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.83 179.977 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.826 0.345 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -100.47 131.96 46.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -108.67 -75.84 0.62 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.998 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -108.62 -57.17 2.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.978 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 50.2 p30 -62.06 174.61 0.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -135.38 100.68 4.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -112.61 147.45 36.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -92.9 122.38 35.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -148.53 156.64 42.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -108.16 137.91 45.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.961 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.0 t -119.02 132.84 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.11 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -158.62 168.66 26.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -79.87 146.31 32.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -60.98 143.19 92.18 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.944 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.7 165.94 31.02 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.587 2.191 . . . . 0.0 112.384 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . 0.407 HG21 HD12 ' A' ' 395' ' ' ILE . 33.6 mm -94.47 135.82 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.03 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . . . . . . . . . 12.7 p -115.9 142.24 30.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.769 179.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.8 mmt -90.13 113.86 25.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.866 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 39.2 t -110.63 119.09 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.011 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.95 27.68 11.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.363 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.88 23.51 45.43 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.785 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 75.8 mtm-85 -137.01 151.68 72.53 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.602 0.239 . . . . 0.0 110.688 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.412 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 57.7 Cg_endo -71.28 135.72 27.48 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.406 2.071 . . . . 0.0 112.411 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 403' ' ' PHE . . . . . 0.412 ' CD1' ' O ' ' A' ' 402' ' ' PRO . 35.1 m-85 -150.67 172.09 16.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.668 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 49.4 m -97.84 136.87 37.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.569 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 405' ' ' TYR . . . . . 0.428 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 41.3 t80 -57.11 -41.71 79.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.913 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.4 t -64.4 -39.57 94.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.843 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.86 -29.22 69.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.109 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.4 HG12 ' CE1' ' A' ' 426' ' ' TYR . 51.5 t -66.59 -47.49 83.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.016 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.0 p -64.45 -29.03 70.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.983 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -76.78 -25.65 53.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.01 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 38.7 mtt85 -124.76 85.57 56.89 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.794 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -51.79 -26.7 24.64 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.623 2.215 . . . . 0.0 112.295 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.61 -29.79 70.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.945 0.403 . . . . 0.0 111.009 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 67.7 mt -66.83 -36.86 83.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.74 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 43.2 t -64.71 -37.95 81.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.948 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -68.09 -28.39 67.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -77.3 -22.46 51.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.121 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 2.6 mtt -73.47 130.28 39.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 419' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.1 p -65.97 171.18 4.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.259 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 50.6 Cg_exo -53.91 -56.2 2.81 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.334 2.023 . . . . 0.0 112.418 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -58.33 -42.66 87.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.857 0.36 . . . . 0.0 110.216 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -65.96 -32.82 74.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.079 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.21 -36.69 84.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.168 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -64.6 -45.82 85.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.59 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.11 -30.81 64.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.119 0.485 . . . . 0.0 110.536 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 426' ' ' TYR . . . . . 0.428 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 63.5 t80 -68.46 -48.27 64.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.273 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.4 mt -74.47 -33.82 34.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.434 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.05 87.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.144 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 68.8 mtm -61.55 -35.81 78.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.891 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.94 -41.57 96.35 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.458 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -62.71 -36.59 83.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 0.0 110.891 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 48.4 mmm-85 -60.87 -36.23 78.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.912 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.78 -27.67 66.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.029 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -156.71 79.55 0.94 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.891 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -80.06 -37.33 34.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.13 0.49 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -159.07 82.92 0.78 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.866 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 47.2 mt -146.01 80.8 1.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -122.0 152.55 39.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.93 179.969 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.847 0.356 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -106.94 150.0 26.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -114.31 153.13 30.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.21 35.19 1.8 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 61.4 44.95 8.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.833 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -131.44 133.18 44.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -102.62 145.3 29.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -128.08 159.99 33.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -117.78 147.47 42.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -123.85 155.9 37.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.6 t -114.18 131.75 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.089 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . 58.52 163.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -130.96 106.21 8.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.56 148.07 85.23 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.927 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.36 158.37 57.74 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.535 2.157 . . . . 0.0 112.265 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.4 mm -80.02 148.28 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.106 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.417 HG11 ' CG2' ' A' ' 408' ' ' VAL . 11.8 p -127.44 139.75 51.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.763 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 19.4 mmt -81.0 113.82 19.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.824 0.345 . . . . 0.0 110.82 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.3 110.27 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.03 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.02 24.38 4.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.28 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.9 -19.68 48.64 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.758 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -98.68 143.6 26.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.651 0.262 . . . . 0.0 110.958 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.56 135.91 16.79 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.651 2.234 . . . . 0.0 112.475 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 403' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -148.47 161.1 42.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.714 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 25.9 p -75.92 141.35 42.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.595 179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -58.24 -40.8 82.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.908 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.7 t -63.59 -40.39 96.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -63.97 -28.79 70.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.418 HG11 ' CE1' ' A' ' 426' ' ' TYR . 37.7 t -70.32 -54.02 20.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.051 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 18.2 m -61.04 -30.17 70.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.94 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -76.19 -25.44 55.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.974 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -124.72 86.79 55.52 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.845 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -51.77 -25.51 21.05 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.559 2.173 . . . . 0.0 112.408 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -61.67 -30.7 70.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.934 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 30.5 mt -68.07 -36.94 80.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.679 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.51 -36.49 77.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.813 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.98 -28.07 67.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.035 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -81.47 -17.16 49.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.227 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 2.9 mtt -77.02 130.93 38.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.151 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 419' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.6 p -67.25 159.07 79.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.982 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 1.2 Cg_endo -44.14 -53.35 4.8 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.694 2.263 . . . . 0.0 112.497 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.27 -41.59 93.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 0.0 110.207 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.46 -33.76 76.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.248 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -65.0 -35.13 80.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.115 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -63.24 -46.27 87.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.637 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.42 -31.51 67.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.222 0.534 . . . . 0.0 110.755 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 426' ' ' TYR . . . . . 0.418 ' CE1' HG11 ' A' ' 408' ' ' VAL . 65.0 t80 -68.62 -46.01 70.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.207 179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . 0.45 HD13 HG22 ' A' ' 427' ' ' ILE . 58.3 mt -76.42 -35.92 27.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.705 -179.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -65.68 -35.19 80.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.932 0.396 . . . . 0.0 111.176 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 60.2 mtp -61.48 -39.69 91.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -63.1 -37.25 94.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.576 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -60.08 -35.86 76.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.836 0.351 . . . . 0.0 110.975 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -69.19 -31.0 69.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.637 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 65.1 mtt -61.22 -27.35 68.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.087 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -106.58 -24.54 12.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.199 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -80.01 -20.64 44.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.281 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -142.21 79.88 1.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.81 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.37 80.05 1.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.867 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -121.46 154.4 36.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.901 179.998 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.718 0.294 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -107.57 139.47 42.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -135.63 135.27 40.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -113.52 140.84 47.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -158.05 93.89 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -145.07 79.92 1.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -143.62 162.5 35.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.92 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -107.2 133.25 52.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.799 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -116.67 155.92 27.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.918 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -102.04 146.87 27.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.851 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.1 t -102.56 131.52 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.064 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -70.67 150.32 46.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.145 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -81.21 116.81 21.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.864 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -120.96 155.79 57.33 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.2 157.84 59.78 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.535 2.157 . . . . 0.0 112.26 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 34.4 mm -96.59 138.73 20.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.128 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.401 ' CG1' HG23 ' A' ' 408' ' ' VAL . 12.6 p -125.22 140.34 48.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.686 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.8 mmt -85.55 113.75 22.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.065 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.407 HG23 ' CE ' ' A' ' 418' ' ' MET . 34.6 t -111.03 120.08 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.851 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.73 23.25 6.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.466 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.81 21.02 37.85 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.825 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -137.11 149.67 66.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.563 0.22 . . . . 0.0 110.74 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.426 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 18.2 Cg_exo -66.29 135.66 40.76 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.474 2.116 . . . . 0.0 112.338 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 403' ' ' PHE . . . . . 0.426 ' CD1' ' O ' ' A' ' 402' ' ' PRO . 17.3 m-85 -148.42 172.13 14.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 22.3 p -97.71 135.37 39.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.431 179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 405' ' ' TYR . . . . . 0.499 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 45.8 t80 -56.98 -39.57 74.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.122 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.1 m -64.44 -39.7 94.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.093 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -68.24 -28.89 67.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.41 HG11 ' CE1' ' A' ' 426' ' ' TYR . 24.3 t -68.25 -55.97 14.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.068 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 1.4 m -59.23 -29.99 67.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -73.74 -26.26 60.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.861 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 41.4 mtt-85 -125.04 87.47 55.41 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.817 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.97 -26.43 18.46 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.535 2.157 . . . . 0.0 112.408 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.52 -28.52 69.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.031 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 68.6 mt -66.56 -39.58 88.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.845 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.5 -37.07 78.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.009 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -68.41 -28.85 67.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.034 0.445 . . . . 0.0 111.158 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -80.11 -19.71 46.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.119 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 418' ' ' MET . . . . . 0.407 ' CE ' HG23 ' A' ' 398' ' ' VAL . 2.8 mtt -75.46 133.33 41.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.055 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 419' ' ' THR . . . . . 0.433 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 6.7 p -62.63 158.41 50.86 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.015 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 2.6 Cg_endo -45.65 -52.85 6.27 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.624 2.216 . . . . 0.0 112.377 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -60.09 -43.38 95.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.925 0.393 . . . . 0.0 110.168 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -65.07 -33.25 75.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.196 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 41.2 tttt -64.66 -38.07 89.74 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.085 179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -65.02 -45.24 86.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.588 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.34 -30.4 64.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.211 0.529 . . . . 0.0 110.712 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 426' ' ' TYR . . . . . 0.499 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 56.1 t80 -69.19 -47.89 63.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.248 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 4.0 mt -74.69 -33.72 32.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.497 -179.511 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.66 -39.49 88.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.167 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 429' ' ' MET . . . . . 0.406 ' HE3' ' CD1' ' A' ' 405' ' ' TYR . 71.6 mtm -60.53 -39.25 87.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.833 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -61.4 -39.84 97.83 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.49 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.49 -33.54 73.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 0.0 110.93 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -70.75 -29.57 65.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.662 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 96.5 mmm -60.02 -26.7 66.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.118 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -116.08 23.25 12.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.273 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -79.99 -19.45 47.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.252 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -143.13 79.89 1.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 110.888 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 98.3 mt -148.65 82.2 1.46 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.833 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -107.75 135.53 49.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.903 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.798 0.333 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -119.69 80.11 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.93 -34.08 39.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.924 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -132.24 -62.09 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -71.19 132.43 45.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -103.48 113.98 27.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.938 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -122.9 134.4 54.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -108.21 124.78 50.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -129.19 151.79 49.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -114.67 136.77 52.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.76 134.67 62.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.039 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -146.89 150.29 34.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.122 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -112.92 166.61 11.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.978 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -92.93 155.56 41.34 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.74 158.72 54.74 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.526 2.15 . . . . 0.0 112.194 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.4 mm -98.85 131.98 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.16 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.422 ' CG1' HG21 ' A' ' 408' ' ' VAL . 11.4 p -117.7 139.34 45.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.688 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.3 mmt -86.9 113.85 23.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.95 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . 0.416 ' HB ' ' CD1' ' A' ' 403' ' ' PHE . 39.9 t -110.03 119.58 59.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.816 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 57.2 24.82 10.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.323 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 88.44 22.07 41.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.835 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 29.4 mtt-85 -136.94 150.71 70.51 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.607 0.242 . . . . 0.0 110.813 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . 0.434 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 17.7 Cg_exo -66.52 135.64 39.93 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.47 2.113 . . . . 0.0 112.372 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 403' ' ' PHE . . . . . 0.434 ' CD1' ' O ' ' A' ' 402' ' ' PRO . 17.9 m-85 -148.82 171.99 15.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.606 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 53.6 p -100.32 134.81 42.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.559 179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 405' ' ' TYR . . . . . 0.481 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 28.3 t80 -56.03 -37.36 69.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 21.7 m -66.46 -41.63 88.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.099 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -66.28 -29.71 69.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 111.256 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.44 ' CG1' ' CE1' ' A' ' 426' ' ' TYR . 44.1 t -65.81 -48.91 80.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.102 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.1 p -64.49 -29.25 70.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -77.91 -25.91 48.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.02 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -124.1 85.76 54.51 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.87 -26.81 18.9 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.569 2.179 . . . . 0.0 112.398 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.31 -28.25 69.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.034 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 71.8 mt -66.48 -39.25 88.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.833 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 38.6 t -63.82 -38.15 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.78 -28.86 67.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.11 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -76.07 -22.88 55.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.053 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 418' ' ' MET . . . . . . . . . . . . . 2.8 mtt -74.21 133.68 42.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 419' ' ' THR . . . . . 0.406 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 3.8 p -66.69 171.25 4.59 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.11 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.406 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 51.1 Cg_exo -53.27 -56.06 3.08 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.247 1.965 . . . . 0.0 112.368 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.0 -41.53 87.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.072 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -65.83 -33.02 74.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.094 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 79.9 tttt -64.43 -37.21 86.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.1 179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -65.4 -45.09 85.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.527 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -56.94 -30.53 64.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.21 0.528 . . . . 0.0 110.537 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 426' ' ' TYR . . . . . 0.481 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 64.3 t80 -68.49 -48.82 63.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.132 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 3.6 mt -73.14 -35.16 46.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.3 -179.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -71.59 -29.23 64.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.065 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 57.7 mtp -70.52 -30.85 67.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -84.1 -42.52 7.53 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.863 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -57.84 -42.48 84.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 111.07 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.24 -29.93 66.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.0 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 94.2 mmm -58.22 -23.38 55.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.263 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -94.8 21.59 7.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.37 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -79.91 -22.54 42.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.848 0.356 . . . . 0.0 111.238 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -151.83 83.97 1.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 83.7 mt -143.18 79.92 1.66 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.817 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -120.96 153.72 36.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.914 -179.984 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 57.3 p30 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.835 0.35 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 47.9 mp0 -98.73 152.14 19.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -79.84 -29.55 40.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -138.88 79.59 1.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -145.67 102.19 3.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.823 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -79.99 110.48 15.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.775 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -123.44 154.22 39.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 387' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 388' ' ' GLU . 66.2 t80 -111.68 155.06 24.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.86 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 388' ' ' GLU . . . . . 0.408 ' O ' ' CD2' ' A' ' 387' ' ' PHE . 96.0 mt-10 -79.84 133.29 36.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.945 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -136.83 164.49 28.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 24.5 t -103.99 131.05 53.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.02 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -104.72 149.47 25.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -79.95 134.03 36.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.825 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.86 151.61 97.17 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.978 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.64 166.07 30.73 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.692 2.261 . . . . 0.0 112.349 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.9 mm -101.19 130.61 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.146 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 396' ' ' VAL . . . . . 0.412 ' CG1' HG21 ' A' ' 408' ' ' VAL . 13.4 p -116.16 137.61 49.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.732 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.1 mmt -85.74 113.94 22.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.04 -179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 398' ' ' VAL . . . . . . . . . . . . . 33.2 t -114.92 123.87 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.928 179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.66 26.88 11.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.23 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.44 22.63 56.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.647 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -137.07 153.34 75.11 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.665 0.269 . . . . 0.0 110.931 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -68.88 135.97 34.08 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.518 2.145 . . . . 0.0 112.339 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 403' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -146.65 171.54 14.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.686 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 50.8 m -97.48 129.71 44.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.619 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -52.29 -40.31 61.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.027 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 41.6 t -67.61 -35.26 78.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.738 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.87 -30.8 70.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.051 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 408' ' ' VAL . . . . . 0.417 HG12 ' CE1' ' A' ' 426' ' ' TYR . 81.9 t -69.83 -44.55 78.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.869 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 32.9 t -62.95 -30.91 71.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.989 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -75.48 -26.59 58.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.996 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 14.6 mtt85 -125.86 84.89 60.17 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.883 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.37 -24.99 23.0 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.597 2.198 . . . . 0.0 112.371 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -61.23 -29.31 69.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.976 0.417 . . . . 0.0 111.064 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 28.8 mt -66.39 -36.23 82.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.761 -179.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.68 -37.71 80.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.4 70.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.035 0.445 . . . . 0.0 111.008 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -79.57 -21.18 45.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.0 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 418' ' ' MET . . . . . 0.424 ' HE3' ' CD1' ' A' ' 426' ' ' TYR . 7.3 mtt -69.19 123.72 21.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.033 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 419' ' ' THR . . . . . 0.403 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 7.0 p -61.53 167.77 3.94 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.172 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 420' ' ' PRO . . . . . 0.403 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 62.4 Cg_exo -51.47 -56.07 3.36 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.288 1.992 . . . . 0.0 112.155 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -59.98 -39.84 87.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 109.882 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.11 -34.23 77.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.27 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -64.82 -36.66 85.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.197 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -64.27 -46.24 84.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.474 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.42 -30.49 66.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.167 0.508 . . . . 0.0 110.607 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 426' ' ' TYR . . . . . 0.424 ' CD1' ' HE3' ' A' ' 418' ' ' MET . 75.1 t80 -69.37 -46.42 66.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.259 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 427' ' ' ILE . . . . . 0.4 HG23 HD12 ' A' ' 427' ' ' ILE . 58.7 mt -77.19 -33.66 20.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.574 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -63.4 -38.38 90.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.249 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 60.0 mtm -60.14 -44.63 94.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.935 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.81 -40.94 97.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.452 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -64.59 -34.5 78.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.763 0.316 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -72.14 -37.31 69.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.746 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 88.0 mtp -58.53 -25.77 62.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 434' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 434' ' ' PHE . 61.1 t80 -96.28 1.54 52.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.409 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -99.95 -19.59 16.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.711 0.291 . . . . 0.0 111.338 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -144.18 80.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.771 0.32 . . . . 0.0 111.011 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.6 86.91 0.94 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -132.08 165.53 23.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.856 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.988 179.983 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.5 mm . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.949 0.404 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.93 HG11 HG21 ' A' ' 408' ' ' VAL . 13.8 p -115.57 142.57 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.803 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.6 mmt -90.81 113.83 26.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.808 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.608 HG22 ' CE ' ' A' ' 418' ' ' MET . 38.1 t -111.75 120.92 63.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.981 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.23 27.34 9.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.439 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.48 23.51 46.99 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.731 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -137.02 152.27 73.61 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.669 0.271 . . . . 0.0 110.738 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 402' ' ' PRO . . . . . 0.402 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 58.3 Cg_endo -71.73 135.84 26.74 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.454 2.103 . . . . 0.0 112.406 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 403' ' ' PHE . . . . . 0.493 ' HB2' HG23 ' A' ' 398' ' ' VAL . 36.2 m-85 -150.52 172.04 16.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.674 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 404' ' ' SER . . . . . 0.668 ' O ' HG23 ' A' ' 408' ' ' VAL . 24.8 p -98.59 136.9 38.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.552 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 405' ' ' TYR . . . . . 0.484 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 35.1 t80 -56.84 -39.31 74.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.032 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.1 m -64.73 -40.68 95.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -66.61 -29.54 69.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.192 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.93 HG21 HG11 ' A' ' 396' ' ' VAL . 48.1 t -68.14 -47.68 77.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.04 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 87.1 p -61.39 -30.39 70.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.941 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -74.07 -26.88 60.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.893 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -125.6 94.89 41.63 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.75 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.31 -23.1 76.36 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.462 2.108 . . . . 0.0 112.367 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.71 -29.05 70.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.701 HD12 ' HA ' ' A' ' 408' ' ' VAL . 30.2 mt -65.09 -38.48 90.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.721 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.4 t -62.61 -39.85 86.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.965 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.1 -27.57 67.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.128 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -80.87 -20.5 42.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.165 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 418' ' ' MET . . . . . 0.608 ' CE ' HG22 ' A' ' 398' ' ' VAL . 3.0 mtt -73.64 131.85 42.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.955 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 6.4 p -63.13 167.37 6.43 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.356 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 53.5 Cg_exo -52.4 -56.07 3.22 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.31 2.007 . . . . 0.0 112.187 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 54.4 mp0 -59.67 -40.17 86.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.01 0.433 . . . . 0.0 109.946 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -65.3 -33.78 76.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.183 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.612 ' O ' HD12 ' A' ' 427' ' ' ILE . 85.0 tttt -65.16 -36.75 85.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.199 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -65.0 -45.45 85.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.528 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.31 -30.37 64.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.147 0.499 . . . . 0.0 110.567 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 426' ' ' TYR . . . . . 0.541 ' CE1' HG11 ' A' ' 408' ' ' VAL . 58.4 t80 -68.87 -48.05 64.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.223 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.2 mt -75.13 -33.54 29.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.512 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.65 -43.0 99.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.208 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 68.9 mtm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.948 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.9 mm . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.905 0.383 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.937 HG11 HG21 ' A' ' 408' ' ' VAL . 12.0 p -127.48 141.07 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.742 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 16.1 mmt -84.26 113.68 21.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.825 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.501 HG13 ' HG2' ' A' ' 418' ' ' MET . 32.8 t -111.76 108.6 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.808 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.76 22.54 7.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.256 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.83 -17.48 49.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.931 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 -100.21 146.04 31.27 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.678 0.275 . . . . 0.0 111.047 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.79 135.92 20.16 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.649 2.233 . . . . 0.0 112.494 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 403' ' ' PHE . . . . . 0.544 ' O ' HG12 ' A' ' 396' ' ' VAL . 57.4 m-85 -148.33 158.75 44.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.751 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 404' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 408' ' ' VAL . 18.0 p -76.92 137.8 39.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.646 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 405' ' ' TYR . . . . . 0.493 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 57.6 t80 -57.58 -40.57 79.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.948 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.0 m -63.49 -39.02 93.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -66.11 -29.39 69.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.937 HG21 HG11 ' A' ' 396' ' ' VAL . 57.1 t -67.41 -46.94 82.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.963 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.8 p -64.22 -29.3 70.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.026 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -75.89 -26.2 56.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.919 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 35.9 mtt-85 -124.0 97.2 41.24 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.824 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.72 -25.59 78.95 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.345 2.03 . . . . 0.0 112.272 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -62.84 -28.47 70.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' A' ' 408' ' ' VAL . 68.7 mt -66.05 -40.24 90.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.846 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.4 -38.38 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.969 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.88 67.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.073 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -79.07 -19.1 52.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.114 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 418' ' ' MET . . . . . 0.501 ' HG2' HG13 ' A' ' 398' ' ' VAL . 3.5 mtt -74.41 129.3 37.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.067 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.476 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 8.7 p -61.69 158.07 43.85 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.208 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 3.0 Cg_endo -45.79 -56.07 3.11 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.661 2.241 . . . . 0.0 112.244 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.1 -38.42 82.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 0.0 109.937 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 422' ' ' GLU . . . . . 0.414 ' OE1' HG23 ' A' ' 419' ' ' THR . 96.0 mt-10 -66.05 -34.53 78.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.159 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -63.23 -36.22 82.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.116 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -64.84 -43.12 94.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.474 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -59.5 -31.69 69.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.193 0.52 . . . . 0.0 110.473 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 426' ' ' TYR . . . . . 0.523 ' HD1' HG21 ' A' ' 396' ' ' VAL . 57.2 t80 -67.78 -45.1 75.81 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.282 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 61.9 mt -79.46 -33.76 15.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.794 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -68.39 -43.26 77.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.336 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 429' ' ' MET . . . . . 0.526 ' HE1' HG23 ' A' ' 396' ' ' VAL . 49.4 mtm . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.14 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.0 mm . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.878 0.37 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.931 HG11 HG21 ' A' ' 408' ' ' VAL . 14.7 p -124.92 142.48 41.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.86 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 15.2 mmt -85.83 113.81 22.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.647 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.414 ' HA ' ' HG2' ' A' ' 418' ' ' MET . 12.6 t -118.75 114.56 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.95 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.41 22.67 6.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.268 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.33 -17.36 57.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.872 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -100.69 146.24 31.73 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.722 0.296 . . . . 0.0 111.032 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.77 135.98 16.47 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.661 2.241 . . . . 0.0 112.525 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 403' ' ' PHE . . . . . 0.624 ' O ' HG12 ' A' ' 396' ' ' VAL . 86.1 m-85 -148.18 157.73 43.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.771 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 404' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 408' ' ' VAL . 49.4 m -71.38 139.98 49.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.527 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -58.01 -40.95 82.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.994 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.3 t -65.86 -38.81 89.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.64 -29.9 70.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.931 HG21 HG11 ' A' ' 396' ' ' VAL . 60.3 t -68.76 -46.3 79.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.004 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.5 p -63.14 -28.94 70.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -74.31 -26.25 60.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.019 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -124.35 87.18 54.19 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.859 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -51.8 -27.21 26.33 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.6 2.2 . . . . 0.0 112.36 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.24 -28.29 69.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 408' ' ' VAL . 69.5 mt -66.57 -38.75 87.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.788 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.25 -37.72 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.02 -28.57 68.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.014 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -79.68 -17.63 53.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.141 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 418' ' ' MET . . . . . 0.419 ' HE3' HG11 ' A' ' 408' ' ' VAL . 7.6 mtt -72.64 132.21 43.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.199 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.467 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 2.9 p -74.6 173.08 7.27 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.066 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.4 Cg_exo -52.94 -55.98 3.23 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.169 1.912 . . . . 0.0 112.264 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -59.83 -40.19 87.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.01 0.433 . . . . 0.0 109.931 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -65.29 -34.23 77.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.229 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -64.49 -36.84 85.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.148 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -63.63 -47.18 82.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.615 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -59.59 -29.71 68.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.12 0.486 . . . . 0.0 110.578 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 426' ' ' TYR . . . . . 0.405 ' CE1' HG11 ' A' ' 408' ' ' VAL . 85.1 t80 -70.11 -45.14 67.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.162 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 57.7 mt -77.92 -35.55 20.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.695 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.76 83.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.827 0.346 . . . . 0.0 111.082 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 76.3 mtp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.901 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.8 mm . . . . . 0 C--O 1.23 0.07 0 CA-C-O 121.038 0.447 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.959 HG11 HG21 ' A' ' 408' ' ' VAL . 12.4 p -129.59 141.94 45.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.906 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 17.8 mmt -82.58 113.76 20.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.817 0.341 . . . . 0.0 110.629 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.686 HG13 ' HG2' ' A' ' 418' ' ' MET . 22.0 t -117.87 112.73 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.965 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.36 23.46 5.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.283 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.11 -15.63 59.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.801 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -103.55 145.82 31.32 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.735 0.303 . . . . 0.0 111.046 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.4 136.03 19.1 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.628 2.219 . . . . 0.0 112.455 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 403' ' ' PHE . . . . . 0.651 ' O ' HG12 ' A' ' 396' ' ' VAL . 64.0 m-85 -147.1 156.9 43.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.751 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 404' ' ' SER . . . . . 0.53 ' O ' HG23 ' A' ' 408' ' ' VAL . 50.0 m -69.04 137.75 53.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.645 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -58.16 -43.3 87.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.958 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.0 t -64.89 -37.44 87.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.19 -29.46 70.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.959 HG21 HG11 ' A' ' 396' ' ' VAL . 53.2 t -69.8 -47.36 70.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.999 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.2 p -64.49 -29.04 70.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.022 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -76.76 -26.35 54.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.974 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -124.16 85.29 55.03 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -51.58 -26.77 23.35 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.595 2.197 . . . . 0.0 112.344 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.0 -28.36 69.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 408' ' ' VAL . 70.0 mt -66.11 -36.75 83.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.797 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 39.7 t -63.92 -38.88 83.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.961 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.76 -28.86 68.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.113 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -76.56 -22.08 54.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.094 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 418' ' ' MET . . . . . 0.686 ' HG2' HG13 ' A' ' 398' ' ' VAL . 4.1 mtt -72.72 130.08 39.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.939 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 3.9 p -65.76 171.49 3.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.072 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 50.2 Cg_exo -53.36 -56.07 3.05 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.196 1.93 . . . . 0.0 112.154 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.01 -37.82 83.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.018 0.437 . . . . 0.0 109.842 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -66.94 -33.38 75.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.249 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.852 ' O ' HD12 ' A' ' 427' ' ' ILE . 0.0 OUTLIER -65.73 -34.08 77.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.203 179.509 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -64.5 -45.62 86.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.65 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.07 -30.92 64.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.145 0.498 . . . . 0.0 110.653 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 426' ' ' TYR . . . . . 0.544 ' CE1' HG11 ' A' ' 408' ' ' VAL . 63.8 t80 -68.51 -48.37 64.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.088 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.852 HD12 ' O ' ' A' ' 423' ' ' LYS . 3.2 mt -73.2 -35.44 47.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.565 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -65.42 -49.14 70.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.173 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 429' ' ' MET . . . . . 0.683 ' CE ' HG23 ' A' ' 396' ' ' VAL . 71.5 mtm . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.844 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.3 mm . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.967 0.413 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.956 HG11 HG21 ' A' ' 408' ' ' VAL . 13.9 p -131.43 142.11 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.893 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 17.2 mmt -84.47 113.7 21.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.597 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.627 HG13 ' HG2' ' A' ' 418' ' ' MET . 22.3 t -118.18 113.6 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.977 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.62 23.17 5.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.295 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.43 -13.82 61.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.956 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 6.8 mtt85 -104.75 146.3 32.37 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.722 0.296 . . . . 0.0 110.991 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.04 136.0 17.85 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.667 2.245 . . . . 0.0 112.526 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 403' ' ' PHE . . . . . 0.651 ' O ' HG12 ' A' ' 396' ' ' VAL . 71.0 m-85 -147.65 158.92 44.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.738 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 404' ' ' SER . . . . . 0.544 ' O ' HG23 ' A' ' 408' ' ' VAL . 63.6 m -71.34 138.76 49.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.694 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -58.25 -43.72 88.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 m -64.69 -38.06 89.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.919 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.73 -29.31 70.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.956 HG21 HG11 ' A' ' 396' ' ' VAL . 60.4 t -70.65 -46.79 67.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.012 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.8 t -63.09 -31.28 72.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.026 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -73.87 -26.72 60.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.001 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -123.77 96.75 42.55 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.785 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.22 -25.94 77.21 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.393 2.062 . . . . 0.0 112.299 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -62.75 -28.61 70.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.95 -38.11 85.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.731 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 35.7 t -63.65 -37.81 80.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.847 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.88 -29.05 68.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.993 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -76.24 -22.06 55.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.063 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 418' ' ' MET . . . . . 0.627 ' HG2' HG13 ' A' ' 398' ' ' VAL . 3.8 mtt -71.88 129.56 38.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.446 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.9 p -64.3 169.95 4.2 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.145 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 51.0 Cg_exo -53.14 -56.05 3.12 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.155 1.904 . . . . 0.0 112.161 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 54.2 mp0 -60.69 -38.31 84.56 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -65.99 -34.61 78.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.288 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -65.26 -34.76 79.11 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.226 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -64.76 -44.7 89.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.76 -30.4 67.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.222 0.534 . . . . 0.0 110.631 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 426' ' ' TYR . . . . . 0.541 ' CE1' HG11 ' A' ' 408' ' ' VAL . 76.4 t80 -69.38 -45.95 68.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.294 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.8 -33.77 19.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.751 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.43 -36.16 77.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.341 . . . . 0.0 111.227 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.942 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.3 mm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.93 0.395 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.895 HG11 HG21 ' A' ' 408' ' ' VAL . 13.6 p -114.02 135.52 53.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.751 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 397' ' ' MET . . . . . 0.432 ' HE2' ' HA ' ' A' ' 402' ' ' PRO . 16.8 mmt -83.77 113.86 21.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.845 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.585 HG11 ' HB3' ' A' ' 414' ' ' LEU . 15.1 t -117.61 118.21 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.943 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.4 22.7 6.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.259 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.59 -14.01 64.7 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.905 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -100.82 147.79 34.15 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.788 0.328 . . . . 0.0 111.011 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 402' ' ' PRO . . . . . 0.432 ' HA ' ' HE2' ' A' ' 397' ' ' MET . 74.1 Cg_endo -75.22 136.01 19.42 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.67 2.247 . . . . 0.0 112.375 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 403' ' ' PHE . . . . . 0.436 ' CD2' ' HB ' ' A' ' 398' ' ' VAL . 77.4 m-85 -147.14 168.41 21.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.72 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 55.5 m -88.66 136.82 32.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.675 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -53.55 -41.67 66.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 0.0 110.988 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 26.4 m -67.96 -34.17 76.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.811 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -67.18 -31.25 71.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.051 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.895 HG21 HG11 ' A' ' 396' ' ' VAL . 84.9 t -67.8 -43.19 86.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.829 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.9 p -63.39 -29.79 71.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.073 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -74.44 -27.96 60.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.934 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 11.3 mtt-85 -124.57 92.99 47.08 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.823 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.13 -23.1 75.25 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.451 2.101 . . . . 0.0 112.411 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -62.47 -29.25 70.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.938 0.399 . . . . 0.0 110.982 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.585 ' HB3' HG11 ' A' ' 398' ' ' VAL . 25.7 mt -66.47 -35.98 81.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.722 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.9 t -62.89 -36.23 74.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -64.4 -29.13 70.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.944 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -81.1 -19.76 42.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.076 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 418' ' ' MET . . . . . 0.46 ' HG3' HG13 ' A' ' 398' ' ' VAL . 6.3 mtt -70.36 124.41 24.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.025 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.429 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 5.3 p -63.65 171.01 2.54 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.115 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.1 Cg_exo -54.5 -56.14 2.74 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.109 1.872 . . . . 0.0 112.118 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.77 -39.79 90.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.018 0.437 . . . . 0.0 109.844 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -65.49 -33.41 75.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.234 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.617 ' O ' HD12 ' A' ' 427' ' ' ILE . 54.9 tttm -65.18 -36.68 84.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.24 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -64.89 -45.87 84.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.597 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.08 -30.18 64.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.151 0.5 . . . . 0.0 110.647 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 426' ' ' TYR . . . . . 0.539 ' HD1' HG21 ' A' ' 396' ' ' VAL . 46.8 t80 -69.17 -48.31 62.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.165 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.617 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.2 mt -74.52 -33.69 33.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.434 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.27 -43.97 98.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.121 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.932 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.9 mm . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.948 0.404 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.956 HG11 HG21 ' A' ' 408' ' ' VAL . 14.6 p -125.75 141.07 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.69 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 17.9 mmt -82.21 113.89 20.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.88 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.449 ' HA ' ' HG2' ' A' ' 418' ' ' MET . 21.5 t -116.16 111.42 35.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.971 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.94 23.92 5.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.288 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.4 -19.25 51.69 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.752 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -99.61 145.32 29.91 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 111.012 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.06 135.93 19.61 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.679 2.253 . . . . 0.0 112.425 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 403' ' ' PHE . . . . . 0.645 ' O ' HG12 ' A' ' 396' ' ' VAL . 59.1 m-85 -147.04 155.65 42.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.79 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 10.9 p -75.97 137.37 40.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.51 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 405' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 55.2 t80 -55.21 -34.63 64.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.018 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 21.8 m -63.88 -38.13 89.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.985 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -69.84 -29.73 67.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.063 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.956 HG21 HG11 ' A' ' 396' ' ' VAL . 43.4 t -68.97 -49.33 64.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.02 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.9 p -66.86 -28.99 68.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.98 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -82.14 -23.58 35.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.106 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 21.7 mtt-85 -123.49 84.71 52.72 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -51.76 -25.51 20.97 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.626 2.217 . . . . 0.0 112.33 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -60.98 -36.21 78.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 72.1 mt -60.84 -40.75 94.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.888 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.46 -35.95 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.808 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.47 69.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -81.59 -16.72 50.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.044 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 418' ' ' MET . . . . . 0.449 ' HG2' ' HA ' ' A' ' 398' ' ' VAL . 3.7 mtt -72.01 127.1 31.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.162 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 1.3 p -66.75 166.7 17.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.173 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 65.9 Cg_exo -50.79 -56.24 3.28 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.26 1.974 . . . . 0.0 112.324 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.25 -39.84 88.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 109.975 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.8 -33.4 75.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.217 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.57 ' O ' HD12 ' A' ' 427' ' ' ILE . 77.4 tttt -64.92 -36.42 84.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.142 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -64.72 -46.22 83.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.512 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.55 -30.29 65.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.137 0.494 . . . . 0.0 110.591 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 426' ' ' TYR . . . . . 0.67 ' CE1' HG11 ' A' ' 408' ' ' VAL . 50.9 t80 -69.05 -47.75 64.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.275 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.57 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.6 mt -75.33 -33.64 28.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.464 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.16 96.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.073 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 429' ' ' MET . . . . . 0.488 ' HE1' ' HB ' ' A' ' 396' ' ' VAL . 71.2 mtm . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.833 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.4 mm . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.959 0.409 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.954 HG11 HG21 ' A' ' 408' ' ' VAL . 12.4 p -132.75 142.52 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.771 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 5.3 mmt -86.65 113.83 22.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 110.889 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.64 HG11 ' HB3' ' A' ' 414' ' ' LEU . 29.5 t -112.8 118.73 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.95 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.07 23.53 5.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.435 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.33 19.58 41.43 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.853 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -136.97 146.45 54.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.668 0.234 . . . . 0.0 110.89 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 402' ' ' PRO . . . . . 0.441 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 17.1 Cg_exo -66.81 135.62 38.89 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.439 2.093 . . . . 0.0 112.319 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 403' ' ' PHE . . . . . 0.582 ' HB2' HG23 ' A' ' 398' ' ' VAL . 20.6 m-85 -149.44 156.04 41.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.64 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 404' ' ' SER . . . . . 0.503 ' O ' HG23 ' A' ' 408' ' ' VAL . 56.2 m -76.27 133.79 39.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.704 0.288 . . . . 0.0 110.572 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -56.23 -41.56 75.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.006 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.9 m -64.57 -36.13 83.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.799 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.45 -29.13 68.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.144 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.954 HG21 HG11 ' A' ' 396' ' ' VAL . 48.7 t -66.49 -47.89 82.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.013 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.1 p -64.14 -29.2 70.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.005 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -81.71 -25.3 35.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.966 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -122.94 91.33 49.87 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.813 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.36 -22.42 74.07 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.5 2.133 . . . . 0.0 112.419 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -61.9 -30.23 70.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.983 0.421 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.64 ' HB3' HG11 ' A' ' 398' ' ' VAL . 20.7 mt -68.67 -36.77 78.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.597 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 22.5 t -64.94 -35.97 76.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.777 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.35 -26.0 66.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.083 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -92.16 -0.5 57.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.358 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 418' ' ' MET . . . . . 0.511 ' HG2' HG13 ' A' ' 398' ' ' VAL . 1.0 OUTLIER -87.47 125.9 34.57 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.74 0.305 . . . . 0.0 111.179 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 14.5 p -61.38 160.64 22.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.321 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 6.9 Cg_endo -49.11 -53.16 7.45 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.55 2.167 . . . . 0.0 112.246 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -60.02 -42.76 95.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 110.159 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -65.57 -32.91 74.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.162 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.553 ' O ' HD12 ' A' ' 427' ' ' ILE . 16.9 tptm -65.03 -37.21 86.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.175 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -64.6 -46.26 83.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.546 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.54 -30.22 65.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.17 0.51 . . . . 0.0 110.585 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 426' ' ' TYR . . . . . 0.626 ' CE1' HG11 ' A' ' 408' ' ' VAL . 46.9 t80 -69.0 -47.95 64.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.259 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.7 mt -75.13 -33.67 29.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.452 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -59.75 -42.87 94.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.132 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 69.1 mtm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 41.0 mm . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.973 0.416 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.97 HG11 HG21 ' A' ' 408' ' ' VAL . 14.8 p -130.24 143.26 41.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 18.3 mmt -87.18 113.83 23.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.704 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.811 HG11 ' HB3' ' A' ' 414' ' ' LEU . 21.3 t -117.25 118.66 59.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 51.41 26.41 3.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.478 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 89.15 20.49 45.69 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.823 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -137.06 143.22 41.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.681 0.277 . . . . 0.0 110.693 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.17 135.92 23.61 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.439 2.093 . . . . 0.0 112.611 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 403' ' ' PHE . . . . . 0.707 ' O ' HG12 ' A' ' 396' ' ' VAL . 46.8 m-85 -150.49 154.26 37.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.687 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 13.3 p -69.72 136.02 50.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.59 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -56.2 -39.77 72.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.062 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.6 m -64.3 -36.43 84.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.979 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -66.11 -30.95 71.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.095 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.97 HG21 HG11 ' A' ' 396' ' ' VAL . 44.6 t -70.9 -48.93 53.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.9 t -62.56 -31.77 72.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.998 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -81.66 -25.7 35.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.053 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 411' ' ' ARG . . . . . 0.445 ' O ' HD12 ' A' ' 414' ' ' LEU . 21.4 mtt180 -127.49 99.53 27.0 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.87 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.29 -15.37 42.29 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.446 2.097 . . . . 0.0 112.606 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -58.4 -33.34 69.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.019 0.438 . . . . 0.0 111.206 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.811 ' HB3' HG11 ' A' ' 398' ' ' VAL . 1.1 mt -72.11 -34.11 68.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.494 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 23.4 t -67.28 -32.98 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.612 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -69.45 -25.6 64.18 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.029 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -90.75 -13.17 34.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.282 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 418' ' ' MET . . . . . 0.637 ' HG2' HG13 ' A' ' 398' ' ' VAL . 1.7 mtt -74.61 124.54 26.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.802 0.334 . . . . 0.0 111.088 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.475 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 10.2 p -61.29 158.25 38.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.107 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 2.5 Cg_endo -45.52 -56.0 3.11 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.547 2.165 . . . . 0.0 112.346 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -60.2 -38.89 84.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.004 0.43 . . . . 0.0 110.002 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -66.41 -33.85 76.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.222 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.548 ' O ' HD12 ' A' ' 427' ' ' ILE . 82.4 tttt -64.85 -35.07 79.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.214 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -64.22 -46.36 84.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.61 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.04 -30.69 64.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.23 0.538 . . . . 0.0 110.603 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 426' ' ' TYR . . . . . 0.552 ' CE1' HG11 ' A' ' 408' ' ' VAL . 42.4 t80 -68.62 -48.37 64.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.254 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.6 mt -74.44 -33.56 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.473 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -58.91 -39.81 82.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.129 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.992 179.882 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.4 mm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.892 0.377 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.943 HG11 HG21 ' A' ' 408' ' ' VAL . 11.6 p -121.16 140.1 46.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.719 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 22.3 mmt -83.19 113.81 20.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.748 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.551 HG13 ' HG2' ' A' ' 418' ' ' MET . 31.4 t -110.61 107.17 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.27 22.9 6.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.254 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 104.99 -20.33 38.68 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.919 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -97.18 145.29 29.37 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.612 0.244 . . . . 0.0 111.096 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.79 135.98 18.31 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.677 2.252 . . . . 0.0 112.503 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 403' ' ' PHE . . . . . 0.517 ' O ' HG12 ' A' ' 396' ' ' VAL . 61.8 m-85 -148.52 156.98 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.687 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 404' ' ' SER . . . . . 0.55 ' O ' HG23 ' A' ' 408' ' ' VAL . 51.3 m -73.49 138.46 45.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.605 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -58.04 -42.27 85.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.934 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.8 t -64.76 -37.37 87.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.85 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -64.69 -29.33 70.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.033 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.943 HG21 HG11 ' A' ' 396' ' ' VAL . 49.0 t -68.48 -47.67 76.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.054 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.4 t -62.89 -31.04 72.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.997 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -74.01 -27.07 60.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.977 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -124.41 85.34 55.87 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.787 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -51.68 -26.82 24.21 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.585 2.19 . . . . 0.0 112.338 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.2 -29.14 70.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.976 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 59.2 mt -65.98 -37.21 85.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.728 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 25.7 t -63.45 -37.78 80.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.951 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.41 -30.77 71.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.077 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -74.13 -23.61 59.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.074 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 418' ' ' MET . . . . . 0.551 ' HG2' HG13 ' A' ' 398' ' ' VAL . 3.5 mtt -72.65 129.08 37.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.986 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.466 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.5 p -64.08 170.74 3.11 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.258 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 65.5 Cg_exo -51.65 -55.96 3.45 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.256 1.971 . . . . 0.0 112.386 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -58.84 -40.54 84.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.429 . . . . 0.0 110.092 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -65.42 -34.41 78.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.237 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -64.26 -36.58 84.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.187 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -64.92 -45.24 86.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.557 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.88 -30.53 65.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.167 0.508 . . . . 0.0 110.633 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 426' ' ' TYR . . . . . 0.516 ' CE1' HG11 ' A' ' 408' ' ' VAL . 79.0 t80 -69.15 -47.01 66.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.32 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 60.4 mt -76.28 -33.82 24.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.62 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.69 -43.13 94.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.143 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 429' ' ' MET . . . . . 0.537 ' HE1' HG23 ' A' ' 396' ' ' VAL . 71.5 mtm . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.972 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.5 mm . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.053 0.454 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.938 HG11 HG21 ' A' ' 408' ' ' VAL . 14.7 p -120.46 143.34 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.733 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.4 mmt -89.5 113.79 25.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.774 0.321 . . . . 0.0 110.68 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.53 HG23 ' HB2' ' A' ' 403' ' ' PHE . 27.3 t -114.8 125.68 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.915 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.94 24.37 5.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.349 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.81 19.89 55.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.767 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -137.05 154.99 76.36 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.601 0.238 . . . . 0.0 110.843 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 402' ' ' PRO . . . . . 0.413 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 12.8 Cg_exo -69.86 135.77 31.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.6 2.2 . . . . 0.0 112.309 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 403' ' ' PHE . . . . . 0.53 ' HB2' HG23 ' A' ' 398' ' ' VAL . 31.7 m-85 -150.56 155.71 39.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.461 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 404' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 408' ' ' VAL . 17.2 p -80.32 135.2 36.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.731 0.301 . . . . 0.0 110.588 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 405' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 61.3 t80 -56.0 -39.62 72.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.007 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 m -64.02 -38.3 90.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -66.82 -29.52 69.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.14 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.938 HG21 HG11 ' A' ' 396' ' ' VAL . 50.7 t -67.25 -47.51 81.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.991 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.7 t -63.04 -31.93 73.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -73.76 -26.67 60.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.969 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -124.1 95.26 44.15 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.789 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.2 -25.46 80.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.484 2.122 . . . . 0.0 112.21 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -62.95 -28.36 70.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.922 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 62.5 mt -67.07 -40.56 87.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 39.1 t -62.88 -36.27 74.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.722 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.79 -29.28 69.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.929 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -80.35 -19.38 46.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.052 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 418' ' ' MET . . . . . 0.43 ' HE3' HG11 ' A' ' 408' ' ' VAL . 6.0 mtt -70.35 128.12 35.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.046 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 3.2 p -68.65 172.02 5.29 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.143 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.4 Cg_exo -53.04 -56.02 3.17 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.188 1.925 . . . . 0.0 112.233 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.23 -41.55 88.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.0 0.428 . . . . 0.0 109.973 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.77 -33.68 76.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.139 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.609 ' O ' HD12 ' A' ' 427' ' ' ILE . 23.6 tptm -64.26 -38.29 90.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.16 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -65.51 -44.76 85.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.577 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.19 -29.92 66.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.136 0.493 . . . . 0.0 110.528 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 426' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 49.8 t80 -69.44 -47.12 65.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.202 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.4 mt -76.42 -33.81 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.53 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -65.86 -45.89 80.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.25 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 429' ' ' MET . . . . . 0.406 ' HE1' HG23 ' A' ' 396' ' ' VAL . 69.0 mtm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.929 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 34.5 mm . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.924 0.392 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.965 HG11 HG21 ' A' ' 408' ' ' VAL . 12.5 p -113.96 139.71 38.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.591 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 21.7 mmt -84.11 113.85 21.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.825 0.345 . . . . 0.0 110.815 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.451 HG23 ' HB2' ' A' ' 403' ' ' PHE . 22.0 t -112.23 112.46 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.838 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.28 22.86 6.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.304 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.97 -16.0 57.67 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.826 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -100.58 148.23 34.69 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.691 0.281 . . . . 0.0 111.052 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.78 136.01 20.3 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.641 2.227 . . . . 0.0 112.472 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 403' ' ' PHE . . . . . 0.483 ' O ' HG12 ' A' ' 396' ' ' VAL . 57.8 m-85 -149.23 156.34 41.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.68 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 404' ' ' SER . . . . . 0.433 ' O ' HG23 ' A' ' 408' ' ' VAL . 15.7 p -79.98 137.6 36.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.504 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 405' ' ' TYR . . . . . 0.498 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 57.5 t80 -55.33 -34.83 64.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.126 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 93.4 p -64.2 -40.67 96.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -67.63 -30.32 69.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.178 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.965 HG21 HG11 ' A' ' 396' ' ' VAL . 45.7 t -66.08 -48.92 79.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.6 t -64.84 -30.57 71.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.008 0.432 . . . . 0.0 110.978 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -77.46 -26.13 51.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.061 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -124.4 84.16 56.79 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.816 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -51.69 -24.91 18.92 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.65 2.233 . . . . 0.0 112.38 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -61.78 -29.81 70.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.002 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 32.3 mt -67.95 -37.76 81.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.728 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 38.9 t -64.36 -35.6 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.765 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.74 -29.97 70.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.879 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -80.21 -19.41 47.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.935 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 418' ' ' MET . . . . . 0.447 ' HG2' ' HA ' ' A' ' 398' ' ' VAL . 4.3 mtt -70.45 124.95 25.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.037 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 17.3 p -61.04 163.18 10.65 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.348 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 76.7 Cg_exo -48.07 -56.06 3.46 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.363 2.042 . . . . 0.0 112.382 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -59.49 -40.03 85.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.008 0.432 . . . . 0.0 110.0 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -65.11 -33.99 77.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.176 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.584 ' O ' HD12 ' A' ' 427' ' ' ILE . 20.9 tptm -63.58 -37.96 89.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.158 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -64.93 -46.18 82.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.569 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.78 -29.5 64.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.16 0.505 . . . . 0.0 110.655 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 426' ' ' TYR . . . . . 0.622 ' CE1' HG11 ' A' ' 408' ' ' VAL . 63.3 t80 -69.72 -47.67 62.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.217 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.5 mt -75.23 -33.98 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.416 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.94 76.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.103 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 59.4 mtp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 179.948 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.9 mm . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.868 0.366 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.941 HG11 HG21 ' A' ' 408' ' ' VAL . 12.4 p -124.05 141.47 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 18.6 mmt -83.36 114.95 21.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.825 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.634 HG23 ' HB2' ' A' ' 403' ' ' PHE . 60.0 t -114.25 106.54 20.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.591 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 63.95 16.55 9.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.342 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 109.57 -22.39 24.31 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.073 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 401' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 398' ' ' VAL . 11.7 ptm180 -99.0 149.76 36.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.85 0.357 . . . . 0.0 111.129 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.25 135.93 32.99 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.806 2.337 . . . . 0.0 113.012 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 403' ' ' PHE . . . . . 0.634 ' HB2' HG23 ' A' ' 398' ' ' VAL . 4.2 m-85 -139.32 172.17 13.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.696 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 404' ' ' SER . . . . . 0.528 ' O ' HG23 ' A' ' 408' ' ' VAL . 0.7 OUTLIER -93.89 130.45 39.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.457 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -54.24 -42.93 70.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.172 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 31.1 m -66.75 -34.85 78.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -67.62 -29.72 69.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.159 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.941 HG21 HG11 ' A' ' 396' ' ' VAL . 55.1 t -70.29 -47.46 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.058 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.9 t -61.6 -31.45 71.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.007 0.432 . . . . 0.0 111.036 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -75.9 -27.49 57.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.948 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -125.87 96.35 37.84 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.832 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.79 -23.94 74.49 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.465 2.11 . . . . 0.0 112.373 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -61.4 -29.25 69.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 110.954 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 408' ' ' VAL . 16.4 mt -67.38 -36.42 81.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.708 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.2 -37.03 78.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.86 -28.58 68.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.015 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -76.7 -22.88 53.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.053 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 418' ' ' MET . . . . . 0.46 ' CE ' HG22 ' A' ' 398' ' ' VAL . 5.0 mtt -71.11 129.29 38.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.464 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.3 p -63.91 171.18 2.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.206 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.4 Cg_exo -52.66 -56.09 3.16 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.179 1.919 . . . . 0.0 112.188 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -60.48 -38.69 85.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -65.45 -34.23 77.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.133 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.6 ' O ' HD12 ' A' ' 427' ' ' ILE . 11.3 tptm -64.34 -36.63 84.74 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.288 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -65.32 -44.36 88.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.597 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.76 -30.45 65.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.181 0.515 . . . . 0.0 110.528 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 426' ' ' TYR . . . . . 0.664 ' CE1' HG11 ' A' ' 408' ' ' VAL . 68.5 t80 -68.78 -47.57 65.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.31 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.2 mt -75.37 -34.03 29.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.532 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.77 -30.1 70.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.239 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 64.0 mtp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.04 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.7 mm . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.904 0.383 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.921 HG11 HG21 ' A' ' 408' ' ' VAL . 14.4 p -119.97 141.94 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.759 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 15.1 mmt -84.76 113.85 21.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.443 ' HA ' ' HG2' ' A' ' 418' ' ' MET . 18.7 t -114.81 113.01 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.944 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.86 23.9 5.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.306 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.85 56.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.804 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.61 146.38 31.73 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.732 0.301 . . . . 0.0 111.05 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.13 135.98 19.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.669 2.246 . . . . 0.0 112.529 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 403' ' ' PHE . . . . . 0.576 ' O ' HG12 ' A' ' 396' ' ' VAL . 62.1 m-85 -148.12 156.26 42.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.682 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 404' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 408' ' ' VAL . 17.3 p -74.82 138.59 42.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.58 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -56.88 -39.91 75.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.003 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.3 m -64.55 -38.21 90.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -65.87 -29.72 70.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.182 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.921 HG21 HG11 ' A' ' 396' ' ' VAL . 59.8 t -67.12 -46.3 84.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.946 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.7 p -65.02 -29.33 70.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.98 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -76.83 -26.14 53.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.947 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -123.7 95.03 45.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.801 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.02 -25.51 77.72 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.389 2.059 . . . . 0.0 112.252 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.34 -28.47 69.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.951 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 65.7 mt -66.57 -38.84 87.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.703 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.41 -36.17 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.735 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -64.62 -29.97 70.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.936 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -80.77 -18.25 48.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.974 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 418' ' ' MET . . . . . 0.443 ' HG2' ' HA ' ' A' ' 398' ' ' VAL . 5.3 mtt -72.71 126.44 29.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.176 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.446 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 2.8 p -69.14 172.57 4.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.049 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 50.5 Cg_exo -53.71 -56.09 2.96 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.188 1.925 . . . . 0.0 112.226 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.33 -41.92 90.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.923 0.392 . . . . 0.0 110.028 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.05 -33.35 75.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.34 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.579 ' O ' HD12 ' A' ' 427' ' ' ILE . 48.6 tttm -65.97 -36.62 83.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.308 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -65.03 -45.8 83.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.639 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.2 -29.48 65.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.11 0.481 . . . . 0.0 110.57 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 426' ' ' TYR . . . . . 0.531 ' CE1' HG11 ' A' ' 408' ' ' VAL . 43.9 t80 -69.82 -47.05 64.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.263 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.579 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.7 mt -76.44 -33.84 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.443 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -63.59 -45.88 88.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.127 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 429' ' ' MET . . . . . 0.467 ' HE1' HG23 ' A' ' 396' ' ' VAL . 66.9 mtm . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.4 mm . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.919 0.39 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.95 HG11 HG21 ' A' ' 408' ' ' VAL . 11.7 p -129.0 140.48 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.725 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 18.2 mmt -81.04 113.72 19.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.669 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.62 HG13 ' HG2' ' A' ' 418' ' ' MET . 23.2 t -115.68 110.44 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.57 23.31 5.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.295 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.19 -17.74 53.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.862 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 35.9 mtp85 -101.54 145.15 29.95 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.737 0.268 . . . . 0.0 111.095 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.29 135.92 19.16 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.689 2.259 . . . . 0.0 112.412 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 403' ' ' PHE . . . . . 0.608 ' O ' HG12 ' A' ' 396' ' ' VAL . 62.0 m-85 -147.4 157.52 43.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.787 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 404' ' ' SER . . . . . 0.586 ' O ' HG23 ' A' ' 408' ' ' VAL . 49.0 m -69.88 138.2 52.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.611 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -58.49 -41.59 85.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.979 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 95.4 p -66.25 -39.89 89.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.14 -29.22 69.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.131 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.95 HG21 HG11 ' A' ' 396' ' ' VAL . 49.4 t -68.46 -47.67 76.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.994 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.7 t -64.08 -30.12 71.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -75.71 -26.31 57.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.025 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -124.35 85.09 55.84 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.08 -27.25 28.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.611 2.207 . . . . 0.0 112.291 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -61.07 -29.27 69.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 63.3 mt -66.17 -37.54 85.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.761 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 37.5 t -63.68 -38.06 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.11 -28.48 68.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.066 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -80.05 -17.73 51.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.116 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 418' ' ' MET . . . . . 0.62 ' HG2' HG13 ' A' ' 398' ' ' VAL . 3.0 mtt -76.35 132.2 39.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.153 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 8.3 p -63.79 158.61 59.8 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.065 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 2.0 Cg_endo -45.05 -56.03 3.0 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.617 2.211 . . . . 0.0 112.257 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.25 -38.55 83.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.969 0.414 . . . . 0.0 109.956 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -66.0 -34.25 77.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.158 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.61 ' O ' HD12 ' A' ' 427' ' ' ILE . 74.9 tttt -63.52 -36.16 82.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.205 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -64.57 -45.46 86.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.634 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -56.87 -31.04 64.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.131 0.491 . . . . 0.0 110.594 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 426' ' ' TYR . . . . . 0.512 ' CE1' HG11 ' A' ' 408' ' ' VAL . 47.4 t80 -68.45 -48.23 65.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.218 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.61 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.1 mt -74.05 -34.03 37.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.519 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.63 83.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.061 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 65.1 mtm . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.826 179.849 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.6 mm . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.916 0.389 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.937 HG11 HG21 ' A' ' 408' ' ' VAL . 12.7 p -115.9 142.24 30.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.769 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 397' ' ' MET . . . . . 0.432 ' HE2' ' HA ' ' A' ' 402' ' ' PRO . 2.8 mmt -90.13 113.86 25.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.866 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.619 HG13 ' HG2' ' A' ' 418' ' ' MET . 39.2 t -110.63 119.09 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.011 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.95 27.68 11.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.363 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.88 23.51 45.43 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.785 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 75.8 mtm-85 -137.01 151.68 72.53 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.602 0.239 . . . . 0.0 110.688 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 402' ' ' PRO . . . . . 0.432 ' HA ' ' HE2' ' A' ' 397' ' ' MET . 57.7 Cg_endo -71.28 135.72 27.48 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.406 2.071 . . . . 0.0 112.411 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 403' ' ' PHE . . . . . 0.523 ' HB2' HG23 ' A' ' 398' ' ' VAL . 35.1 m-85 -150.67 172.09 16.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.668 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 404' ' ' SER . . . . . 0.728 ' O ' HG23 ' A' ' 408' ' ' VAL . 49.4 m -97.84 136.87 37.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.569 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 405' ' ' TYR . . . . . 0.428 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 41.3 t80 -57.11 -41.71 79.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.913 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.4 t -64.4 -39.57 94.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.843 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.86 -29.22 69.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.109 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.937 HG21 HG11 ' A' ' 396' ' ' VAL . 51.5 t -66.59 -47.49 83.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.016 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.0 p -64.45 -29.03 70.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.983 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -76.78 -25.65 53.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.01 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 38.7 mtt85 -124.76 85.57 56.89 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.794 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -51.79 -26.7 24.64 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.623 2.215 . . . . 0.0 112.295 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.61 -29.79 70.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.945 0.403 . . . . 0.0 111.009 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 67.7 mt -66.83 -36.86 83.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.74 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 415' ' ' VAL . . . . . 0.651 HG13 ' NZ ' ' A' ' 423' ' ' LYS . 43.2 t -64.71 -37.95 81.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.948 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -68.09 -28.39 67.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -77.3 -22.46 51.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.121 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 418' ' ' MET . . . . . 0.619 ' HG2' HG13 ' A' ' 398' ' ' VAL . 2.6 mtt -73.47 130.28 39.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.439 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.1 p -65.97 171.18 4.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.259 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 50.6 Cg_exo -53.91 -56.2 2.81 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.334 2.023 . . . . 0.0 112.418 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -58.33 -42.66 87.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.857 0.36 . . . . 0.0 110.216 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -65.96 -32.82 74.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.079 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.651 ' NZ ' HG13 ' A' ' 415' ' ' VAL . 0.5 OUTLIER -65.21 -36.69 84.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.168 179.371 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -64.6 -45.82 85.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.59 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.11 -30.81 64.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.119 0.485 . . . . 0.0 110.536 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 426' ' ' TYR . . . . . 0.552 ' CE1' HG11 ' A' ' 408' ' ' VAL . 63.5 t80 -68.46 -48.27 64.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.273 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.566 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.4 mt -74.47 -33.82 34.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.434 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.05 87.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.144 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 68.8 mtm . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.891 179.894 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.4 mm . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.923 0.392 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.959 HG11 HG21 ' A' ' 408' ' ' VAL . 11.8 p -127.44 139.75 51.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.763 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 19.4 mmt -81.0 113.82 19.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.824 0.345 . . . . 0.0 110.82 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.577 HG13 ' HG2' ' A' ' 418' ' ' MET . 21.7 t -115.3 110.27 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.03 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.02 24.38 4.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.28 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.9 -19.68 48.64 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.758 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -98.68 143.6 26.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.651 0.262 . . . . 0.0 110.958 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.56 135.91 16.79 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.651 2.234 . . . . 0.0 112.475 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 403' ' ' PHE . . . . . 0.571 ' O ' HG12 ' A' ' 396' ' ' VAL . 48.7 m-85 -148.47 161.1 42.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.714 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 404' ' ' SER . . . . . 0.619 ' O ' HG23 ' A' ' 408' ' ' VAL . 25.9 p -75.92 141.35 42.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.595 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -58.24 -40.8 82.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.908 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.7 t -63.59 -40.39 96.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -63.97 -28.79 70.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.959 HG21 HG11 ' A' ' 396' ' ' VAL . 37.7 t -70.32 -54.02 20.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.051 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 18.2 m -61.04 -30.17 70.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.94 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -76.19 -25.44 55.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.974 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -124.72 86.79 55.52 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.845 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -51.77 -25.51 21.05 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.559 2.173 . . . . 0.0 112.408 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -61.67 -30.7 70.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.934 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 408' ' ' VAL . 30.5 mt -68.07 -36.94 80.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.679 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.51 -36.49 77.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.813 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.98 -28.07 67.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.035 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -81.47 -17.16 49.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.227 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 418' ' ' MET . . . . . 0.577 ' HG2' HG13 ' A' ' 398' ' ' VAL . 2.9 mtt -77.02 130.93 38.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.151 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.502 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.6 p -67.25 159.07 79.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.982 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 1.2 Cg_endo -44.14 -53.35 4.8 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.694 2.263 . . . . 0.0 112.497 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.27 -41.59 93.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 0.0 110.207 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.46 -33.76 76.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.248 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -65.0 -35.13 80.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.115 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -63.24 -46.27 87.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.637 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.42 -31.51 67.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.222 0.534 . . . . 0.0 110.755 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 426' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -68.62 -46.01 70.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.207 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 58.3 mt -76.42 -35.92 27.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.705 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -65.68 -35.19 80.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.932 0.396 . . . . 0.0 111.176 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 60.2 mtp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 179.943 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 34.4 mm . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.921 0.391 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.96 HG11 HG21 ' A' ' 408' ' ' VAL . 12.6 p -125.22 140.34 48.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.686 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.8 mmt -85.55 113.75 22.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.065 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.687 HG23 ' HB2' ' A' ' 403' ' ' PHE . 34.6 t -111.03 120.08 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.851 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.73 23.25 6.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.466 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.81 21.02 37.85 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.825 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -137.11 149.67 66.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.563 0.22 . . . . 0.0 110.74 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 402' ' ' PRO . . . . . 0.426 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 18.2 Cg_exo -66.29 135.66 40.76 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.474 2.116 . . . . 0.0 112.338 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 403' ' ' PHE . . . . . 0.687 ' HB2' HG23 ' A' ' 398' ' ' VAL . 17.3 m-85 -148.42 172.13 14.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 404' ' ' SER . . . . . 0.719 ' O ' HG23 ' A' ' 408' ' ' VAL . 22.3 p -97.71 135.37 39.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.431 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 405' ' ' TYR . . . . . 0.499 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 45.8 t80 -56.98 -39.57 74.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.122 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.1 m -64.44 -39.7 94.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.093 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -68.24 -28.89 67.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.96 HG21 HG11 ' A' ' 396' ' ' VAL . 24.3 t -68.25 -55.97 14.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.068 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 1.4 m -59.23 -29.99 67.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -73.74 -26.26 60.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.861 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 41.4 mtt-85 -125.04 87.47 55.41 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.817 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.97 -26.43 18.46 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.535 2.157 . . . . 0.0 112.408 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.52 -28.52 69.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.031 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.654 HD12 ' HA ' ' A' ' 408' ' ' VAL . 68.6 mt -66.56 -39.58 88.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.845 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.5 -37.07 78.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.009 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -68.41 -28.85 67.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.034 0.445 . . . . 0.0 111.158 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -80.11 -19.71 46.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.119 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 418' ' ' MET . . . . . 0.535 ' HG2' HG13 ' A' ' 398' ' ' VAL . 2.8 mtt -75.46 133.33 41.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.055 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.487 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 6.7 p -62.63 158.41 50.86 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.015 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 2.6 Cg_endo -45.65 -52.85 6.27 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.624 2.216 . . . . 0.0 112.377 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -60.09 -43.38 95.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.925 0.393 . . . . 0.0 110.168 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -65.07 -33.25 75.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.196 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.654 ' O ' HD12 ' A' ' 427' ' ' ILE . 41.2 tttt -64.66 -38.07 89.74 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.085 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -65.02 -45.24 86.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.588 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.34 -30.4 64.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.211 0.529 . . . . 0.0 110.712 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 426' ' ' TYR . . . . . 0.499 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 56.1 t80 -69.19 -47.89 63.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.248 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.654 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.0 mt -74.69 -33.72 32.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.497 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.66 -39.49 88.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.167 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.833 179.955 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.4 mm . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.933 0.397 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.932 HG11 HG21 ' A' ' 408' ' ' VAL . 11.4 p -117.7 139.34 45.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.688 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 397' ' ' MET . . . . . 0.434 ' HE2' ' HA ' ' A' ' 402' ' ' PRO . 2.3 mmt -86.9 113.85 23.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.95 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' A' ' 403' ' ' PHE . 39.9 t -110.03 119.58 59.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.816 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 57.2 24.82 10.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.323 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 88.44 22.07 41.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.835 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 29.4 mtt-85 -136.94 150.71 70.51 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.607 0.242 . . . . 0.0 110.813 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 402' ' ' PRO . . . . . 0.434 ' HA ' ' HE2' ' A' ' 397' ' ' MET . 17.7 Cg_exo -66.52 135.64 39.93 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.47 2.113 . . . . 0.0 112.372 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 403' ' ' PHE . . . . . 0.66 ' HB2' HG23 ' A' ' 398' ' ' VAL . 17.9 m-85 -148.82 171.99 15.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.606 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 404' ' ' SER . . . . . 0.675 ' O ' HG23 ' A' ' 408' ' ' VAL . 53.6 p -100.32 134.81 42.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.559 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 405' ' ' TYR . . . . . 0.481 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 28.3 t80 -56.03 -37.36 69.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 21.7 m -66.46 -41.63 88.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.099 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -66.28 -29.71 69.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 111.256 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.932 HG21 HG11 ' A' ' 396' ' ' VAL . 44.1 t -65.81 -48.91 80.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.102 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.1 p -64.49 -29.25 70.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -77.91 -25.91 48.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.02 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -124.1 85.76 54.51 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.87 -26.81 18.9 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.569 2.179 . . . . 0.0 112.398 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.31 -28.25 69.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.034 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 408' ' ' VAL . 71.8 mt -66.48 -39.25 88.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.833 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 38.6 t -63.82 -38.15 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.78 -28.86 67.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.11 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -76.07 -22.88 55.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.053 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 418' ' ' MET . . . . . 0.601 ' HG2' HG13 ' A' ' 398' ' ' VAL . 2.8 mtt -74.21 133.68 42.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.444 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 3.8 p -66.69 171.25 4.59 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.11 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 51.1 Cg_exo -53.27 -56.06 3.08 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.247 1.965 . . . . 0.0 112.368 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.0 -41.53 87.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.072 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -65.83 -33.02 74.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.094 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 423' ' ' LYS . . . . . 0.694 ' O ' HD12 ' A' ' 427' ' ' ILE . 79.9 tttt -64.43 -37.21 86.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.1 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -65.4 -45.09 85.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.527 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -56.94 -30.53 64.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.21 0.528 . . . . 0.0 110.537 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 426' ' ' TYR . . . . . 0.646 ' CE1' HG11 ' A' ' 408' ' ' VAL . 64.3 t80 -68.49 -48.82 63.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.132 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 427' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 423' ' ' LYS . 3.6 mt -73.14 -35.16 46.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.3 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -71.59 -29.23 64.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.065 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 57.7 mtp . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.899 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.9 mm . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.859 0.361 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 396' ' ' VAL . . . . . 0.897 HG11 HG21 ' A' ' 408' ' ' VAL . 13.4 p -116.16 137.61 49.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.732 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 397' ' ' MET . . . . . 0.437 ' HE2' ' HA ' ' A' ' 402' ' ' PRO . 2.1 mmt -85.74 113.94 22.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.04 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 398' ' ' VAL . . . . . 0.54 HG23 ' HB2' ' A' ' 403' ' ' PHE . 33.2 t -114.92 123.87 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.928 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.66 26.88 11.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.23 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.44 22.63 56.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.647 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -137.07 153.34 75.11 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.665 0.269 . . . . 0.0 110.931 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 402' ' ' PRO . . . . . 0.437 ' HA ' ' HE2' ' A' ' 397' ' ' MET . 48.4 Cg_endo -68.88 135.97 34.08 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.518 2.145 . . . . 0.0 112.339 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 403' ' ' PHE . . . . . 0.54 ' HB2' HG23 ' A' ' 398' ' ' VAL . 14.4 m-85 -146.65 171.54 14.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 50.8 m -97.48 129.71 44.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.619 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -52.29 -40.31 61.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.027 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 41.6 t -67.61 -35.26 78.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.738 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.87 -30.8 70.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.051 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 408' ' ' VAL . . . . . 0.897 HG21 HG11 ' A' ' 396' ' ' VAL . 81.9 t -69.83 -44.55 78.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.869 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 32.9 t -62.95 -30.91 71.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.989 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -75.48 -26.59 58.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.996 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 14.6 mtt85 -125.86 84.89 60.17 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.883 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.37 -24.99 23.0 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.597 2.198 . . . . 0.0 112.371 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -61.23 -29.31 69.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.976 0.417 . . . . 0.0 111.064 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 414' ' ' LEU . . . . . 0.508 HD12 ' HA ' ' A' ' 408' ' ' VAL . 28.8 mt -66.39 -36.23 82.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.761 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.68 -37.71 80.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.4 70.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.035 0.445 . . . . 0.0 111.008 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -79.57 -21.18 45.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.0 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 418' ' ' MET . . . . . 0.443 ' HE3' HG11 ' A' ' 408' ' ' VAL . 7.3 mtt -69.19 123.72 21.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.033 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 419' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 7.0 p -61.53 167.77 3.94 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.172 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 420' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 62.4 Cg_exo -51.47 -56.07 3.36 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.288 1.992 . . . . 0.0 112.155 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -59.98 -39.84 87.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 109.882 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.11 -34.23 77.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.27 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -64.82 -36.66 85.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.197 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -64.27 -46.24 84.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.474 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.42 -30.49 66.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.167 0.508 . . . . 0.0 110.607 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 426' ' ' TYR . . . . . 0.567 ' HD1' HG21 ' A' ' 396' ' ' VAL . 75.1 t80 -69.37 -46.42 66.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.259 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 58.7 mt -77.19 -33.66 20.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.574 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -63.4 -38.38 90.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.249 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 60.0 mtm . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.935 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 52.0 t0 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.803 0.335 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -109.78 154.03 23.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.92 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -92.2 135.34 34.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -99.69 29.02 4.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.001 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -93.94 16.27 14.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.228 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -95.5 111.97 23.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.787 0.327 . . . . 0.0 110.834 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -132.6 139.89 48.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -114.29 126.51 55.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -143.66 153.96 43.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.98 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -152.13 79.94 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.915 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.2 t -137.27 128.98 41.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.054 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -175.88 147.51 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.162 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -81.16 140.82 34.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.812 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -60.91 139.95 93.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.48 166.05 30.31 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.494 2.129 . . . . 0.0 112.418 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.5 mm -104.41 135.01 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.034 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.93 HG11 HG21 ' A' ' 408' ' ' VAL . 13.8 p -115.57 142.57 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.803 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.6 mmt -90.81 113.83 26.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.808 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.608 HG22 ' CE ' ' A' ' 418' ' ' MET . 38.1 t -111.75 120.92 63.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.981 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.23 27.34 9.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.439 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.48 23.51 46.99 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.731 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -137.02 152.27 73.61 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.669 0.271 . . . . 0.0 110.738 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.402 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 58.3 Cg_endo -71.73 135.84 26.74 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.454 2.103 . . . . 0.0 112.406 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 403' ' ' PHE . . . . . 0.493 ' HB2' HG23 ' A' ' 398' ' ' VAL . 36.2 m-85 -150.52 172.04 16.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.674 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 404' ' ' SER . . . . . 0.668 ' O ' HG23 ' A' ' 408' ' ' VAL . 24.8 p -98.59 136.9 38.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.552 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 405' ' ' TYR . . . . . 0.484 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 35.1 t80 -56.84 -39.31 74.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.032 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.1 m -64.73 -40.68 95.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -66.61 -29.54 69.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.192 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.93 HG21 HG11 ' A' ' 396' ' ' VAL . 48.1 t -68.14 -47.68 77.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.04 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 87.1 p -61.39 -30.39 70.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.941 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -74.07 -26.88 60.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.893 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -125.6 94.89 41.63 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.75 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.31 -23.1 76.36 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.462 2.108 . . . . 0.0 112.367 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.71 -29.05 70.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.701 HD12 ' HA ' ' A' ' 408' ' ' VAL . 30.2 mt -65.09 -38.48 90.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.721 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.4 t -62.61 -39.85 86.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.965 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.1 -27.57 67.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.128 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -80.87 -20.5 42.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.165 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 418' ' ' MET . . . . . 0.608 ' CE ' HG22 ' A' ' 398' ' ' VAL . 3.0 mtt -73.64 131.85 42.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.955 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 6.4 p -63.13 167.37 6.43 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.356 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 53.5 Cg_exo -52.4 -56.07 3.22 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.31 2.007 . . . . 0.0 112.187 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 54.4 mp0 -59.67 -40.17 86.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.01 0.433 . . . . 0.0 109.946 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -65.3 -33.78 76.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.183 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.612 ' O ' HD12 ' A' ' 427' ' ' ILE . 85.0 tttt -65.16 -36.75 85.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.199 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -65.0 -45.45 85.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.528 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.31 -30.37 64.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.147 0.499 . . . . 0.0 110.567 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 426' ' ' TYR . . . . . 0.541 ' CE1' HG11 ' A' ' 408' ' ' VAL . 58.4 t80 -68.87 -48.05 64.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.223 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.2 mt -75.13 -33.54 29.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.512 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.65 -43.0 99.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.208 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 68.9 mtm -60.43 -37.75 81.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.948 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.66 -44.9 96.49 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.527 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -64.64 -38.6 91.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.777 0.322 . . . . 0.0 110.927 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -60.48 -39.01 86.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.019 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 70.2 mtm -75.08 -25.94 58.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.237 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 434' ' ' PHE . . . . . 0.702 ' HA ' HD13 ' A' ' 437' ' ' LEU . 6.1 t80 -99.9 29.8 4.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.017 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -79.87 -21.21 44.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.263 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 436' ' ' ASP . . . . . 0.507 ' C ' HD12 ' A' ' 437' ' ' LEU . 52.1 t0 -145.06 80.51 1.62 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.965 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.702 HD13 ' HA ' ' A' ' 434' ' ' PHE . 3.8 mp -148.51 80.6 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -104.07 132.77 49.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.961 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.939 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.777 0.322 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -103.15 136.38 43.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.958 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.55 143.33 42.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.966 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -97.49 142.39 29.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.885 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -59.69 -38.81 82.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 385' ' ' ASP . . . . . 0.407 ' HB3' ' CE2' ' A' ' 387' ' ' PHE . 89.6 m-20 -135.17 164.35 27.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.838 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -133.09 80.01 1.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.407 ' CE2' ' HB3' ' A' ' 385' ' ' ASP . 99.1 m-85 -121.84 152.3 39.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.821 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -150.82 -65.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -108.39 135.32 49.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.952 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.1 t -125.77 135.07 65.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.135 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -147.65 150.99 35.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.123 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -105.13 154.32 20.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.97 149.86 40.61 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.07 160.75 48.51 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.565 2.177 . . . . 0.0 112.351 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.9 mm -84.83 148.7 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.111 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.937 HG11 HG21 ' A' ' 408' ' ' VAL . 12.0 p -127.48 141.07 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.742 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 16.1 mmt -84.26 113.68 21.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.825 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.501 HG13 ' HG2' ' A' ' 418' ' ' MET . 32.8 t -111.76 108.6 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.808 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.76 22.54 7.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.256 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.83 -17.48 49.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.931 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 -100.21 146.04 31.27 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.678 0.275 . . . . 0.0 111.047 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.79 135.92 20.16 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.649 2.233 . . . . 0.0 112.494 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 403' ' ' PHE . . . . . 0.544 ' O ' HG12 ' A' ' 396' ' ' VAL . 57.4 m-85 -148.33 158.75 44.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.751 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 404' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 408' ' ' VAL . 18.0 p -76.92 137.8 39.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.646 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 405' ' ' TYR . . . . . 0.493 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 57.6 t80 -57.58 -40.57 79.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.948 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.0 m -63.49 -39.02 93.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -66.11 -29.39 69.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.937 HG21 HG11 ' A' ' 396' ' ' VAL . 57.1 t -67.41 -46.94 82.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.963 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.8 p -64.22 -29.3 70.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.026 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -75.89 -26.2 56.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.919 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 35.9 mtt-85 -124.0 97.2 41.24 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.824 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.72 -25.59 78.95 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.345 2.03 . . . . 0.0 112.272 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -62.84 -28.47 70.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' A' ' 408' ' ' VAL . 68.7 mt -66.05 -40.24 90.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.846 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.4 -38.38 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.969 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.88 67.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.073 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -79.07 -19.1 52.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.114 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 418' ' ' MET . . . . . 0.501 ' HG2' HG13 ' A' ' 398' ' ' VAL . 3.5 mtt -74.41 129.3 37.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.067 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.476 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 8.7 p -61.69 158.07 43.85 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.208 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 3.0 Cg_endo -45.79 -56.07 3.11 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.661 2.241 . . . . 0.0 112.244 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.1 -38.42 82.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 0.0 109.937 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 422' ' ' GLU . . . . . 0.414 ' OE1' HG23 ' A' ' 419' ' ' THR . 96.0 mt-10 -66.05 -34.53 78.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.159 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -63.23 -36.22 82.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.116 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -64.84 -43.12 94.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.474 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -59.5 -31.69 69.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.193 0.52 . . . . 0.0 110.473 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 426' ' ' TYR . . . . . 0.523 ' HD1' HG21 ' A' ' 396' ' ' VAL . 57.2 t80 -67.78 -45.1 75.81 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.282 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 61.9 mt -79.46 -33.76 15.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.794 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -68.39 -43.26 77.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.336 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 429' ' ' MET . . . . . 0.526 ' HE1' HG23 ' A' ' 396' ' ' VAL . 49.4 mtm -56.31 -35.0 67.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.14 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.38 -46.8 93.3 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.489 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -71.13 -36.64 72.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.772 0.32 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -56.23 -32.46 64.48 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.13 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 433' ' ' MET . . . . . 0.743 ' O ' HD12 ' A' ' 437' ' ' LEU . 73.3 mtm -59.27 -25.37 64.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.167 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -117.42 14.73 14.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.423 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -80.01 -23.99 41.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.744 0.307 . . . . 0.0 111.151 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -157.84 86.1 0.91 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.034 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.743 HD12 ' O ' ' A' ' 433' ' ' MET . 20.5 mt -158.08 87.07 0.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -103.24 131.73 50.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.883 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.909 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 47.1 p30 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.826 0.346 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -101.69 142.26 33.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -79.98 150.54 30.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -79.81 -37.55 34.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.961 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -175.87 -46.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.984 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -158.02 163.61 37.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -100.64 163.33 12.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -89.6 132.67 35.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -105.13 142.13 35.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -103.16 146.07 28.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 p -126.86 142.17 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.08 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -110.46 156.73 20.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.02 162.11 25.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.813 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -60.92 142.72 92.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.918 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.33 165.19 33.21 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.599 2.199 . . . . 0.0 112.366 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.0 mm -99.66 148.64 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.977 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.931 HG11 HG21 ' A' ' 408' ' ' VAL . 14.7 p -124.92 142.48 41.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.86 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 15.2 mmt -85.83 113.81 22.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.647 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.414 ' HA ' ' HG2' ' A' ' 418' ' ' MET . 12.6 t -118.75 114.56 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.95 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.41 22.67 6.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.268 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.33 -17.36 57.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.872 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -100.69 146.24 31.73 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.722 0.296 . . . . 0.0 111.032 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.77 135.98 16.47 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.661 2.241 . . . . 0.0 112.525 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 403' ' ' PHE . . . . . 0.624 ' O ' HG12 ' A' ' 396' ' ' VAL . 86.1 m-85 -148.18 157.73 43.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.771 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 404' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 408' ' ' VAL . 49.4 m -71.38 139.98 49.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.527 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -58.01 -40.95 82.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.994 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.3 t -65.86 -38.81 89.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.64 -29.9 70.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.931 HG21 HG11 ' A' ' 396' ' ' VAL . 60.3 t -68.76 -46.3 79.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.004 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.5 p -63.14 -28.94 70.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -74.31 -26.25 60.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.019 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -124.35 87.18 54.19 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.859 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -51.8 -27.21 26.33 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.6 2.2 . . . . 0.0 112.36 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.24 -28.29 69.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 408' ' ' VAL . 69.5 mt -66.57 -38.75 87.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.788 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.25 -37.72 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.02 -28.57 68.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.014 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -79.68 -17.63 53.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.141 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 418' ' ' MET . . . . . 0.419 ' HE3' HG11 ' A' ' 408' ' ' VAL . 7.6 mtt -72.64 132.21 43.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.199 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.467 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 2.9 p -74.6 173.08 7.27 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.066 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.4 Cg_exo -52.94 -55.98 3.23 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.169 1.912 . . . . 0.0 112.264 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -59.83 -40.19 87.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.01 0.433 . . . . 0.0 109.931 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -65.29 -34.23 77.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.229 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -64.49 -36.84 85.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.148 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -63.63 -47.18 82.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.615 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -59.59 -29.71 68.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.12 0.486 . . . . 0.0 110.578 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 426' ' ' TYR . . . . . 0.405 ' CE1' HG11 ' A' ' 408' ' ' VAL . 85.1 t80 -70.11 -45.14 67.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.162 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 57.7 mt -77.92 -35.55 20.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.695 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.76 83.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.827 0.346 . . . . 0.0 111.082 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 76.3 mtp -61.86 -37.29 83.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.22 -36.78 90.24 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.42 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.92 -38.83 83.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -64.99 -32.88 74.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.948 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 87.5 mtp -59.02 -25.59 63.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.135 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -79.91 -6.95 58.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.432 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -79.85 -21.97 43.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.709 0.29 . . . . 0.0 111.119 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -153.41 84.72 1.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.942 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.25 83.69 1.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.832 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -109.19 135.98 49.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.887 -179.942 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.809 0.337 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -80.05 141.07 36.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -117.98 150.44 39.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.85 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -102.63 -72.66 0.68 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.009 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.33 -41.3 93.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -92.75 118.02 30.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -124.52 136.21 53.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.838 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -122.61 154.33 38.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -107.16 139.34 41.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -116.31 153.81 31.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.914 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 p -131.78 141.9 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.07 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -63.75 147.65 51.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -79.94 135.82 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.05 157.06 87.41 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.96 163.66 32.88 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.604 2.203 . . . . 0.0 112.284 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.8 mm -95.37 147.65 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.089 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.959 HG11 HG21 ' A' ' 408' ' ' VAL . 12.4 p -129.59 141.94 45.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.906 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 17.8 mmt -82.58 113.76 20.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.817 0.341 . . . . 0.0 110.629 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.686 HG13 ' HG2' ' A' ' 418' ' ' MET . 22.0 t -117.87 112.73 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.965 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.36 23.46 5.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.283 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.11 -15.63 59.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.801 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -103.55 145.82 31.32 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.735 0.303 . . . . 0.0 111.046 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.4 136.03 19.1 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.628 2.219 . . . . 0.0 112.455 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 403' ' ' PHE . . . . . 0.651 ' O ' HG12 ' A' ' 396' ' ' VAL . 64.0 m-85 -147.1 156.9 43.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.751 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 404' ' ' SER . . . . . 0.53 ' O ' HG23 ' A' ' 408' ' ' VAL . 50.0 m -69.04 137.75 53.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.645 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -58.16 -43.3 87.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.958 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.0 t -64.89 -37.44 87.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.19 -29.46 70.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.959 HG21 HG11 ' A' ' 396' ' ' VAL . 53.2 t -69.8 -47.36 70.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.999 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.2 p -64.49 -29.04 70.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.022 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -76.76 -26.35 54.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.974 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -124.16 85.29 55.03 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -51.58 -26.77 23.35 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.595 2.197 . . . . 0.0 112.344 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.0 -28.36 69.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 408' ' ' VAL . 70.0 mt -66.11 -36.75 83.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.797 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 39.7 t -63.92 -38.88 83.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.961 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.76 -28.86 68.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.113 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -76.56 -22.08 54.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.094 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 418' ' ' MET . . . . . 0.686 ' HG2' HG13 ' A' ' 398' ' ' VAL . 4.1 mtt -72.72 130.08 39.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.939 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 3.9 p -65.76 171.49 3.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.072 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 50.2 Cg_exo -53.36 -56.07 3.05 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.196 1.93 . . . . 0.0 112.154 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.01 -37.82 83.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.018 0.437 . . . . 0.0 109.842 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -66.94 -33.38 75.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.249 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.852 ' O ' HD12 ' A' ' 427' ' ' ILE . 0.0 OUTLIER -65.73 -34.08 77.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.203 179.509 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -64.5 -45.62 86.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.65 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.07 -30.92 64.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.145 0.498 . . . . 0.0 110.653 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 426' ' ' TYR . . . . . 0.544 ' CE1' HG11 ' A' ' 408' ' ' VAL . 63.8 t80 -68.51 -48.37 64.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.088 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.852 HD12 ' O ' ' A' ' 423' ' ' LYS . 3.2 mt -73.2 -35.44 47.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.565 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -65.42 -49.14 70.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.173 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 429' ' ' MET . . . . . 0.683 ' CE ' HG23 ' A' ' 396' ' ' VAL . 71.5 mtm -62.12 -36.93 83.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.844 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.43 -35.92 87.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.445 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.02 -40.37 89.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.331 . . . . 0.0 110.843 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -66.24 -32.02 73.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.884 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 94.2 mmm -58.52 -24.2 59.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.139 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 434' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 434' ' ' PHE . 68.2 t80 -94.56 20.58 8.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -79.98 -23.51 41.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.802 0.334 . . . . 0.0 111.023 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -143.21 80.03 1.66 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.787 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.87 82.1 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.823 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -124.69 161.36 26.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 50.2 mp0 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.9 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.804 0.335 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -110.77 158.72 18.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -97.57 154.37 17.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 50.2 mp0 -79.98 85.13 5.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -135.76 160.93 37.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -103.86 154.27 19.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -122.23 153.43 38.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -101.64 125.9 48.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.843 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -132.03 141.15 49.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -99.12 130.61 45.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.926 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.2 133.85 67.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.157 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -109.75 151.55 26.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.993 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -79.99 89.44 5.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.08 163.79 27.71 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.38 152.59 78.75 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.591 2.194 . . . . 0.0 112.284 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.3 mm -71.71 152.27 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.11 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.956 HG11 HG21 ' A' ' 408' ' ' VAL . 13.9 p -131.43 142.11 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.893 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 17.2 mmt -84.47 113.7 21.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.597 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.627 HG13 ' HG2' ' A' ' 418' ' ' MET . 22.3 t -118.18 113.6 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.977 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.62 23.17 5.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.295 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.43 -13.82 61.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.956 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 6.8 mtt85 -104.75 146.3 32.37 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.722 0.296 . . . . 0.0 110.991 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.04 136.0 17.85 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.667 2.245 . . . . 0.0 112.526 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 403' ' ' PHE . . . . . 0.651 ' O ' HG12 ' A' ' 396' ' ' VAL . 71.0 m-85 -147.65 158.92 44.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.738 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 404' ' ' SER . . . . . 0.544 ' O ' HG23 ' A' ' 408' ' ' VAL . 63.6 m -71.34 138.76 49.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.694 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -58.25 -43.72 88.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 m -64.69 -38.06 89.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.919 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.73 -29.31 70.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.956 HG21 HG11 ' A' ' 396' ' ' VAL . 60.4 t -70.65 -46.79 67.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.012 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.8 t -63.09 -31.28 72.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.026 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -73.87 -26.72 60.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.001 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -123.77 96.75 42.55 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.785 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.22 -25.94 77.21 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.393 2.062 . . . . 0.0 112.299 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -62.75 -28.61 70.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.95 -38.11 85.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.731 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 35.7 t -63.65 -37.81 80.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.847 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.88 -29.05 68.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.993 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -76.24 -22.06 55.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.063 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 418' ' ' MET . . . . . 0.627 ' HG2' HG13 ' A' ' 398' ' ' VAL . 3.8 mtt -71.88 129.56 38.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.446 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.9 p -64.3 169.95 4.2 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.145 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 51.0 Cg_exo -53.14 -56.05 3.12 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.155 1.904 . . . . 0.0 112.161 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 54.2 mp0 -60.69 -38.31 84.56 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -65.99 -34.61 78.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.288 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -65.26 -34.76 79.11 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.226 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -64.76 -44.7 89.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.76 -30.4 67.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.222 0.534 . . . . 0.0 110.631 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 426' ' ' TYR . . . . . 0.541 ' CE1' HG11 ' A' ' 408' ' ' VAL . 76.4 t80 -69.38 -45.95 68.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.294 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.8 -33.77 19.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.751 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.43 -36.16 77.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.341 . . . . 0.0 111.227 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 67.4 mtm -59.61 -35.27 74.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.942 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.14 -43.51 95.26 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.428 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -65.39 -36.98 85.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 0.0 110.801 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -61.95 -30.43 70.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 433' ' ' MET . . . . . 0.48 ' O ' HD12 ' A' ' 437' ' ' LEU . 95.9 mmm -57.51 -27.82 62.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.1 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -79.97 -17.97 51.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.172 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -79.89 -18.06 51.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.266 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -143.27 79.95 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.859 0.362 . . . . 0.0 110.948 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 433' ' ' MET . 8.1 mt -148.26 79.91 1.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.902 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -123.76 146.29 48.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.299 -0.857 . . . . 0.0 110.881 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.806 0.336 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -110.74 145.7 37.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.942 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -113.53 135.89 53.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -122.56 139.89 53.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -133.15 27.38 4.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.047 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -159.19 162.44 36.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -82.54 122.06 27.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -107.9 132.4 53.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.927 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -111.23 148.75 32.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -113.12 155.64 24.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.934 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 390' ' ' VAL . 7.7 p -107.13 79.88 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.043 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . 58.4 164.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 48.2 p30 -102.24 173.66 6.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.919 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.01 144.63 90.51 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.897 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 394' ' ' PRO . . . . . 0.415 ' HG3' ' HE2' ' A' ' 433' ' ' MET . 53.2 Cg_endo -69.26 161.68 44.87 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.574 2.182 . . . . 0.0 112.307 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.3 mm -98.84 137.27 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.088 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.895 HG11 HG21 ' A' ' 408' ' ' VAL . 13.6 p -114.02 135.52 53.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.751 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 397' ' ' MET . . . . . 0.432 ' HE2' ' HA ' ' A' ' 402' ' ' PRO . 16.8 mmt -83.77 113.86 21.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.845 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.585 HG11 ' HB3' ' A' ' 414' ' ' LEU . 15.1 t -117.61 118.21 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.943 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.4 22.7 6.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.259 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.59 -14.01 64.7 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.905 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -100.82 147.79 34.15 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.788 0.328 . . . . 0.0 111.011 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.432 ' HA ' ' HE2' ' A' ' 397' ' ' MET . 74.1 Cg_endo -75.22 136.01 19.42 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.67 2.247 . . . . 0.0 112.375 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 403' ' ' PHE . . . . . 0.436 ' CD2' ' HB ' ' A' ' 398' ' ' VAL . 77.4 m-85 -147.14 168.41 21.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.72 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 55.5 m -88.66 136.82 32.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.675 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 405' ' ' TYR . . . . . 0.445 ' CD2' ' CE ' ' A' ' 433' ' ' MET . 42.2 t80 -53.55 -41.67 66.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 0.0 110.988 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 26.4 m -67.96 -34.17 76.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.811 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -67.18 -31.25 71.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.051 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.895 HG21 HG11 ' A' ' 396' ' ' VAL . 84.9 t -67.8 -43.19 86.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.829 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.9 p -63.39 -29.79 71.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.073 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -74.44 -27.96 60.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.934 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 11.3 mtt-85 -124.57 92.99 47.08 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.823 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.13 -23.1 75.25 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.451 2.101 . . . . 0.0 112.411 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -62.47 -29.25 70.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.938 0.399 . . . . 0.0 110.982 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.585 ' HB3' HG11 ' A' ' 398' ' ' VAL . 25.7 mt -66.47 -35.98 81.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.722 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.9 t -62.89 -36.23 74.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -64.4 -29.13 70.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.944 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -81.1 -19.76 42.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.076 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 418' ' ' MET . . . . . 0.46 ' HG3' HG13 ' A' ' 398' ' ' VAL . 6.3 mtt -70.36 124.41 24.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.025 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.429 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 5.3 p -63.65 171.01 2.54 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.115 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.1 Cg_exo -54.5 -56.14 2.74 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.109 1.872 . . . . 0.0 112.118 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.77 -39.79 90.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.018 0.437 . . . . 0.0 109.844 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -65.49 -33.41 75.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.234 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.617 ' O ' HD12 ' A' ' 427' ' ' ILE . 54.9 tttm -65.18 -36.68 84.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.24 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -64.89 -45.87 84.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.597 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.08 -30.18 64.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.151 0.5 . . . . 0.0 110.647 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 426' ' ' TYR . . . . . 0.539 ' HD1' HG21 ' A' ' 396' ' ' VAL . 46.8 t80 -69.17 -48.31 62.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.165 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.617 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.2 mt -74.52 -33.69 33.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.434 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.27 -43.97 98.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.121 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 69.8 mtm -62.94 -37.25 86.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.932 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.99 -39.68 94.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.619 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -61.66 -40.72 95.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.961 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -64.44 -38.35 90.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.002 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 433' ' ' MET . . . . . 0.526 ' O ' HD11 ' A' ' 437' ' ' LEU . 65.4 mtt -61.36 -29.01 69.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.066 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 434' ' ' PHE . . . . . 0.4 ' O ' ' CD2' ' A' ' 434' ' ' PHE . 58.2 t80 -99.02 25.02 7.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.044 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -79.93 -23.93 41.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.116 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 436' ' ' ASP . . . . . 0.609 ' O ' HD23 ' A' ' 437' ' ' LEU . 52.7 t0 -159.89 87.81 0.81 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 436' ' ' ASP . 88.8 mt -143.85 79.97 1.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.931 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -113.95 139.35 49.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.905 179.919 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.764 0.316 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -108.19 147.13 31.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -153.04 -72.04 0.14 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -154.81 54.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -96.15 21.14 9.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.155 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -104.35 154.2 20.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -79.88 150.75 30.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -119.45 152.21 37.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -127.34 155.95 42.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.99 155.47 20.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.9 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 30.6 t -111.24 136.18 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.089 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -136.88 158.19 45.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -80.65 115.61 20.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.89 163.65 57.0 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.916 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.86 155.26 68.67 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.573 2.182 . . . . 0.0 112.302 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.9 mm -76.25 145.12 10.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.956 HG11 HG21 ' A' ' 408' ' ' VAL . 14.6 p -125.75 141.07 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.69 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 17.9 mmt -82.21 113.89 20.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.88 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.449 ' HA ' ' HG2' ' A' ' 418' ' ' MET . 21.5 t -116.16 111.42 35.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.971 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.94 23.92 5.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.288 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.4 -19.25 51.69 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.752 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -99.61 145.32 29.91 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 111.012 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.06 135.93 19.61 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.679 2.253 . . . . 0.0 112.425 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 403' ' ' PHE . . . . . 0.645 ' O ' HG12 ' A' ' 396' ' ' VAL . 59.1 m-85 -147.04 155.65 42.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.79 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 10.9 p -75.97 137.37 40.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.51 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 405' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 55.2 t80 -55.21 -34.63 64.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.018 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 21.8 m -63.88 -38.13 89.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.985 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -69.84 -29.73 67.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.063 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.956 HG21 HG11 ' A' ' 396' ' ' VAL . 43.4 t -68.97 -49.33 64.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.02 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.9 p -66.86 -28.99 68.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.98 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -82.14 -23.58 35.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.106 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 21.7 mtt-85 -123.49 84.71 52.72 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -51.76 -25.51 20.97 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.626 2.217 . . . . 0.0 112.33 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -60.98 -36.21 78.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 72.1 mt -60.84 -40.75 94.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.888 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.46 -35.95 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.808 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.47 69.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -81.59 -16.72 50.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.044 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 418' ' ' MET . . . . . 0.449 ' HG2' ' HA ' ' A' ' 398' ' ' VAL . 3.7 mtt -72.01 127.1 31.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.162 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 1.3 p -66.75 166.7 17.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.173 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 65.9 Cg_exo -50.79 -56.24 3.28 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.26 1.974 . . . . 0.0 112.324 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.25 -39.84 88.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 109.975 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.8 -33.4 75.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.217 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.57 ' O ' HD12 ' A' ' 427' ' ' ILE . 77.4 tttt -64.92 -36.42 84.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.142 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -64.72 -46.22 83.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.512 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.55 -30.29 65.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.137 0.494 . . . . 0.0 110.591 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 426' ' ' TYR . . . . . 0.67 ' CE1' HG11 ' A' ' 408' ' ' VAL . 50.9 t80 -69.05 -47.75 64.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.275 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.57 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.6 mt -75.33 -33.64 28.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.464 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.16 96.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.073 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 429' ' ' MET . . . . . 0.488 ' HE1' ' HB ' ' A' ' 396' ' ' VAL . 71.2 mtm -62.85 -37.66 87.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.833 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.33 95.99 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.447 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.34 -37.94 82.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.84 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 42.0 mmt180 -62.14 -35.09 77.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.969 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 433' ' ' MET . . . . . 0.44 ' O ' HD12 ' A' ' 437' ' ' LEU . 65.0 mtt -59.64 -27.61 66.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.061 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -81.0 -2.37 47.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.414 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -79.96 -23.74 41.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.742 0.306 . . . . 0.0 111.195 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -150.4 81.55 1.36 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 433' ' ' MET . 21.7 mt -156.89 86.58 0.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.926 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -129.59 161.89 29.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.884 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.827 0.346 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -111.58 147.56 35.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -99.81 28.39 4.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.961 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -99.23 -59.11 1.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.023 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -104.09 22.94 13.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.104 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -90.21 118.47 29.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.904 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -96.07 150.11 20.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -129.28 157.11 42.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -124.43 138.89 54.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.83 132.58 45.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.9 p -137.05 143.29 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.175 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -100.52 141.24 33.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.026 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -82.45 113.51 20.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -71.73 147.52 91.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.948 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.27 155.02 70.84 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.553 2.169 . . . . 0.0 112.292 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.4 mm -97.12 148.82 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.066 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.954 HG11 HG21 ' A' ' 408' ' ' VAL . 12.4 p -132.75 142.52 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.771 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 5.3 mmt -86.65 113.83 22.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 110.889 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.64 HG11 ' HB3' ' A' ' 414' ' ' LEU . 29.5 t -112.8 118.73 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.95 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.07 23.53 5.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.435 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.33 19.58 41.43 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.853 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -136.97 146.45 54.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.668 0.234 . . . . 0.0 110.89 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.441 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 17.1 Cg_exo -66.81 135.62 38.89 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.439 2.093 . . . . 0.0 112.319 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 403' ' ' PHE . . . . . 0.582 ' HB2' HG23 ' A' ' 398' ' ' VAL . 20.6 m-85 -149.44 156.04 41.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.64 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 404' ' ' SER . . . . . 0.503 ' O ' HG23 ' A' ' 408' ' ' VAL . 56.2 m -76.27 133.79 39.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.704 0.288 . . . . 0.0 110.572 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -56.23 -41.56 75.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.006 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.9 m -64.57 -36.13 83.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.799 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.45 -29.13 68.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.144 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.954 HG21 HG11 ' A' ' 396' ' ' VAL . 48.7 t -66.49 -47.89 82.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.013 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.1 p -64.14 -29.2 70.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.005 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -81.71 -25.3 35.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.966 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -122.94 91.33 49.87 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.813 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.36 -22.42 74.07 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.5 2.133 . . . . 0.0 112.419 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -61.9 -30.23 70.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.983 0.421 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.64 ' HB3' HG11 ' A' ' 398' ' ' VAL . 20.7 mt -68.67 -36.77 78.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.597 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 22.5 t -64.94 -35.97 76.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.777 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.35 -26.0 66.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.083 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -92.16 -0.5 57.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.358 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 418' ' ' MET . . . . . 0.511 ' HG2' HG13 ' A' ' 398' ' ' VAL . 1.0 OUTLIER -87.47 125.9 34.57 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.74 0.305 . . . . 0.0 111.179 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 14.5 p -61.38 160.64 22.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.321 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 6.9 Cg_endo -49.11 -53.16 7.45 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.55 2.167 . . . . 0.0 112.246 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -60.02 -42.76 95.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 110.159 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -65.57 -32.91 74.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.162 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.553 ' O ' HD12 ' A' ' 427' ' ' ILE . 16.9 tptm -65.03 -37.21 86.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.175 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -64.6 -46.26 83.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.546 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.54 -30.22 65.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.17 0.51 . . . . 0.0 110.585 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 426' ' ' TYR . . . . . 0.626 ' CE1' HG11 ' A' ' 408' ' ' VAL . 46.9 t80 -69.0 -47.95 64.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.259 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.7 mt -75.13 -33.67 29.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.452 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -59.75 -42.87 94.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.132 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 69.1 mtm -62.03 -38.2 87.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.93 -36.73 91.1 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.479 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -60.31 -37.07 79.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.33 . . . . 0.0 110.952 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -60.38 -40.09 89.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 65.0 mtt -62.96 -28.47 70.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.014 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -116.91 30.56 7.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.957 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -79.78 -23.96 41.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.073 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -143.62 79.93 1.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.56 87.46 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -106.61 132.39 52.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.224 -0.894 . . . . 0.0 110.919 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.867 0.365 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -104.2 147.16 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -97.35 28.65 3.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.05 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.96 -36.06 36.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -59.09 -38.06 78.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.951 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -85.3 112.73 21.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -126.84 143.59 51.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.48 135.51 47.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.848 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.01 -37.57 33.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -128.62 124.75 36.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.4 t -133.2 133.01 58.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -152.12 148.0 27.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.105 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -109.53 152.09 25.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.51 146.46 98.96 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.02 151.8 77.3 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.548 2.166 . . . . 0.0 112.182 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 41.0 mm -95.49 144.73 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.061 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.97 HG11 HG21 ' A' ' 408' ' ' VAL . 14.8 p -130.24 143.26 41.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 18.3 mmt -87.18 113.83 23.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.704 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.811 HG11 ' HB3' ' A' ' 414' ' ' LEU . 21.3 t -117.25 118.66 59.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 51.41 26.41 3.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.478 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 89.15 20.49 45.69 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.823 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -137.06 143.22 41.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.681 0.277 . . . . 0.0 110.693 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.17 135.92 23.61 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.439 2.093 . . . . 0.0 112.611 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 403' ' ' PHE . . . . . 0.707 ' O ' HG12 ' A' ' 396' ' ' VAL . 46.8 m-85 -150.49 154.26 37.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.687 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 13.3 p -69.72 136.02 50.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.59 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -56.2 -39.77 72.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.062 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.6 m -64.3 -36.43 84.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.979 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -66.11 -30.95 71.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.095 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.97 HG21 HG11 ' A' ' 396' ' ' VAL . 44.6 t -70.9 -48.93 53.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.9 t -62.56 -31.77 72.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.998 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -81.66 -25.7 35.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.053 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 411' ' ' ARG . . . . . 0.445 ' O ' HD12 ' A' ' 414' ' ' LEU . 21.4 mtt180 -127.49 99.53 27.0 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.87 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.29 -15.37 42.29 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.446 2.097 . . . . 0.0 112.606 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -58.4 -33.34 69.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.019 0.438 . . . . 0.0 111.206 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.811 ' HB3' HG11 ' A' ' 398' ' ' VAL . 1.1 mt -72.11 -34.11 68.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.494 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 23.4 t -67.28 -32.98 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.612 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -69.45 -25.6 64.18 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.029 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -90.75 -13.17 34.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.282 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 418' ' ' MET . . . . . 0.637 ' HG2' HG13 ' A' ' 398' ' ' VAL . 1.7 mtt -74.61 124.54 26.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.802 0.334 . . . . 0.0 111.088 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.475 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 10.2 p -61.29 158.25 38.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.107 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 2.5 Cg_endo -45.52 -56.0 3.11 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.547 2.165 . . . . 0.0 112.346 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -60.2 -38.89 84.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.004 0.43 . . . . 0.0 110.002 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -66.41 -33.85 76.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.222 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.548 ' O ' HD12 ' A' ' 427' ' ' ILE . 82.4 tttt -64.85 -35.07 79.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.214 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -64.22 -46.36 84.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.61 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.04 -30.69 64.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.23 0.538 . . . . 0.0 110.603 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 426' ' ' TYR . . . . . 0.552 ' CE1' HG11 ' A' ' 408' ' ' VAL . 42.4 t80 -68.62 -48.37 64.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.254 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.6 mt -74.44 -33.56 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.473 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -58.91 -39.81 82.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.129 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 66.9 mtm -63.39 -38.29 90.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.992 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.66 -40.06 94.26 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.645 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.35 -39.34 90.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 110.909 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 26.8 mmt85 -64.18 -36.91 85.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.006 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 97.0 mmm -61.58 -27.54 68.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.146 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 434' ' ' PHE . . . . . 0.425 ' CD2' HD12 ' A' ' 437' ' ' LEU . 2.2 t80 -122.74 31.27 6.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.903 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -79.86 -24.35 41.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.176 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 436' ' ' ASP . . . . . 0.594 ' O ' HD23 ' A' ' 437' ' ' LEU . 78.6 m-20 -144.78 80.17 1.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.977 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 436' ' ' ASP . 93.9 mt -146.65 80.0 1.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.894 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -127.08 155.91 42.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.934 -179.923 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.838 0.351 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -104.55 135.81 45.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -117.33 135.94 53.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -138.71 154.68 48.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -129.59 -66.22 0.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -80.0 134.8 36.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -129.68 148.61 51.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.465 ' CE2' HG22 ' A' ' 390' ' ' VAL . 55.5 p90 -136.03 157.85 45.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -101.24 -53.46 3.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -112.92 154.86 25.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.93 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.465 HG22 ' CE2' ' A' ' 387' ' ' PHE . 31.1 t -110.58 130.38 64.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.051 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -111.2 147.83 34.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -80.0 131.61 35.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -121.03 150.38 53.2 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.926 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.4 164.63 34.47 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.59 2.193 . . . . 0.0 112.352 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.4 mm -100.32 143.17 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.943 HG11 HG21 ' A' ' 408' ' ' VAL . 11.6 p -121.16 140.1 46.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.719 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 22.3 mmt -83.19 113.81 20.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.748 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.551 HG13 ' HG2' ' A' ' 418' ' ' MET . 31.4 t -110.61 107.17 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.27 22.9 6.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.254 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 104.99 -20.33 38.68 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.919 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -97.18 145.29 29.37 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.612 0.244 . . . . 0.0 111.096 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.79 135.98 18.31 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.677 2.252 . . . . 0.0 112.503 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 403' ' ' PHE . . . . . 0.517 ' O ' HG12 ' A' ' 396' ' ' VAL . 61.8 m-85 -148.52 156.98 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.687 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 404' ' ' SER . . . . . 0.55 ' O ' HG23 ' A' ' 408' ' ' VAL . 51.3 m -73.49 138.46 45.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.605 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -58.04 -42.27 85.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.934 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.8 t -64.76 -37.37 87.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.85 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -64.69 -29.33 70.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.033 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.943 HG21 HG11 ' A' ' 396' ' ' VAL . 49.0 t -68.48 -47.67 76.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.054 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.4 t -62.89 -31.04 72.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.997 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -74.01 -27.07 60.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.977 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -124.41 85.34 55.87 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.787 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -51.68 -26.82 24.21 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.585 2.19 . . . . 0.0 112.338 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.2 -29.14 70.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.976 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 59.2 mt -65.98 -37.21 85.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.728 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 25.7 t -63.45 -37.78 80.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.951 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.41 -30.77 71.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.077 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -74.13 -23.61 59.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.074 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 418' ' ' MET . . . . . 0.551 ' HG2' HG13 ' A' ' 398' ' ' VAL . 3.5 mtt -72.65 129.08 37.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.986 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.466 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.5 p -64.08 170.74 3.11 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.258 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 65.5 Cg_exo -51.65 -55.96 3.45 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.256 1.971 . . . . 0.0 112.386 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -58.84 -40.54 84.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.429 . . . . 0.0 110.092 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -65.42 -34.41 78.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.237 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -64.26 -36.58 84.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.187 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -64.92 -45.24 86.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.557 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.88 -30.53 65.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.167 0.508 . . . . 0.0 110.633 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 426' ' ' TYR . . . . . 0.516 ' CE1' HG11 ' A' ' 408' ' ' VAL . 79.0 t80 -69.15 -47.01 66.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.32 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 60.4 mt -76.28 -33.82 24.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.62 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.69 -43.13 94.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.143 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 429' ' ' MET . . . . . 0.537 ' HE1' HG23 ' A' ' 396' ' ' VAL . 71.5 mtm -62.27 -40.86 97.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.972 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.83 -42.59 98.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.573 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -62.5 -32.55 73.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.862 0.363 . . . . 0.0 110.958 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -75.23 -28.61 59.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.791 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 62.7 mtt -59.11 -25.47 63.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.219 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.74 27.6 3.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.095 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -80.07 -26.45 39.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.389 . . . . 0.0 111.168 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 436' ' ' ASP . . . . . 0.422 ' O ' HD23 ' A' ' 437' ' ' LEU . 34.1 m-20 -160.04 87.82 0.8 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.06 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 436' ' ' ASP . 58.7 mt -143.61 79.87 1.64 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.899 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -125.31 154.41 41.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.308 -0.854 . . . . 0.0 110.876 179.932 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 51.8 t0 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.882 0.372 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 47.9 mp0 -108.75 150.26 27.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -111.39 149.83 30.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.91 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -116.11 49.74 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.79 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -97.8 25.34 5.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.976 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -135.61 160.45 38.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -112.32 139.79 47.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -117.71 142.22 47.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -120.02 142.51 48.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -119.24 145.5 46.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 390' ' ' VAL . 11.9 p -92.71 118.25 37.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.147 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -175.63 150.39 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.103 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -94.52 117.91 30.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -117.09 146.65 38.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.9 159.39 50.56 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.516 2.144 . . . . 0.0 112.321 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.5 mm -99.11 140.64 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.024 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.938 HG11 HG21 ' A' ' 408' ' ' VAL . 14.7 p -120.46 143.34 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.733 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.4 mmt -89.5 113.79 25.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.774 0.321 . . . . 0.0 110.68 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.53 HG23 ' HB2' ' A' ' 403' ' ' PHE . 27.3 t -114.8 125.68 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.915 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.94 24.37 5.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.349 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.81 19.89 55.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.767 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -137.05 154.99 76.36 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.601 0.238 . . . . 0.0 110.843 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.413 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 12.8 Cg_exo -69.86 135.77 31.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.6 2.2 . . . . 0.0 112.309 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 403' ' ' PHE . . . . . 0.53 ' HB2' HG23 ' A' ' 398' ' ' VAL . 31.7 m-85 -150.56 155.71 39.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.461 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 404' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 408' ' ' VAL . 17.2 p -80.32 135.2 36.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.731 0.301 . . . . 0.0 110.588 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 405' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 61.3 t80 -56.0 -39.62 72.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.007 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 m -64.02 -38.3 90.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -66.82 -29.52 69.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.14 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.938 HG21 HG11 ' A' ' 396' ' ' VAL . 50.7 t -67.25 -47.51 81.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.991 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.7 t -63.04 -31.93 73.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -73.76 -26.67 60.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.969 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -124.1 95.26 44.15 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.789 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.2 -25.46 80.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.484 2.122 . . . . 0.0 112.21 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -62.95 -28.36 70.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.922 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 62.5 mt -67.07 -40.56 87.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 39.1 t -62.88 -36.27 74.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.722 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.79 -29.28 69.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.929 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -80.35 -19.38 46.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.052 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 418' ' ' MET . . . . . 0.43 ' HE3' HG11 ' A' ' 408' ' ' VAL . 6.0 mtt -70.35 128.12 35.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.046 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 3.2 p -68.65 172.02 5.29 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.143 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.4 Cg_exo -53.04 -56.02 3.17 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.188 1.925 . . . . 0.0 112.233 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.23 -41.55 88.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.0 0.428 . . . . 0.0 109.973 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.77 -33.68 76.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.139 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.609 ' O ' HD12 ' A' ' 427' ' ' ILE . 23.6 tptm -64.26 -38.29 90.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.16 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -65.51 -44.76 85.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.577 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.19 -29.92 66.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.136 0.493 . . . . 0.0 110.528 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 426' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 49.8 t80 -69.44 -47.12 65.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.202 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.4 mt -76.42 -33.81 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.53 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -65.86 -45.89 80.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.25 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 429' ' ' MET . . . . . 0.406 ' HE1' HG23 ' A' ' 396' ' ' VAL . 69.0 mtm -59.78 -35.42 74.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.929 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.24 -45.48 94.08 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.535 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -66.8 -36.85 83.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -60.28 -36.49 77.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.957 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 73.0 mtm -59.72 -27.26 66.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.049 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 434' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' A' ' 434' ' ' PHE . 39.5 t80 -101.74 25.28 8.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.998 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -79.98 -22.13 42.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.159 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -143.61 79.94 1.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.904 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.64 79.98 1.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -133.3 162.39 31.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.911 179.965 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.856 0.36 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -110.02 153.71 24.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -100.39 139.14 36.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -80.01 140.8 36.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -167.62 95.54 0.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -84.15 112.34 20.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.796 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -125.21 149.12 48.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.823 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -117.19 144.54 44.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.871 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -108.24 129.93 55.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.967 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -133.09 152.79 51.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.1 t -118.27 130.03 73.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.104 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -158.92 152.22 22.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.051 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -80.43 122.12 26.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -120.97 149.34 50.82 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.972 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.47 160.45 49.73 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.558 2.172 . . . . 0.0 112.131 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 34.5 mm -97.13 134.62 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.028 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.965 HG11 HG21 ' A' ' 408' ' ' VAL . 12.5 p -113.96 139.71 38.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.591 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 21.7 mmt -84.11 113.85 21.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.825 0.345 . . . . 0.0 110.815 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.451 HG23 ' HB2' ' A' ' 403' ' ' PHE . 22.0 t -112.23 112.46 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.838 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.28 22.86 6.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.304 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.97 -16.0 57.67 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.826 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -100.58 148.23 34.69 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.691 0.281 . . . . 0.0 111.052 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.78 136.01 20.3 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.641 2.227 . . . . 0.0 112.472 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 403' ' ' PHE . . . . . 0.483 ' O ' HG12 ' A' ' 396' ' ' VAL . 57.8 m-85 -149.23 156.34 41.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.68 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 404' ' ' SER . . . . . 0.433 ' O ' HG23 ' A' ' 408' ' ' VAL . 15.7 p -79.98 137.6 36.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.504 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 405' ' ' TYR . . . . . 0.498 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 57.5 t80 -55.33 -34.83 64.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.126 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 93.4 p -64.2 -40.67 96.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -67.63 -30.32 69.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.178 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.965 HG21 HG11 ' A' ' 396' ' ' VAL . 45.7 t -66.08 -48.92 79.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.6 t -64.84 -30.57 71.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.008 0.432 . . . . 0.0 110.978 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -77.46 -26.13 51.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.061 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -124.4 84.16 56.79 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.816 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -51.69 -24.91 18.92 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.65 2.233 . . . . 0.0 112.38 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -61.78 -29.81 70.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.002 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 32.3 mt -67.95 -37.76 81.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.728 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 38.9 t -64.36 -35.6 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.765 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.74 -29.97 70.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.879 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -80.21 -19.41 47.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.935 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 418' ' ' MET . . . . . 0.447 ' HG2' ' HA ' ' A' ' 398' ' ' VAL . 4.3 mtt -70.45 124.95 25.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.037 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 17.3 p -61.04 163.18 10.65 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.348 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 76.7 Cg_exo -48.07 -56.06 3.46 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.363 2.042 . . . . 0.0 112.382 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -59.49 -40.03 85.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.008 0.432 . . . . 0.0 110.0 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -65.11 -33.99 77.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.176 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.584 ' O ' HD12 ' A' ' 427' ' ' ILE . 20.9 tptm -63.58 -37.96 89.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.158 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -64.93 -46.18 82.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.569 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.78 -29.5 64.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.16 0.505 . . . . 0.0 110.655 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 426' ' ' TYR . . . . . 0.622 ' CE1' HG11 ' A' ' 408' ' ' VAL . 63.3 t80 -69.72 -47.67 62.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.217 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.5 mt -75.23 -33.98 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.416 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.94 76.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.103 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 59.4 mtp -59.98 -37.55 79.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.16 -39.7 92.65 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.482 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -61.62 -31.93 72.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.861 0.362 . . . . 0.0 110.884 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -78.21 -29.8 48.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.686 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 96.6 mmm -58.87 -22.69 59.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.217 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -90.96 12.65 18.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.459 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -79.96 -24.99 40.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.762 0.315 . . . . 0.0 111.077 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -147.93 82.01 1.5 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.27 83.06 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.883 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -109.47 138.32 46.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.912 179.996 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.86 0.362 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -109.35 151.27 26.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -111.8 155.77 23.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -79.84 -35.45 38.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -89.05 123.67 33.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -81.96 116.99 21.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.9 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -79.98 137.69 36.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.97 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -124.27 154.6 39.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.89 115.83 19.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -136.85 159.76 40.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.3 t -113.72 130.5 67.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -109.49 140.67 42.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -88.99 130.93 35.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.982 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -97.47 149.19 35.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.802 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.8 150.56 85.88 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.498 2.132 . . . . 0.0 112.274 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.71 139.93 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.062 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.941 HG11 HG21 ' A' ' 408' ' ' VAL . 12.4 p -124.05 141.47 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 18.6 mmt -83.36 114.95 21.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.825 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.634 HG23 ' HB2' ' A' ' 403' ' ' PHE . 60.0 t -114.25 106.54 20.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.591 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 63.95 16.55 9.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.342 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 109.57 -22.39 24.31 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.073 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 401' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 398' ' ' VAL . 11.7 ptm180 -99.0 149.76 36.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.85 0.357 . . . . 0.0 111.129 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.25 135.93 32.99 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.806 2.337 . . . . 0.0 113.012 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 403' ' ' PHE . . . . . 0.634 ' HB2' HG23 ' A' ' 398' ' ' VAL . 4.2 m-85 -139.32 172.17 13.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.696 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 404' ' ' SER . . . . . 0.528 ' O ' HG23 ' A' ' 408' ' ' VAL . 0.7 OUTLIER -93.89 130.45 39.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.457 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -54.24 -42.93 70.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.172 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 31.1 m -66.75 -34.85 78.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -67.62 -29.72 69.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.159 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.941 HG21 HG11 ' A' ' 396' ' ' VAL . 55.1 t -70.29 -47.46 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.058 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.9 t -61.6 -31.45 71.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.007 0.432 . . . . 0.0 111.036 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -75.9 -27.49 57.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.948 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -125.87 96.35 37.84 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.832 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.79 -23.94 74.49 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.465 2.11 . . . . 0.0 112.373 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -61.4 -29.25 69.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 110.954 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 408' ' ' VAL . 16.4 mt -67.38 -36.42 81.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.708 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.2 -37.03 78.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.86 -28.58 68.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.015 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -76.7 -22.88 53.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.053 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 418' ' ' MET . . . . . 0.46 ' CE ' HG22 ' A' ' 398' ' ' VAL . 5.0 mtt -71.11 129.29 38.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.464 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.3 p -63.91 171.18 2.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.206 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.4 Cg_exo -52.66 -56.09 3.16 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.179 1.919 . . . . 0.0 112.188 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -60.48 -38.69 85.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -65.45 -34.23 77.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.133 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.6 ' O ' HD12 ' A' ' 427' ' ' ILE . 11.3 tptm -64.34 -36.63 84.74 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.288 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -65.32 -44.36 88.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.597 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.76 -30.45 65.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.181 0.515 . . . . 0.0 110.528 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 426' ' ' TYR . . . . . 0.664 ' CE1' HG11 ' A' ' 408' ' ' VAL . 68.5 t80 -68.78 -47.57 65.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.31 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.2 mt -75.37 -34.03 29.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.532 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.77 -30.1 70.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.239 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 64.0 mtp -57.84 -35.14 70.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.04 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 430' ' ' GLY . . . . . 0.412 ' O ' ' CE1' ' A' ' 434' ' ' PHE . . . -59.21 -48.04 87.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.477 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 431' ' ' GLN . . . . . 0.451 ' HA ' ' CE1' ' A' ' 434' ' ' PHE . 95.1 mt-30 -63.34 -38.46 91.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.782 0.325 . . . . 0.0 110.89 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -50.62 -31.59 16.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 86.1 mtp -72.99 -29.37 63.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.903 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 434' ' ' PHE . . . . . 0.451 ' CE1' ' HA ' ' A' ' 431' ' ' GLN . 49.9 p90 -131.58 45.37 2.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.164 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -111.64 -18.79 12.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.342 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -154.07 85.31 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.84 0.352 . . . . 0.0 110.958 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 2.4 mp -143.02 79.86 1.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.76 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -120.27 156.26 31.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.952 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 50.7 mp0 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.849 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.796 0.331 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -107.31 145.54 32.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 49.2 mp0 -126.52 147.45 49.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -146.79 141.71 26.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -59.73 -37.47 79.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 48.3 p30 -145.76 164.27 32.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.965 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 50.2 mp0 -121.31 132.36 54.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -111.67 129.78 55.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.817 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -160.09 -47.06 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -125.13 163.77 21.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.6 p -126.43 137.41 57.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.08 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -174.28 145.3 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.052 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -79.99 136.57 36.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -117.69 146.26 38.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.852 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.25 164.54 35.32 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.576 2.184 . . . . 0.0 112.357 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.7 mm -99.01 143.2 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.028 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.921 HG11 HG21 ' A' ' 408' ' ' VAL . 14.4 p -119.97 141.94 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.759 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 15.1 mmt -84.76 113.85 21.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.443 ' HA ' ' HG2' ' A' ' 418' ' ' MET . 18.7 t -114.81 113.01 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.944 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.86 23.9 5.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.306 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.85 56.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.804 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.61 146.38 31.73 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.732 0.301 . . . . 0.0 111.05 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.13 135.98 19.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.669 2.246 . . . . 0.0 112.529 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 403' ' ' PHE . . . . . 0.576 ' O ' HG12 ' A' ' 396' ' ' VAL . 62.1 m-85 -148.12 156.26 42.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.682 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 404' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 408' ' ' VAL . 17.3 p -74.82 138.59 42.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.58 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -56.88 -39.91 75.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.003 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.3 m -64.55 -38.21 90.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -65.87 -29.72 70.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.182 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.921 HG21 HG11 ' A' ' 396' ' ' VAL . 59.8 t -67.12 -46.3 84.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.946 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.7 p -65.02 -29.33 70.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.98 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -76.83 -26.14 53.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.947 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -123.7 95.03 45.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.801 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.02 -25.51 77.72 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.389 2.059 . . . . 0.0 112.252 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.34 -28.47 69.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.951 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 65.7 mt -66.57 -38.84 87.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.703 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.41 -36.17 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.735 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -64.62 -29.97 70.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.936 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -80.77 -18.25 48.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.974 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 418' ' ' MET . . . . . 0.443 ' HG2' ' HA ' ' A' ' 398' ' ' VAL . 5.3 mtt -72.71 126.44 29.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.176 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.446 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 2.8 p -69.14 172.57 4.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.049 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 50.5 Cg_exo -53.71 -56.09 2.96 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.188 1.925 . . . . 0.0 112.226 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.33 -41.92 90.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.923 0.392 . . . . 0.0 110.028 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.05 -33.35 75.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.34 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.579 ' O ' HD12 ' A' ' 427' ' ' ILE . 48.6 tttm -65.97 -36.62 83.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.308 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -65.03 -45.8 83.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.639 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.2 -29.48 65.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.11 0.481 . . . . 0.0 110.57 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 426' ' ' TYR . . . . . 0.531 ' CE1' HG11 ' A' ' 408' ' ' VAL . 43.9 t80 -69.82 -47.05 64.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.263 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.579 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.7 mt -76.44 -33.84 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.443 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -63.59 -45.88 88.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.127 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 429' ' ' MET . . . . . 0.467 ' HE1' HG23 ' A' ' 396' ' ' VAL . 66.9 mtm -62.34 -37.29 85.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.5 -37.24 87.93 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.458 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.91 -32.11 71.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.891 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 3.8 ttm105 -80.5 -29.4 37.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.734 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 95.5 mmm -58.32 -27.61 64.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.089 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.27 24.37 10.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.997 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -79.87 -22.9 42.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.189 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 436' ' ' ASP . . . . . 0.621 ' O ' HD23 ' A' ' 437' ' ' LEU . 34.7 p30 -152.14 83.96 1.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.038 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 436' ' ' ASP . 87.4 mt -142.95 79.91 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -120.68 152.72 37.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 50.7 mp0 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.922 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 47.5 p30 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.84 0.352 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -99.66 136.63 39.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -79.83 -36.0 37.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -113.71 150.75 32.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -130.93 -45.63 1.04 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.046 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -160.03 95.49 1.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.043 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -114.31 141.66 47.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.89 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.596 ' CE2' HG22 ' A' ' 390' ' ' VAL . 0.1 OUTLIER -160.04 85.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -79.86 -37.91 33.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.999 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -128.58 148.57 50.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 390' ' ' VAL . . . . . 0.596 HG22 ' CE2' ' A' ' 387' ' ' PHE . 26.9 t -124.29 132.28 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.979 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -156.08 148.46 23.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -90.47 120.23 31.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -117.87 150.89 48.0 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.75 163.45 37.12 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.613 2.209 . . . . 0.0 112.269 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.4 mm -101.57 146.37 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.174 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.95 HG11 HG21 ' A' ' 408' ' ' VAL . 11.7 p -129.0 140.48 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.725 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 18.2 mmt -81.04 113.72 19.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.669 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.62 HG13 ' HG2' ' A' ' 418' ' ' MET . 23.2 t -115.68 110.44 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.57 23.31 5.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.295 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.19 -17.74 53.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.862 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 35.9 mtp85 -101.54 145.15 29.95 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.737 0.268 . . . . 0.0 111.095 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.29 135.92 19.16 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.689 2.259 . . . . 0.0 112.412 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 403' ' ' PHE . . . . . 0.608 ' O ' HG12 ' A' ' 396' ' ' VAL . 62.0 m-85 -147.4 157.52 43.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.787 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 404' ' ' SER . . . . . 0.586 ' O ' HG23 ' A' ' 408' ' ' VAL . 49.0 m -69.88 138.2 52.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.611 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -58.49 -41.59 85.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.979 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 95.4 p -66.25 -39.89 89.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.14 -29.22 69.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.131 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.95 HG21 HG11 ' A' ' 396' ' ' VAL . 49.4 t -68.46 -47.67 76.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.994 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.7 t -64.08 -30.12 71.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -75.71 -26.31 57.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.025 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -124.35 85.09 55.84 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.08 -27.25 28.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.611 2.207 . . . . 0.0 112.291 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -61.07 -29.27 69.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 63.3 mt -66.17 -37.54 85.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.761 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 37.5 t -63.68 -38.06 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.11 -28.48 68.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.066 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -80.05 -17.73 51.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.116 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 418' ' ' MET . . . . . 0.62 ' HG2' HG13 ' A' ' 398' ' ' VAL . 3.0 mtt -76.35 132.2 39.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.153 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 8.3 p -63.79 158.61 59.8 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.065 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 2.0 Cg_endo -45.05 -56.03 3.0 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.617 2.211 . . . . 0.0 112.257 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.25 -38.55 83.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.969 0.414 . . . . 0.0 109.956 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -66.0 -34.25 77.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.158 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.61 ' O ' HD12 ' A' ' 427' ' ' ILE . 74.9 tttt -63.52 -36.16 82.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.205 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -64.57 -45.46 86.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.634 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -56.87 -31.04 64.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.131 0.491 . . . . 0.0 110.594 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 426' ' ' TYR . . . . . 0.512 ' CE1' HG11 ' A' ' 408' ' ' VAL . 47.4 t80 -68.45 -48.23 65.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.218 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.61 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.1 mt -74.05 -34.03 37.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.519 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.63 83.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.061 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 65.1 mtm -62.69 -36.99 84.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.826 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.99 -35.99 86.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.464 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -59.97 -40.01 87.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.797 0.332 . . . . 0.0 110.828 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -69.53 -29.83 67.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.942 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 16.3 mmt -57.48 -22.82 46.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.209 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 434' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 434' ' ' PHE . 55.7 t80 -91.9 45.98 1.25 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.076 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -109.31 -21.14 12.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.12 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 436' ' ' ASP . . . . . 0.832 ' O ' HD22 ' A' ' 437' ' ' LEU . 82.7 m-20 -142.9 79.96 1.67 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.854 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.832 HD22 ' O ' ' A' ' 436' ' ' ASP . 1.3 mm? -142.58 79.88 1.67 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.724 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -90.98 133.39 35.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.881 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.83 179.977 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.826 0.345 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -100.47 131.96 46.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -108.67 -75.84 0.62 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.998 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -108.62 -57.17 2.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.978 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 50.2 p30 -62.06 174.61 0.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -135.38 100.68 4.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -112.61 147.45 36.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -92.9 122.38 35.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -148.53 156.64 42.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -108.16 137.91 45.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.961 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.0 t -119.02 132.84 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.11 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -158.62 168.66 26.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -79.87 146.31 32.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -60.98 143.19 92.18 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.944 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.7 165.94 31.02 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.587 2.191 . . . . 0.0 112.384 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.6 mm -94.47 135.82 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.03 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.937 HG11 HG21 ' A' ' 408' ' ' VAL . 12.7 p -115.9 142.24 30.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.769 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 397' ' ' MET . . . . . 0.432 ' HE2' ' HA ' ' A' ' 402' ' ' PRO . 2.8 mmt -90.13 113.86 25.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.866 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.619 HG13 ' HG2' ' A' ' 418' ' ' MET . 39.2 t -110.63 119.09 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.011 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.95 27.68 11.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.363 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.88 23.51 45.43 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.785 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 75.8 mtm-85 -137.01 151.68 72.53 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.602 0.239 . . . . 0.0 110.688 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.432 ' HA ' ' HE2' ' A' ' 397' ' ' MET . 57.7 Cg_endo -71.28 135.72 27.48 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.406 2.071 . . . . 0.0 112.411 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 403' ' ' PHE . . . . . 0.523 ' HB2' HG23 ' A' ' 398' ' ' VAL . 35.1 m-85 -150.67 172.09 16.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.668 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 404' ' ' SER . . . . . 0.728 ' O ' HG23 ' A' ' 408' ' ' VAL . 49.4 m -97.84 136.87 37.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.569 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 405' ' ' TYR . . . . . 0.428 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 41.3 t80 -57.11 -41.71 79.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.913 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.4 t -64.4 -39.57 94.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.843 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.86 -29.22 69.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.109 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.937 HG21 HG11 ' A' ' 396' ' ' VAL . 51.5 t -66.59 -47.49 83.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.016 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.0 p -64.45 -29.03 70.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.983 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -76.78 -25.65 53.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.01 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 38.7 mtt85 -124.76 85.57 56.89 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.794 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -51.79 -26.7 24.64 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.623 2.215 . . . . 0.0 112.295 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.61 -29.79 70.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.945 0.403 . . . . 0.0 111.009 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 67.7 mt -66.83 -36.86 83.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.74 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 415' ' ' VAL . . . . . 0.651 HG13 ' NZ ' ' A' ' 423' ' ' LYS . 43.2 t -64.71 -37.95 81.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.948 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -68.09 -28.39 67.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -77.3 -22.46 51.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.121 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 418' ' ' MET . . . . . 0.619 ' HG2' HG13 ' A' ' 398' ' ' VAL . 2.6 mtt -73.47 130.28 39.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.439 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.1 p -65.97 171.18 4.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.259 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 50.6 Cg_exo -53.91 -56.2 2.81 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.334 2.023 . . . . 0.0 112.418 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -58.33 -42.66 87.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.857 0.36 . . . . 0.0 110.216 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -65.96 -32.82 74.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.079 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.651 ' NZ ' HG13 ' A' ' 415' ' ' VAL . 0.5 OUTLIER -65.21 -36.69 84.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.168 179.371 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -64.6 -45.82 85.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.59 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.11 -30.81 64.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.119 0.485 . . . . 0.0 110.536 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 426' ' ' TYR . . . . . 0.552 ' CE1' HG11 ' A' ' 408' ' ' VAL . 63.5 t80 -68.46 -48.27 64.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.273 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.566 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.4 mt -74.47 -33.82 34.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.434 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.05 87.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.144 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 68.8 mtm -61.55 -35.81 78.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.891 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.94 -41.57 96.35 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.458 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -62.71 -36.59 83.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 0.0 110.891 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 48.4 mmm-85 -60.87 -36.23 78.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.912 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.78 -27.67 66.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.029 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -156.71 79.55 0.94 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.891 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -80.06 -37.33 34.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.13 0.49 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 436' ' ' ASP . . . . . 0.715 ' O ' HD23 ' A' ' 437' ' ' LEU . 52.2 t0 -159.07 82.92 0.78 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.866 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 436' ' ' ASP . 47.2 mt -146.01 80.8 1.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -122.0 152.55 39.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.93 179.969 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.847 0.356 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -106.94 150.0 26.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -114.31 153.13 30.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.21 35.19 1.8 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 61.4 44.95 8.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.833 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -131.44 133.18 44.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -102.62 145.3 29.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -128.08 159.99 33.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -117.78 147.47 42.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -123.85 155.9 37.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.6 t -114.18 131.75 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.089 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . 58.52 163.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -130.96 106.21 8.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.56 148.07 85.23 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.927 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.36 158.37 57.74 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.535 2.157 . . . . 0.0 112.265 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.4 mm -80.02 148.28 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.106 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.959 HG11 HG21 ' A' ' 408' ' ' VAL . 11.8 p -127.44 139.75 51.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.763 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 19.4 mmt -81.0 113.82 19.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.824 0.345 . . . . 0.0 110.82 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.577 HG13 ' HG2' ' A' ' 418' ' ' MET . 21.7 t -115.3 110.27 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.03 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.02 24.38 4.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.28 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.9 -19.68 48.64 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.758 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -98.68 143.6 26.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.651 0.262 . . . . 0.0 110.958 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.56 135.91 16.79 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.651 2.234 . . . . 0.0 112.475 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 403' ' ' PHE . . . . . 0.571 ' O ' HG12 ' A' ' 396' ' ' VAL . 48.7 m-85 -148.47 161.1 42.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.714 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 404' ' ' SER . . . . . 0.619 ' O ' HG23 ' A' ' 408' ' ' VAL . 25.9 p -75.92 141.35 42.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.595 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -58.24 -40.8 82.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.908 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.7 t -63.59 -40.39 96.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -63.97 -28.79 70.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.959 HG21 HG11 ' A' ' 396' ' ' VAL . 37.7 t -70.32 -54.02 20.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.051 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 18.2 m -61.04 -30.17 70.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.94 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -76.19 -25.44 55.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.974 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -124.72 86.79 55.52 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.845 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -51.77 -25.51 21.05 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.559 2.173 . . . . 0.0 112.408 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -61.67 -30.7 70.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.934 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 408' ' ' VAL . 30.5 mt -68.07 -36.94 80.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.679 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.51 -36.49 77.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.813 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.98 -28.07 67.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.035 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -81.47 -17.16 49.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.227 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 418' ' ' MET . . . . . 0.577 ' HG2' HG13 ' A' ' 398' ' ' VAL . 2.9 mtt -77.02 130.93 38.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.151 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.502 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.6 p -67.25 159.07 79.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.982 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 1.2 Cg_endo -44.14 -53.35 4.8 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.694 2.263 . . . . 0.0 112.497 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.27 -41.59 93.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 0.0 110.207 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.46 -33.76 76.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.248 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -65.0 -35.13 80.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.115 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -63.24 -46.27 87.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.637 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.42 -31.51 67.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.222 0.534 . . . . 0.0 110.755 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 426' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -68.62 -46.01 70.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.207 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 58.3 mt -76.42 -35.92 27.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.705 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -65.68 -35.19 80.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.932 0.396 . . . . 0.0 111.176 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 60.2 mtp -61.48 -39.69 91.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -63.1 -37.25 94.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.576 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -60.08 -35.86 76.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.836 0.351 . . . . 0.0 110.975 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -69.19 -31.0 69.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.637 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 65.1 mtt -61.22 -27.35 68.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.087 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -106.58 -24.54 12.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.199 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -80.01 -20.64 44.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.281 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -142.21 79.88 1.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.81 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.37 80.05 1.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.867 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -121.46 154.4 36.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.901 179.998 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.718 0.294 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -107.57 139.47 42.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -135.63 135.27 40.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -113.52 140.84 47.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -158.05 93.89 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -145.07 79.92 1.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -143.62 162.5 35.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.92 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -107.2 133.25 52.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.799 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -116.67 155.92 27.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.918 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -102.04 146.87 27.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.851 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.1 t -102.56 131.52 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.064 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -70.67 150.32 46.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.145 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -81.21 116.81 21.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.864 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -120.96 155.79 57.33 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.2 157.84 59.78 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.535 2.157 . . . . 0.0 112.26 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 34.4 mm -96.59 138.73 20.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.128 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.96 HG11 HG21 ' A' ' 408' ' ' VAL . 12.6 p -125.22 140.34 48.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.686 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.8 mmt -85.55 113.75 22.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.065 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.687 HG23 ' HB2' ' A' ' 403' ' ' PHE . 34.6 t -111.03 120.08 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.851 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.73 23.25 6.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.466 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.81 21.02 37.85 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.825 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -137.11 149.67 66.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.563 0.22 . . . . 0.0 110.74 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.426 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 18.2 Cg_exo -66.29 135.66 40.76 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.474 2.116 . . . . 0.0 112.338 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 403' ' ' PHE . . . . . 0.687 ' HB2' HG23 ' A' ' 398' ' ' VAL . 17.3 m-85 -148.42 172.13 14.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 404' ' ' SER . . . . . 0.719 ' O ' HG23 ' A' ' 408' ' ' VAL . 22.3 p -97.71 135.37 39.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.431 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 405' ' ' TYR . . . . . 0.499 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 45.8 t80 -56.98 -39.57 74.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.122 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.1 m -64.44 -39.7 94.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.093 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -68.24 -28.89 67.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.96 HG21 HG11 ' A' ' 396' ' ' VAL . 24.3 t -68.25 -55.97 14.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.068 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 1.4 m -59.23 -29.99 67.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -73.74 -26.26 60.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.861 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 41.4 mtt-85 -125.04 87.47 55.41 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.817 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.97 -26.43 18.46 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.535 2.157 . . . . 0.0 112.408 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.52 -28.52 69.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.031 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.654 HD12 ' HA ' ' A' ' 408' ' ' VAL . 68.6 mt -66.56 -39.58 88.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.845 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.5 -37.07 78.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.009 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -68.41 -28.85 67.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.034 0.445 . . . . 0.0 111.158 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -80.11 -19.71 46.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.119 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 418' ' ' MET . . . . . 0.535 ' HG2' HG13 ' A' ' 398' ' ' VAL . 2.8 mtt -75.46 133.33 41.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.055 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.487 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 6.7 p -62.63 158.41 50.86 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.015 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 2.6 Cg_endo -45.65 -52.85 6.27 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.624 2.216 . . . . 0.0 112.377 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -60.09 -43.38 95.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.925 0.393 . . . . 0.0 110.168 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -65.07 -33.25 75.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.196 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.654 ' O ' HD12 ' A' ' 427' ' ' ILE . 41.2 tttt -64.66 -38.07 89.74 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.085 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -65.02 -45.24 86.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.588 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.34 -30.4 64.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.211 0.529 . . . . 0.0 110.712 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 426' ' ' TYR . . . . . 0.499 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 56.1 t80 -69.19 -47.89 63.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.248 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.654 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.0 mt -74.69 -33.72 32.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.497 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.66 -39.49 88.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.167 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 71.6 mtm -60.53 -39.25 87.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.833 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -61.4 -39.84 97.83 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.49 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.49 -33.54 73.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 0.0 110.93 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -70.75 -29.57 65.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.662 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 96.5 mmm -60.02 -26.7 66.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.118 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 434' ' ' PHE . . . . . 0.511 ' HA ' HD12 ' A' ' 437' ' ' LEU . 98.0 m-85 -116.08 23.25 12.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.273 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -79.99 -19.45 47.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.252 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -143.13 79.89 1.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 110.888 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 434' ' ' PHE . 98.3 mt -148.65 82.2 1.46 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.833 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -107.75 135.53 49.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.903 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.798 0.333 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -119.69 80.11 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.93 -34.08 39.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.924 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -132.24 -62.09 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -71.19 132.43 45.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -103.48 113.98 27.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.938 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -122.9 134.4 54.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -108.21 124.78 50.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -129.19 151.79 49.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -114.67 136.77 52.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.76 134.67 62.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.039 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -146.89 150.29 34.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.122 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -112.92 166.61 11.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.978 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -92.93 155.56 41.34 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.74 158.72 54.74 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.526 2.15 . . . . 0.0 112.194 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.4 mm -98.85 131.98 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.16 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.932 HG11 HG21 ' A' ' 408' ' ' VAL . 11.4 p -117.7 139.34 45.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.688 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 397' ' ' MET . . . . . 0.434 ' HE2' ' HA ' ' A' ' 402' ' ' PRO . 2.3 mmt -86.9 113.85 23.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.95 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' A' ' 403' ' ' PHE . 39.9 t -110.03 119.58 59.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.816 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 57.2 24.82 10.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.323 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 88.44 22.07 41.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.835 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 29.4 mtt-85 -136.94 150.71 70.51 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.607 0.242 . . . . 0.0 110.813 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.434 ' HA ' ' HE2' ' A' ' 397' ' ' MET . 17.7 Cg_exo -66.52 135.64 39.93 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.47 2.113 . . . . 0.0 112.372 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 403' ' ' PHE . . . . . 0.66 ' HB2' HG23 ' A' ' 398' ' ' VAL . 17.9 m-85 -148.82 171.99 15.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.606 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 404' ' ' SER . . . . . 0.675 ' O ' HG23 ' A' ' 408' ' ' VAL . 53.6 p -100.32 134.81 42.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.559 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 405' ' ' TYR . . . . . 0.481 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 28.3 t80 -56.03 -37.36 69.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 21.7 m -66.46 -41.63 88.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.099 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -66.28 -29.71 69.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 111.256 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.932 HG21 HG11 ' A' ' 396' ' ' VAL . 44.1 t -65.81 -48.91 80.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.102 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.1 p -64.49 -29.25 70.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -77.91 -25.91 48.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.02 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -124.1 85.76 54.51 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.87 -26.81 18.9 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.569 2.179 . . . . 0.0 112.398 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.31 -28.25 69.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.034 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 408' ' ' VAL . 71.8 mt -66.48 -39.25 88.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.833 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 38.6 t -63.82 -38.15 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.78 -28.86 67.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.11 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -76.07 -22.88 55.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.053 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 418' ' ' MET . . . . . 0.601 ' HG2' HG13 ' A' ' 398' ' ' VAL . 2.8 mtt -74.21 133.68 42.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.444 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 3.8 p -66.69 171.25 4.59 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.11 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 51.1 Cg_exo -53.27 -56.06 3.08 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.247 1.965 . . . . 0.0 112.368 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.0 -41.53 87.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.072 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -65.83 -33.02 74.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.094 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 423' ' ' LYS . . . . . 0.694 ' O ' HD12 ' A' ' 427' ' ' ILE . 79.9 tttt -64.43 -37.21 86.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.1 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -65.4 -45.09 85.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.527 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -56.94 -30.53 64.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.21 0.528 . . . . 0.0 110.537 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 426' ' ' TYR . . . . . 0.646 ' CE1' HG11 ' A' ' 408' ' ' VAL . 64.3 t80 -68.49 -48.82 63.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.132 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 427' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 423' ' ' LYS . 3.6 mt -73.14 -35.16 46.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.3 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -71.59 -29.23 64.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.065 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 57.7 mtp -70.52 -30.85 67.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -84.1 -42.52 7.53 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.863 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 431' ' ' GLN . . . . . 0.422 ' HG3' ' HD3' ' A' ' 432' ' ' ARG . 21.5 pt20 -57.84 -42.48 84.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 111.07 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 432' ' ' ARG . . . . . 0.422 ' HD3' ' HG3' ' A' ' 431' ' ' GLN . 0.1 OUTLIER -58.24 -29.93 66.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.0 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 94.2 mmm -58.22 -23.38 55.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.263 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -94.8 21.59 7.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.37 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -79.91 -22.54 42.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.848 0.356 . . . . 0.0 111.238 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 436' ' ' ASP . . . . . 0.677 ' O ' HD23 ' A' ' 437' ' ' LEU . 51.9 t0 -151.83 83.97 1.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 437' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 436' ' ' ASP . 83.7 mt -143.18 79.92 1.66 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.817 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -120.96 153.72 36.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.914 -179.984 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 57.3 p30 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.835 0.35 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 47.9 mp0 -98.73 152.14 19.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -79.84 -29.55 40.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -138.88 79.59 1.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -145.67 102.19 3.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.823 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -79.99 110.48 15.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.775 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -123.44 154.22 39.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 387' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 388' ' ' GLU . 66.2 t80 -111.68 155.06 24.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.86 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 388' ' ' GLU . . . . . 0.408 ' O ' ' CD2' ' A' ' 387' ' ' PHE . 96.0 mt-10 -79.84 133.29 36.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.945 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -136.83 164.49 28.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 24.5 t -103.99 131.05 53.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.02 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -104.72 149.47 25.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -79.95 134.03 36.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.825 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.86 151.61 97.17 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.978 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.64 166.07 30.73 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.692 2.261 . . . . 0.0 112.349 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.9 mm -101.19 130.61 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.146 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 396' ' ' VAL . . . . . 0.897 HG11 HG21 ' A' ' 408' ' ' VAL . 13.4 p -116.16 137.61 49.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.732 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 397' ' ' MET . . . . . 0.437 ' HE2' ' HA ' ' A' ' 402' ' ' PRO . 2.1 mmt -85.74 113.94 22.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.04 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 398' ' ' VAL . . . . . 0.54 HG23 ' HB2' ' A' ' 403' ' ' PHE . 33.2 t -114.92 123.87 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.928 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.66 26.88 11.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.23 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.44 22.63 56.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.647 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -137.07 153.34 75.11 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.665 0.269 . . . . 0.0 110.931 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 402' ' ' PRO . . . . . 0.437 ' HA ' ' HE2' ' A' ' 397' ' ' MET . 48.4 Cg_endo -68.88 135.97 34.08 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.518 2.145 . . . . 0.0 112.339 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 403' ' ' PHE . . . . . 0.54 ' HB2' HG23 ' A' ' 398' ' ' VAL . 14.4 m-85 -146.65 171.54 14.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 50.8 m -97.48 129.71 44.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.619 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -52.29 -40.31 61.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.027 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 41.6 t -67.61 -35.26 78.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.738 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.87 -30.8 70.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.051 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 408' ' ' VAL . . . . . 0.897 HG21 HG11 ' A' ' 396' ' ' VAL . 81.9 t -69.83 -44.55 78.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.869 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 32.9 t -62.95 -30.91 71.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.989 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -75.48 -26.59 58.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.996 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 14.6 mtt85 -125.86 84.89 60.17 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.883 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.37 -24.99 23.0 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.597 2.198 . . . . 0.0 112.371 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -61.23 -29.31 69.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.976 0.417 . . . . 0.0 111.064 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 414' ' ' LEU . . . . . 0.508 HD12 ' HA ' ' A' ' 408' ' ' VAL . 28.8 mt -66.39 -36.23 82.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.761 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.68 -37.71 80.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.4 70.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.035 0.445 . . . . 0.0 111.008 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -79.57 -21.18 45.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.0 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 418' ' ' MET . . . . . 0.443 ' HE3' HG11 ' A' ' 408' ' ' VAL . 7.3 mtt -69.19 123.72 21.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.033 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 419' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 7.0 p -61.53 167.77 3.94 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.172 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 420' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 62.4 Cg_exo -51.47 -56.07 3.36 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.288 1.992 . . . . 0.0 112.155 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -59.98 -39.84 87.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 109.882 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.11 -34.23 77.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.27 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -64.82 -36.66 85.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.197 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -64.27 -46.24 84.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.474 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.42 -30.49 66.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.167 0.508 . . . . 0.0 110.607 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 426' ' ' TYR . . . . . 0.567 ' HD1' HG21 ' A' ' 396' ' ' VAL . 75.1 t80 -69.37 -46.42 66.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.259 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 58.7 mt -77.19 -33.66 20.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.574 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -63.4 -38.38 90.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.249 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 60.0 mtm -60.14 -44.63 94.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.935 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.81 -40.94 97.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.452 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -64.59 -34.5 78.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.763 0.316 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -72.14 -37.31 69.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.746 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 88.0 mtp -58.53 -25.77 62.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 434' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 434' ' ' PHE . 61.1 t80 -96.28 1.54 52.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.409 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -99.95 -19.59 16.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.711 0.291 . . . . 0.0 111.338 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -144.18 80.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.771 0.32 . . . . 0.0 111.011 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.6 86.91 0.94 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -132.08 165.53 23.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.856 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.988 179.983 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.5 mm . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.949 0.404 . . . . 0.0 111.034 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.93 HG11 HG21 ' A' ' 408' ' ' VAL . 13.8 p -115.57 142.57 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.803 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.6 mmt -90.81 113.83 26.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.808 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.608 HG22 ' CE ' ' A' ' 418' ' ' MET . 38.1 t -111.75 120.92 63.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.981 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.23 27.34 9.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.439 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.48 23.51 46.99 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.731 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -137.02 152.27 73.61 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.669 0.271 . . . . 0.0 110.738 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 402' ' ' PRO . . . . . 0.402 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 58.3 Cg_endo -71.73 135.84 26.74 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.454 2.103 . . . . 0.0 112.406 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 403' ' ' PHE . . . . . 0.493 ' HB2' HG23 ' A' ' 398' ' ' VAL . 36.2 m-85 -150.52 172.04 16.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.674 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . 0.668 ' O ' HG23 ' A' ' 408' ' ' VAL . 24.8 p -98.59 136.9 38.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.552 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 405' ' ' TYR . . . . . 0.484 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 35.1 t80 -56.84 -39.31 74.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.032 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.1 m -64.73 -40.68 95.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -66.61 -29.54 69.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.192 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.93 HG21 HG11 ' A' ' 396' ' ' VAL . 48.1 t -68.14 -47.68 77.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.04 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 87.1 p -61.39 -30.39 70.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.941 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -74.07 -26.88 60.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.893 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -125.6 94.89 41.63 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.75 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.31 -23.1 76.36 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.462 2.108 . . . . 0.0 112.367 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.71 -29.05 70.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.701 HD12 ' HA ' ' A' ' 408' ' ' VAL . 30.2 mt -65.09 -38.48 90.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.721 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.4 t -62.61 -39.85 86.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.965 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.1 -27.57 67.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.128 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -80.87 -20.5 42.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.165 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 418' ' ' MET . . . . . 0.608 ' CE ' HG22 ' A' ' 398' ' ' VAL . 3.0 mtt -73.64 131.85 42.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.955 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 6.4 p -63.13 167.37 6.43 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.356 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 53.5 Cg_exo -52.4 -56.07 3.22 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.31 2.007 . . . . 0.0 112.187 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 54.4 mp0 -59.67 -40.17 86.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.01 0.433 . . . . 0.0 109.946 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -65.3 -33.78 76.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.183 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.612 ' O ' HD12 ' A' ' 427' ' ' ILE . 85.0 tttt -65.16 -36.75 85.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.199 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -65.0 -45.45 85.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.528 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.31 -30.37 64.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.147 0.499 . . . . 0.0 110.567 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 426' ' ' TYR . . . . . 0.541 ' CE1' HG11 ' A' ' 408' ' ' VAL . 58.4 t80 -68.87 -48.05 64.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.223 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.2 mt -75.13 -33.54 29.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.512 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.65 -43.0 99.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.208 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 68.9 mtm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.948 179.98 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.9 mm . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.905 0.383 . . . . 0.0 111.111 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.937 HG11 HG21 ' A' ' 408' ' ' VAL . 12.0 p -127.48 141.07 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.742 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 16.1 mmt -84.26 113.68 21.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.825 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.501 HG13 ' HG2' ' A' ' 418' ' ' MET . 32.8 t -111.76 108.6 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.808 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.76 22.54 7.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.256 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.83 -17.48 49.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.931 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 -100.21 146.04 31.27 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.678 0.275 . . . . 0.0 111.047 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.79 135.92 20.16 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.649 2.233 . . . . 0.0 112.494 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 403' ' ' PHE . . . . . 0.544 ' O ' HG12 ' A' ' 396' ' ' VAL . 57.4 m-85 -148.33 158.75 44.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.751 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 408' ' ' VAL . 18.0 p -76.92 137.8 39.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.646 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 405' ' ' TYR . . . . . 0.493 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 57.6 t80 -57.58 -40.57 79.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.948 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.0 m -63.49 -39.02 93.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -66.11 -29.39 69.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.937 HG21 HG11 ' A' ' 396' ' ' VAL . 57.1 t -67.41 -46.94 82.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.963 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.8 p -64.22 -29.3 70.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.026 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -75.89 -26.2 56.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.919 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 35.9 mtt-85 -124.0 97.2 41.24 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.824 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.72 -25.59 78.95 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.345 2.03 . . . . 0.0 112.272 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -62.84 -28.47 70.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' A' ' 408' ' ' VAL . 68.7 mt -66.05 -40.24 90.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.846 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.4 -38.38 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.969 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.88 67.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.073 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -79.07 -19.1 52.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.114 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 418' ' ' MET . . . . . 0.501 ' HG2' HG13 ' A' ' 398' ' ' VAL . 3.5 mtt -74.41 129.3 37.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.067 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.476 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 8.7 p -61.69 158.07 43.85 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.208 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 3.0 Cg_endo -45.79 -56.07 3.11 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.661 2.241 . . . . 0.0 112.244 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.1 -38.42 82.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 0.0 109.937 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . 0.414 ' OE1' HG23 ' A' ' 419' ' ' THR . 96.0 mt-10 -66.05 -34.53 78.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.159 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -63.23 -36.22 82.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.116 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -64.84 -43.12 94.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.474 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -59.5 -31.69 69.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.193 0.52 . . . . 0.0 110.473 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 426' ' ' TYR . . . . . 0.523 ' HD1' HG21 ' A' ' 396' ' ' VAL . 57.2 t80 -67.78 -45.1 75.81 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.282 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 61.9 mt -79.46 -33.76 15.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.794 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -68.39 -43.26 77.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.336 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 429' ' ' MET . . . . . 0.526 ' HE1' HG23 ' A' ' 396' ' ' VAL . 49.4 mtm . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.14 -179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.0 mm . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.878 0.37 . . . . 0.0 110.977 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.931 HG11 HG21 ' A' ' 408' ' ' VAL . 14.7 p -124.92 142.48 41.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.86 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 15.2 mmt -85.83 113.81 22.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.647 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.414 ' HA ' ' HG2' ' A' ' 418' ' ' MET . 12.6 t -118.75 114.56 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.95 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.41 22.67 6.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.268 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.33 -17.36 57.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.872 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -100.69 146.24 31.73 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.722 0.296 . . . . 0.0 111.032 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.77 135.98 16.47 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.661 2.241 . . . . 0.0 112.525 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 403' ' ' PHE . . . . . 0.624 ' O ' HG12 ' A' ' 396' ' ' VAL . 86.1 m-85 -148.18 157.73 43.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.771 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 408' ' ' VAL . 49.4 m -71.38 139.98 49.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.527 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -58.01 -40.95 82.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.994 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.3 t -65.86 -38.81 89.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.64 -29.9 70.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.931 HG21 HG11 ' A' ' 396' ' ' VAL . 60.3 t -68.76 -46.3 79.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.004 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.5 p -63.14 -28.94 70.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -74.31 -26.25 60.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.019 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -124.35 87.18 54.19 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.859 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -51.8 -27.21 26.33 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.6 2.2 . . . . 0.0 112.36 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.24 -28.29 69.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 408' ' ' VAL . 69.5 mt -66.57 -38.75 87.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.788 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.25 -37.72 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.02 -28.57 68.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.014 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -79.68 -17.63 53.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.141 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 418' ' ' MET . . . . . 0.419 ' HE3' HG11 ' A' ' 408' ' ' VAL . 7.6 mtt -72.64 132.21 43.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.199 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.467 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 2.9 p -74.6 173.08 7.27 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.066 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.4 Cg_exo -52.94 -55.98 3.23 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.169 1.912 . . . . 0.0 112.264 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -59.83 -40.19 87.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.01 0.433 . . . . 0.0 109.931 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -65.29 -34.23 77.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.229 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -64.49 -36.84 85.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.148 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -63.63 -47.18 82.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.615 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -59.59 -29.71 68.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.12 0.486 . . . . 0.0 110.578 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 426' ' ' TYR . . . . . 0.405 ' CE1' HG11 ' A' ' 408' ' ' VAL . 85.1 t80 -70.11 -45.14 67.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.162 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 57.7 mt -77.92 -35.55 20.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.695 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.76 83.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.827 0.346 . . . . 0.0 111.082 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 76.3 mtp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.901 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.8 mm . . . . . 0 C--O 1.23 0.07 0 CA-C-O 121.038 0.447 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.959 HG11 HG21 ' A' ' 408' ' ' VAL . 12.4 p -129.59 141.94 45.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.906 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 17.8 mmt -82.58 113.76 20.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.817 0.341 . . . . 0.0 110.629 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.686 HG13 ' HG2' ' A' ' 418' ' ' MET . 22.0 t -117.87 112.73 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.965 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.36 23.46 5.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.283 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.11 -15.63 59.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.801 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -103.55 145.82 31.32 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.735 0.303 . . . . 0.0 111.046 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.4 136.03 19.1 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.628 2.219 . . . . 0.0 112.455 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 403' ' ' PHE . . . . . 0.651 ' O ' HG12 ' A' ' 396' ' ' VAL . 64.0 m-85 -147.1 156.9 43.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.751 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . 0.53 ' O ' HG23 ' A' ' 408' ' ' VAL . 50.0 m -69.04 137.75 53.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.645 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -58.16 -43.3 87.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.958 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.0 t -64.89 -37.44 87.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.19 -29.46 70.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.959 HG21 HG11 ' A' ' 396' ' ' VAL . 53.2 t -69.8 -47.36 70.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.999 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.2 p -64.49 -29.04 70.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.022 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -76.76 -26.35 54.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.974 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -124.16 85.29 55.03 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -51.58 -26.77 23.35 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.595 2.197 . . . . 0.0 112.344 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.0 -28.36 69.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 408' ' ' VAL . 70.0 mt -66.11 -36.75 83.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.797 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 39.7 t -63.92 -38.88 83.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.961 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.76 -28.86 68.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.113 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -76.56 -22.08 54.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.094 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 418' ' ' MET . . . . . 0.686 ' HG2' HG13 ' A' ' 398' ' ' VAL . 4.1 mtt -72.72 130.08 39.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.939 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 3.9 p -65.76 171.49 3.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.072 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 50.2 Cg_exo -53.36 -56.07 3.05 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.196 1.93 . . . . 0.0 112.154 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.01 -37.82 83.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.018 0.437 . . . . 0.0 109.842 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -66.94 -33.38 75.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.249 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.852 ' O ' HD12 ' A' ' 427' ' ' ILE . 0.0 OUTLIER -65.73 -34.08 77.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.203 179.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -64.5 -45.62 86.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.65 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.07 -30.92 64.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.145 0.498 . . . . 0.0 110.653 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 426' ' ' TYR . . . . . 0.544 ' CE1' HG11 ' A' ' 408' ' ' VAL . 63.8 t80 -68.51 -48.37 64.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.088 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.852 HD12 ' O ' ' A' ' 423' ' ' LYS . 3.2 mt -73.2 -35.44 47.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.565 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -65.42 -49.14 70.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.173 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 429' ' ' MET . . . . . 0.683 ' CE ' HG23 ' A' ' 396' ' ' VAL . 71.5 mtm . . . . . 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.844 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.3 mm . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.967 0.413 . . . . 0.0 111.11 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.956 HG11 HG21 ' A' ' 408' ' ' VAL . 13.9 p -131.43 142.11 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.893 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 17.2 mmt -84.47 113.7 21.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.597 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.627 HG13 ' HG2' ' A' ' 418' ' ' MET . 22.3 t -118.18 113.6 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.977 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.62 23.17 5.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.295 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.43 -13.82 61.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.956 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 6.8 mtt85 -104.75 146.3 32.37 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.722 0.296 . . . . 0.0 110.991 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.04 136.0 17.85 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.667 2.245 . . . . 0.0 112.526 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 403' ' ' PHE . . . . . 0.651 ' O ' HG12 ' A' ' 396' ' ' VAL . 71.0 m-85 -147.65 158.92 44.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.738 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . 0.544 ' O ' HG23 ' A' ' 408' ' ' VAL . 63.6 m -71.34 138.76 49.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.694 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -58.25 -43.72 88.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 m -64.69 -38.06 89.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.919 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.73 -29.31 70.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.956 HG21 HG11 ' A' ' 396' ' ' VAL . 60.4 t -70.65 -46.79 67.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.012 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.8 t -63.09 -31.28 72.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.026 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -73.87 -26.72 60.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.001 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -123.77 96.75 42.55 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.785 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.22 -25.94 77.21 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.393 2.062 . . . . 0.0 112.299 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -62.75 -28.61 70.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.95 -38.11 85.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.731 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 35.7 t -63.65 -37.81 80.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.847 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.88 -29.05 68.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.993 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -76.24 -22.06 55.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.063 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 418' ' ' MET . . . . . 0.627 ' HG2' HG13 ' A' ' 398' ' ' VAL . 3.8 mtt -71.88 129.56 38.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.446 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.9 p -64.3 169.95 4.2 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.145 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 51.0 Cg_exo -53.14 -56.05 3.12 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.155 1.904 . . . . 0.0 112.161 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 54.2 mp0 -60.69 -38.31 84.56 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -65.99 -34.61 78.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.288 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -65.26 -34.76 79.11 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.226 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -64.76 -44.7 89.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.76 -30.4 67.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.222 0.534 . . . . 0.0 110.631 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 426' ' ' TYR . . . . . 0.541 ' CE1' HG11 ' A' ' 408' ' ' VAL . 76.4 t80 -69.38 -45.95 68.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.294 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.8 -33.77 19.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.751 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.43 -36.16 77.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.341 . . . . 0.0 111.227 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 67.4 mtm . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.942 179.951 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.3 mm . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.93 0.395 . . . . 0.0 111.088 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.895 HG11 HG21 ' A' ' 408' ' ' VAL . 13.6 p -114.02 135.52 53.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.751 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . 0.432 ' HE2' ' HA ' ' A' ' 402' ' ' PRO . 16.8 mmt -83.77 113.86 21.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.845 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.585 HG11 ' HB3' ' A' ' 414' ' ' LEU . 15.1 t -117.61 118.21 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.943 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.4 22.7 6.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.259 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.59 -14.01 64.7 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.905 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -100.82 147.79 34.15 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.788 0.328 . . . . 0.0 111.011 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 402' ' ' PRO . . . . . 0.432 ' HA ' ' HE2' ' A' ' 397' ' ' MET . 74.1 Cg_endo -75.22 136.01 19.42 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.67 2.247 . . . . 0.0 112.375 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 403' ' ' PHE . . . . . 0.436 ' CD2' ' HB ' ' A' ' 398' ' ' VAL . 77.4 m-85 -147.14 168.41 21.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.72 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 55.5 m -88.66 136.82 32.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.675 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -53.55 -41.67 66.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 0.0 110.988 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 26.4 m -67.96 -34.17 76.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.811 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -67.18 -31.25 71.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.051 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.895 HG21 HG11 ' A' ' 396' ' ' VAL . 84.9 t -67.8 -43.19 86.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.829 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.9 p -63.39 -29.79 71.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.073 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -74.44 -27.96 60.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.934 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 11.3 mtt-85 -124.57 92.99 47.08 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.823 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.13 -23.1 75.25 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.451 2.101 . . . . 0.0 112.411 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -62.47 -29.25 70.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.938 0.399 . . . . 0.0 110.982 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.585 ' HB3' HG11 ' A' ' 398' ' ' VAL . 25.7 mt -66.47 -35.98 81.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.722 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.9 t -62.89 -36.23 74.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -64.4 -29.13 70.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.944 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -81.1 -19.76 42.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.076 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 418' ' ' MET . . . . . 0.46 ' HG3' HG13 ' A' ' 398' ' ' VAL . 6.3 mtt -70.36 124.41 24.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.025 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.429 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 5.3 p -63.65 171.01 2.54 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.115 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.1 Cg_exo -54.5 -56.14 2.74 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.109 1.872 . . . . 0.0 112.118 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.77 -39.79 90.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.018 0.437 . . . . 0.0 109.844 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -65.49 -33.41 75.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.234 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.617 ' O ' HD12 ' A' ' 427' ' ' ILE . 54.9 tttm -65.18 -36.68 84.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.24 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -64.89 -45.87 84.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.597 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.08 -30.18 64.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.151 0.5 . . . . 0.0 110.647 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 426' ' ' TYR . . . . . 0.539 ' HD1' HG21 ' A' ' 396' ' ' VAL . 46.8 t80 -69.17 -48.31 62.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.165 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.617 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.2 mt -74.52 -33.69 33.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.434 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.27 -43.97 98.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.121 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 69.8 mtm . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.932 179.995 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.9 mm . . . . . 0 N--CA 1.457 -0.089 0 CA-C-O 120.948 0.404 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.956 HG11 HG21 ' A' ' 408' ' ' VAL . 14.6 p -125.75 141.07 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.69 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 17.9 mmt -82.21 113.89 20.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.88 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.449 ' HA ' ' HG2' ' A' ' 418' ' ' MET . 21.5 t -116.16 111.42 35.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.971 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.94 23.92 5.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.288 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.4 -19.25 51.69 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.752 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -99.61 145.32 29.91 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 111.012 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.06 135.93 19.61 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.679 2.253 . . . . 0.0 112.425 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 403' ' ' PHE . . . . . 0.645 ' O ' HG12 ' A' ' 396' ' ' VAL . 59.1 m-85 -147.04 155.65 42.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.79 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 10.9 p -75.97 137.37 40.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.51 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 405' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 55.2 t80 -55.21 -34.63 64.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.018 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 21.8 m -63.88 -38.13 89.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.985 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -69.84 -29.73 67.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.063 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.956 HG21 HG11 ' A' ' 396' ' ' VAL . 43.4 t -68.97 -49.33 64.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.02 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.9 p -66.86 -28.99 68.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.98 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -82.14 -23.58 35.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.106 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 21.7 mtt-85 -123.49 84.71 52.72 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -51.76 -25.51 20.97 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.626 2.217 . . . . 0.0 112.33 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -60.98 -36.21 78.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 72.1 mt -60.84 -40.75 94.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.888 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.46 -35.95 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.808 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.47 69.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -81.59 -16.72 50.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.044 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 418' ' ' MET . . . . . 0.449 ' HG2' ' HA ' ' A' ' 398' ' ' VAL . 3.7 mtt -72.01 127.1 31.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.162 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 1.3 p -66.75 166.7 17.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.173 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 65.9 Cg_exo -50.79 -56.24 3.28 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.26 1.974 . . . . 0.0 112.324 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.25 -39.84 88.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 109.975 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.8 -33.4 75.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.217 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.57 ' O ' HD12 ' A' ' 427' ' ' ILE . 77.4 tttt -64.92 -36.42 84.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.142 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -64.72 -46.22 83.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.512 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.55 -30.29 65.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.137 0.494 . . . . 0.0 110.591 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 426' ' ' TYR . . . . . 0.67 ' CE1' HG11 ' A' ' 408' ' ' VAL . 50.9 t80 -69.05 -47.75 64.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.275 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.57 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.6 mt -75.33 -33.64 28.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.464 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.16 96.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.073 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 429' ' ' MET . . . . . 0.488 ' HE1' ' HB ' ' A' ' 396' ' ' VAL . 71.2 mtm . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.833 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.4 mm . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.959 0.409 . . . . 0.0 111.066 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.954 HG11 HG21 ' A' ' 408' ' ' VAL . 12.4 p -132.75 142.52 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.771 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 5.3 mmt -86.65 113.83 22.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 110.889 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.64 HG11 ' HB3' ' A' ' 414' ' ' LEU . 29.5 t -112.8 118.73 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.95 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.07 23.53 5.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.435 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.33 19.58 41.43 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.853 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -136.97 146.45 54.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.668 0.234 . . . . 0.0 110.89 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 402' ' ' PRO . . . . . 0.441 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 17.1 Cg_exo -66.81 135.62 38.89 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.439 2.093 . . . . 0.0 112.319 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 403' ' ' PHE . . . . . 0.582 ' HB2' HG23 ' A' ' 398' ' ' VAL . 20.6 m-85 -149.44 156.04 41.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.64 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . 0.503 ' O ' HG23 ' A' ' 408' ' ' VAL . 56.2 m -76.27 133.79 39.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.704 0.288 . . . . 0.0 110.572 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -56.23 -41.56 75.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.006 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.9 m -64.57 -36.13 83.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.799 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.45 -29.13 68.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.144 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.954 HG21 HG11 ' A' ' 396' ' ' VAL . 48.7 t -66.49 -47.89 82.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.013 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.1 p -64.14 -29.2 70.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.005 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -81.71 -25.3 35.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.966 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -122.94 91.33 49.87 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.813 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.36 -22.42 74.07 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.5 2.133 . . . . 0.0 112.419 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -61.9 -30.23 70.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.983 0.421 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.64 ' HB3' HG11 ' A' ' 398' ' ' VAL . 20.7 mt -68.67 -36.77 78.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.597 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 22.5 t -64.94 -35.97 76.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.777 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.35 -26.0 66.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.083 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -92.16 -0.5 57.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.358 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 418' ' ' MET . . . . . 0.511 ' HG2' HG13 ' A' ' 398' ' ' VAL . 1.0 OUTLIER -87.47 125.9 34.57 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.74 0.305 . . . . 0.0 111.179 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 14.5 p -61.38 160.64 22.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.321 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 6.9 Cg_endo -49.11 -53.16 7.45 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.55 2.167 . . . . 0.0 112.246 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -60.02 -42.76 95.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 110.159 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -65.57 -32.91 74.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.162 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.553 ' O ' HD12 ' A' ' 427' ' ' ILE . 16.9 tptm -65.03 -37.21 86.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.175 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -64.6 -46.26 83.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.546 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.54 -30.22 65.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.17 0.51 . . . . 0.0 110.585 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 426' ' ' TYR . . . . . 0.626 ' CE1' HG11 ' A' ' 408' ' ' VAL . 46.9 t80 -69.0 -47.95 64.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.259 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.7 mt -75.13 -33.67 29.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.452 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -59.75 -42.87 94.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.132 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 69.1 mtm . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.966 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 41.0 mm . . . . . 0 N--CA 1.457 -0.123 0 CA-C-O 120.973 0.416 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.97 HG11 HG21 ' A' ' 408' ' ' VAL . 14.8 p -130.24 143.26 41.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 18.3 mmt -87.18 113.83 23.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.704 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.811 HG11 ' HB3' ' A' ' 414' ' ' LEU . 21.3 t -117.25 118.66 59.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 51.41 26.41 3.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.478 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 89.15 20.49 45.69 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.823 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -137.06 143.22 41.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.681 0.277 . . . . 0.0 110.693 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.17 135.92 23.61 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.439 2.093 . . . . 0.0 112.611 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 403' ' ' PHE . . . . . 0.707 ' O ' HG12 ' A' ' 396' ' ' VAL . 46.8 m-85 -150.49 154.26 37.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.687 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 13.3 p -69.72 136.02 50.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.59 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -56.2 -39.77 72.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.062 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.6 m -64.3 -36.43 84.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.979 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -66.11 -30.95 71.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.095 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.97 HG21 HG11 ' A' ' 396' ' ' VAL . 44.6 t -70.9 -48.93 53.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.9 t -62.56 -31.77 72.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.998 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -81.66 -25.7 35.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.053 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . 0.445 ' O ' HD12 ' A' ' 414' ' ' LEU . 21.4 mtt180 -127.49 99.53 27.0 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.87 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.29 -15.37 42.29 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.446 2.097 . . . . 0.0 112.606 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -58.4 -33.34 69.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.019 0.438 . . . . 0.0 111.206 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.811 ' HB3' HG11 ' A' ' 398' ' ' VAL . 1.1 mt -72.11 -34.11 68.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.494 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 23.4 t -67.28 -32.98 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.612 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -69.45 -25.6 64.18 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.029 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -90.75 -13.17 34.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.282 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 418' ' ' MET . . . . . 0.637 ' HG2' HG13 ' A' ' 398' ' ' VAL . 1.7 mtt -74.61 124.54 26.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.802 0.334 . . . . 0.0 111.088 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.475 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 10.2 p -61.29 158.25 38.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.107 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 2.5 Cg_endo -45.52 -56.0 3.11 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.547 2.165 . . . . 0.0 112.346 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -60.2 -38.89 84.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.004 0.43 . . . . 0.0 110.002 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -66.41 -33.85 76.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.222 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.548 ' O ' HD12 ' A' ' 427' ' ' ILE . 82.4 tttt -64.85 -35.07 79.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.214 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -64.22 -46.36 84.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.61 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.04 -30.69 64.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.23 0.538 . . . . 0.0 110.603 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 426' ' ' TYR . . . . . 0.552 ' CE1' HG11 ' A' ' 408' ' ' VAL . 42.4 t80 -68.62 -48.37 64.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.254 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.6 mt -74.44 -33.56 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.473 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -58.91 -39.81 82.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.129 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 66.9 mtm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.992 179.882 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.4 mm . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.892 0.377 . . . . 0.0 111.103 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.943 HG11 HG21 ' A' ' 408' ' ' VAL . 11.6 p -121.16 140.1 46.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.719 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 22.3 mmt -83.19 113.81 20.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.748 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.551 HG13 ' HG2' ' A' ' 418' ' ' MET . 31.4 t -110.61 107.17 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.27 22.9 6.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.254 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 104.99 -20.33 38.68 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.919 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -97.18 145.29 29.37 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.612 0.244 . . . . 0.0 111.096 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.79 135.98 18.31 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.677 2.252 . . . . 0.0 112.503 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 403' ' ' PHE . . . . . 0.517 ' O ' HG12 ' A' ' 396' ' ' VAL . 61.8 m-85 -148.52 156.98 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.687 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . 0.55 ' O ' HG23 ' A' ' 408' ' ' VAL . 51.3 m -73.49 138.46 45.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.605 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -58.04 -42.27 85.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.934 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.8 t -64.76 -37.37 87.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.85 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -64.69 -29.33 70.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.033 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.943 HG21 HG11 ' A' ' 396' ' ' VAL . 49.0 t -68.48 -47.67 76.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.054 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.4 t -62.89 -31.04 72.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.997 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -74.01 -27.07 60.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.977 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -124.41 85.34 55.87 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.787 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -51.68 -26.82 24.21 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.585 2.19 . . . . 0.0 112.338 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.2 -29.14 70.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.976 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 59.2 mt -65.98 -37.21 85.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.728 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 25.7 t -63.45 -37.78 80.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.951 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.41 -30.77 71.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.077 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -74.13 -23.61 59.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.074 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 418' ' ' MET . . . . . 0.551 ' HG2' HG13 ' A' ' 398' ' ' VAL . 3.5 mtt -72.65 129.08 37.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.986 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.466 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.5 p -64.08 170.74 3.11 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.258 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 65.5 Cg_exo -51.65 -55.96 3.45 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.256 1.971 . . . . 0.0 112.386 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -58.84 -40.54 84.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.429 . . . . 0.0 110.092 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -65.42 -34.41 78.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.237 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -64.26 -36.58 84.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.187 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -64.92 -45.24 86.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.557 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.88 -30.53 65.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.167 0.508 . . . . 0.0 110.633 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 426' ' ' TYR . . . . . 0.516 ' CE1' HG11 ' A' ' 408' ' ' VAL . 79.0 t80 -69.15 -47.01 66.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.32 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 60.4 mt -76.28 -33.82 24.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.62 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.69 -43.13 94.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.143 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 429' ' ' MET . . . . . 0.537 ' HE1' HG23 ' A' ' 396' ' ' VAL . 71.5 mtm . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.972 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.5 mm . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.053 0.454 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.938 HG11 HG21 ' A' ' 408' ' ' VAL . 14.7 p -120.46 143.34 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.733 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.4 mmt -89.5 113.79 25.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.774 0.321 . . . . 0.0 110.68 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.53 HG23 ' HB2' ' A' ' 403' ' ' PHE . 27.3 t -114.8 125.68 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.915 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.94 24.37 5.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.349 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.81 19.89 55.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.767 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -137.05 154.99 76.36 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.601 0.238 . . . . 0.0 110.843 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 402' ' ' PRO . . . . . 0.413 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 12.8 Cg_exo -69.86 135.77 31.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.6 2.2 . . . . 0.0 112.309 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 403' ' ' PHE . . . . . 0.53 ' HB2' HG23 ' A' ' 398' ' ' VAL . 31.7 m-85 -150.56 155.71 39.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.461 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 408' ' ' VAL . 17.2 p -80.32 135.2 36.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.731 0.301 . . . . 0.0 110.588 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 405' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 61.3 t80 -56.0 -39.62 72.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.007 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 m -64.02 -38.3 90.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -66.82 -29.52 69.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.14 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.938 HG21 HG11 ' A' ' 396' ' ' VAL . 50.7 t -67.25 -47.51 81.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.991 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.7 t -63.04 -31.93 73.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -73.76 -26.67 60.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.969 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -124.1 95.26 44.15 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.789 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.2 -25.46 80.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.484 2.122 . . . . 0.0 112.21 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -62.95 -28.36 70.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.922 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 62.5 mt -67.07 -40.56 87.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 39.1 t -62.88 -36.27 74.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.722 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.79 -29.28 69.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.929 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -80.35 -19.38 46.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.052 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 418' ' ' MET . . . . . 0.43 ' HE3' HG11 ' A' ' 408' ' ' VAL . 6.0 mtt -70.35 128.12 35.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.046 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 3.2 p -68.65 172.02 5.29 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.143 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.4 Cg_exo -53.04 -56.02 3.17 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.188 1.925 . . . . 0.0 112.233 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.23 -41.55 88.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.0 0.428 . . . . 0.0 109.973 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.77 -33.68 76.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.139 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.609 ' O ' HD12 ' A' ' 427' ' ' ILE . 23.6 tptm -64.26 -38.29 90.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.16 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -65.51 -44.76 85.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.577 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.19 -29.92 66.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.136 0.493 . . . . 0.0 110.528 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 426' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 49.8 t80 -69.44 -47.12 65.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.202 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.4 mt -76.42 -33.81 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.53 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -65.86 -45.89 80.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.25 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 429' ' ' MET . . . . . 0.406 ' HE1' HG23 ' A' ' 396' ' ' VAL . 69.0 mtm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.929 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 34.5 mm . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.924 0.392 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.965 HG11 HG21 ' A' ' 408' ' ' VAL . 12.5 p -113.96 139.71 38.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.591 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 21.7 mmt -84.11 113.85 21.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.825 0.345 . . . . 0.0 110.815 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.451 HG23 ' HB2' ' A' ' 403' ' ' PHE . 22.0 t -112.23 112.46 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.838 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.28 22.86 6.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.304 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.97 -16.0 57.67 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.826 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -100.58 148.23 34.69 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.691 0.281 . . . . 0.0 111.052 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.78 136.01 20.3 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.641 2.227 . . . . 0.0 112.472 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 403' ' ' PHE . . . . . 0.483 ' O ' HG12 ' A' ' 396' ' ' VAL . 57.8 m-85 -149.23 156.34 41.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.68 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . 0.433 ' O ' HG23 ' A' ' 408' ' ' VAL . 15.7 p -79.98 137.6 36.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.504 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 405' ' ' TYR . . . . . 0.498 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 57.5 t80 -55.33 -34.83 64.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.126 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 93.4 p -64.2 -40.67 96.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -67.63 -30.32 69.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.178 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.965 HG21 HG11 ' A' ' 396' ' ' VAL . 45.7 t -66.08 -48.92 79.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.6 t -64.84 -30.57 71.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.008 0.432 . . . . 0.0 110.978 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -77.46 -26.13 51.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.061 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -124.4 84.16 56.79 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.816 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -51.69 -24.91 18.92 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.65 2.233 . . . . 0.0 112.38 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -61.78 -29.81 70.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.002 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 32.3 mt -67.95 -37.76 81.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.728 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 38.9 t -64.36 -35.6 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.765 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.74 -29.97 70.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.879 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -80.21 -19.41 47.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.935 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 418' ' ' MET . . . . . 0.447 ' HG2' ' HA ' ' A' ' 398' ' ' VAL . 4.3 mtt -70.45 124.95 25.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.037 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 17.3 p -61.04 163.18 10.65 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.348 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 76.7 Cg_exo -48.07 -56.06 3.46 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.363 2.042 . . . . 0.0 112.382 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -59.49 -40.03 85.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.008 0.432 . . . . 0.0 110.0 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -65.11 -33.99 77.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.176 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.584 ' O ' HD12 ' A' ' 427' ' ' ILE . 20.9 tptm -63.58 -37.96 89.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.158 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -64.93 -46.18 82.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.569 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.78 -29.5 64.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.16 0.505 . . . . 0.0 110.655 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 426' ' ' TYR . . . . . 0.622 ' CE1' HG11 ' A' ' 408' ' ' VAL . 63.3 t80 -69.72 -47.67 62.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.217 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.5 mt -75.23 -33.98 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.416 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.94 76.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.103 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 59.4 mtp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 179.948 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.9 mm . . . . . 0 N--CA 1.457 -0.103 0 CA-C-O 120.868 0.366 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.941 HG11 HG21 ' A' ' 408' ' ' VAL . 12.4 p -124.05 141.47 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 18.6 mmt -83.36 114.95 21.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.825 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.634 HG23 ' HB2' ' A' ' 403' ' ' PHE . 60.0 t -114.25 106.54 20.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.591 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 63.95 16.55 9.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.342 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 109.57 -22.39 24.31 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.073 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 398' ' ' VAL . 11.7 ptm180 -99.0 149.76 36.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.85 0.357 . . . . 0.0 111.129 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.25 135.93 32.99 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.806 2.337 . . . . 0.0 113.012 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 403' ' ' PHE . . . . . 0.634 ' HB2' HG23 ' A' ' 398' ' ' VAL . 4.2 m-85 -139.32 172.17 13.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.696 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . 0.528 ' O ' HG23 ' A' ' 408' ' ' VAL . 0.7 OUTLIER -93.89 130.45 39.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.457 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -54.24 -42.93 70.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.172 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 31.1 m -66.75 -34.85 78.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -67.62 -29.72 69.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.159 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.941 HG21 HG11 ' A' ' 396' ' ' VAL . 55.1 t -70.29 -47.46 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.058 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.9 t -61.6 -31.45 71.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.007 0.432 . . . . 0.0 111.036 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -75.9 -27.49 57.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.948 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -125.87 96.35 37.84 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.832 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.79 -23.94 74.49 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.465 2.11 . . . . 0.0 112.373 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -61.4 -29.25 69.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 110.954 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 408' ' ' VAL . 16.4 mt -67.38 -36.42 81.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.708 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.2 -37.03 78.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.86 -28.58 68.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.015 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -76.7 -22.88 53.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.053 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 418' ' ' MET . . . . . 0.46 ' CE ' HG22 ' A' ' 398' ' ' VAL . 5.0 mtt -71.11 129.29 38.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.464 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.3 p -63.91 171.18 2.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.206 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.4 Cg_exo -52.66 -56.09 3.16 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.179 1.919 . . . . 0.0 112.188 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -60.48 -38.69 85.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -65.45 -34.23 77.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.133 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.6 ' O ' HD12 ' A' ' 427' ' ' ILE . 11.3 tptm -64.34 -36.63 84.74 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.288 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -65.32 -44.36 88.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.597 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.76 -30.45 65.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.181 0.515 . . . . 0.0 110.528 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 426' ' ' TYR . . . . . 0.664 ' CE1' HG11 ' A' ' 408' ' ' VAL . 68.5 t80 -68.78 -47.57 65.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.31 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.2 mt -75.37 -34.03 29.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.532 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.77 -30.1 70.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.239 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 64.0 mtp . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.04 -179.982 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.7 mm . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.904 0.383 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.921 HG11 HG21 ' A' ' 408' ' ' VAL . 14.4 p -119.97 141.94 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.759 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 15.1 mmt -84.76 113.85 21.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.443 ' HA ' ' HG2' ' A' ' 418' ' ' MET . 18.7 t -114.81 113.01 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.944 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.86 23.9 5.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.306 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.85 56.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.804 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.61 146.38 31.73 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.732 0.301 . . . . 0.0 111.05 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.13 135.98 19.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.669 2.246 . . . . 0.0 112.529 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 403' ' ' PHE . . . . . 0.576 ' O ' HG12 ' A' ' 396' ' ' VAL . 62.1 m-85 -148.12 156.26 42.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.682 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 408' ' ' VAL . 17.3 p -74.82 138.59 42.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.58 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -56.88 -39.91 75.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.003 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.3 m -64.55 -38.21 90.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -65.87 -29.72 70.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.182 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.921 HG21 HG11 ' A' ' 396' ' ' VAL . 59.8 t -67.12 -46.3 84.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.946 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.7 p -65.02 -29.33 70.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.98 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -76.83 -26.14 53.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.947 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -123.7 95.03 45.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.801 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.02 -25.51 77.72 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.389 2.059 . . . . 0.0 112.252 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.34 -28.47 69.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.951 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 65.7 mt -66.57 -38.84 87.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.703 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.41 -36.17 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.735 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -64.62 -29.97 70.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.936 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -80.77 -18.25 48.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.974 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 418' ' ' MET . . . . . 0.443 ' HG2' ' HA ' ' A' ' 398' ' ' VAL . 5.3 mtt -72.71 126.44 29.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.176 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.446 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 2.8 p -69.14 172.57 4.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.049 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 50.5 Cg_exo -53.71 -56.09 2.96 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.188 1.925 . . . . 0.0 112.226 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.33 -41.92 90.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.923 0.392 . . . . 0.0 110.028 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.05 -33.35 75.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.34 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.579 ' O ' HD12 ' A' ' 427' ' ' ILE . 48.6 tttm -65.97 -36.62 83.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.308 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -65.03 -45.8 83.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.639 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.2 -29.48 65.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.11 0.481 . . . . 0.0 110.57 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 426' ' ' TYR . . . . . 0.531 ' CE1' HG11 ' A' ' 408' ' ' VAL . 43.9 t80 -69.82 -47.05 64.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.263 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.579 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.7 mt -76.44 -33.84 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.443 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -63.59 -45.88 88.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.127 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 429' ' ' MET . . . . . 0.467 ' HE1' HG23 ' A' ' 396' ' ' VAL . 66.9 mtm . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.4 mm . . . . . 0 N--CA 1.457 -0.077 0 CA-C-O 120.919 0.39 . . . . 0.0 111.174 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.95 HG11 HG21 ' A' ' 408' ' ' VAL . 11.7 p -129.0 140.48 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.725 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 18.2 mmt -81.04 113.72 19.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.669 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.62 HG13 ' HG2' ' A' ' 418' ' ' MET . 23.2 t -115.68 110.44 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.57 23.31 5.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.295 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.19 -17.74 53.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.862 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 35.9 mtp85 -101.54 145.15 29.95 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.737 0.268 . . . . 0.0 111.095 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.29 135.92 19.16 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.689 2.259 . . . . 0.0 112.412 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 403' ' ' PHE . . . . . 0.608 ' O ' HG12 ' A' ' 396' ' ' VAL . 62.0 m-85 -147.4 157.52 43.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.787 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . 0.586 ' O ' HG23 ' A' ' 408' ' ' VAL . 49.0 m -69.88 138.2 52.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.611 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -58.49 -41.59 85.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.979 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 95.4 p -66.25 -39.89 89.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.14 -29.22 69.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.131 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.95 HG21 HG11 ' A' ' 396' ' ' VAL . 49.4 t -68.46 -47.67 76.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.994 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.7 t -64.08 -30.12 71.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -75.71 -26.31 57.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.025 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -124.35 85.09 55.84 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.08 -27.25 28.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.611 2.207 . . . . 0.0 112.291 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -61.07 -29.27 69.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 63.3 mt -66.17 -37.54 85.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.761 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 37.5 t -63.68 -38.06 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.11 -28.48 68.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.066 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -80.05 -17.73 51.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.116 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 418' ' ' MET . . . . . 0.62 ' HG2' HG13 ' A' ' 398' ' ' VAL . 3.0 mtt -76.35 132.2 39.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.153 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 8.3 p -63.79 158.61 59.8 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.065 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 2.0 Cg_endo -45.05 -56.03 3.0 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.617 2.211 . . . . 0.0 112.257 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.25 -38.55 83.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.969 0.414 . . . . 0.0 109.956 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -66.0 -34.25 77.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.158 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.61 ' O ' HD12 ' A' ' 427' ' ' ILE . 74.9 tttt -63.52 -36.16 82.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.205 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -64.57 -45.46 86.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.634 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -56.87 -31.04 64.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.131 0.491 . . . . 0.0 110.594 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 426' ' ' TYR . . . . . 0.512 ' CE1' HG11 ' A' ' 408' ' ' VAL . 47.4 t80 -68.45 -48.23 65.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.218 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.61 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.1 mt -74.05 -34.03 37.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.519 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.63 83.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.061 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 65.1 mtm . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.826 179.849 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.6 mm . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 120.916 0.389 . . . . 0.0 111.03 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.937 HG11 HG21 ' A' ' 408' ' ' VAL . 12.7 p -115.9 142.24 30.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.769 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . 0.432 ' HE2' ' HA ' ' A' ' 402' ' ' PRO . 2.8 mmt -90.13 113.86 25.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.866 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.619 HG13 ' HG2' ' A' ' 418' ' ' MET . 39.2 t -110.63 119.09 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.011 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.95 27.68 11.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.363 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.88 23.51 45.43 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.785 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 75.8 mtm-85 -137.01 151.68 72.53 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.602 0.239 . . . . 0.0 110.688 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 402' ' ' PRO . . . . . 0.432 ' HA ' ' HE2' ' A' ' 397' ' ' MET . 57.7 Cg_endo -71.28 135.72 27.48 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.406 2.071 . . . . 0.0 112.411 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 403' ' ' PHE . . . . . 0.523 ' HB2' HG23 ' A' ' 398' ' ' VAL . 35.1 m-85 -150.67 172.09 16.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.668 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . 0.728 ' O ' HG23 ' A' ' 408' ' ' VAL . 49.4 m -97.84 136.87 37.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.569 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 405' ' ' TYR . . . . . 0.428 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 41.3 t80 -57.11 -41.71 79.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.913 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.4 t -64.4 -39.57 94.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.843 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.86 -29.22 69.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.109 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.937 HG21 HG11 ' A' ' 396' ' ' VAL . 51.5 t -66.59 -47.49 83.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.016 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.0 p -64.45 -29.03 70.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.983 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -76.78 -25.65 53.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.01 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 38.7 mtt85 -124.76 85.57 56.89 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.794 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -51.79 -26.7 24.64 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.623 2.215 . . . . 0.0 112.295 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.61 -29.79 70.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.945 0.403 . . . . 0.0 111.009 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 67.7 mt -66.83 -36.86 83.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.74 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . 0.651 HG13 ' NZ ' ' A' ' 423' ' ' LYS . 43.2 t -64.71 -37.95 81.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.948 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -68.09 -28.39 67.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -77.3 -22.46 51.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.121 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 418' ' ' MET . . . . . 0.619 ' HG2' HG13 ' A' ' 398' ' ' VAL . 2.6 mtt -73.47 130.28 39.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.439 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.1 p -65.97 171.18 4.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.259 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 50.6 Cg_exo -53.91 -56.2 2.81 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.334 2.023 . . . . 0.0 112.418 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -58.33 -42.66 87.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.857 0.36 . . . . 0.0 110.216 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -65.96 -32.82 74.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.079 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.651 ' NZ ' HG13 ' A' ' 415' ' ' VAL . 0.5 OUTLIER -65.21 -36.69 84.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.168 179.371 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -64.6 -45.82 85.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.59 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.11 -30.81 64.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.119 0.485 . . . . 0.0 110.536 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 426' ' ' TYR . . . . . 0.552 ' CE1' HG11 ' A' ' 408' ' ' VAL . 63.5 t80 -68.46 -48.27 64.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.273 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.566 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.4 mt -74.47 -33.82 34.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.434 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.05 87.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.144 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 68.8 mtm . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.891 179.894 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.4 mm . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.923 0.392 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.959 HG11 HG21 ' A' ' 408' ' ' VAL . 11.8 p -127.44 139.75 51.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.763 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 19.4 mmt -81.0 113.82 19.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.824 0.345 . . . . 0.0 110.82 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.577 HG13 ' HG2' ' A' ' 418' ' ' MET . 21.7 t -115.3 110.27 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.03 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.02 24.38 4.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.28 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.9 -19.68 48.64 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.758 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -98.68 143.6 26.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.651 0.262 . . . . 0.0 110.958 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.56 135.91 16.79 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.651 2.234 . . . . 0.0 112.475 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 403' ' ' PHE . . . . . 0.571 ' O ' HG12 ' A' ' 396' ' ' VAL . 48.7 m-85 -148.47 161.1 42.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.714 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . 0.619 ' O ' HG23 ' A' ' 408' ' ' VAL . 25.9 p -75.92 141.35 42.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.595 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -58.24 -40.8 82.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.908 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.7 t -63.59 -40.39 96.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -63.97 -28.79 70.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.959 HG21 HG11 ' A' ' 396' ' ' VAL . 37.7 t -70.32 -54.02 20.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.051 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 18.2 m -61.04 -30.17 70.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.94 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -76.19 -25.44 55.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.974 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -124.72 86.79 55.52 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.845 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -51.77 -25.51 21.05 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.559 2.173 . . . . 0.0 112.408 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -61.67 -30.7 70.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.934 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 408' ' ' VAL . 30.5 mt -68.07 -36.94 80.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.679 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.51 -36.49 77.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.813 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.98 -28.07 67.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.035 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -81.47 -17.16 49.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.227 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 418' ' ' MET . . . . . 0.577 ' HG2' HG13 ' A' ' 398' ' ' VAL . 2.9 mtt -77.02 130.93 38.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.151 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.502 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.6 p -67.25 159.07 79.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.982 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 1.2 Cg_endo -44.14 -53.35 4.8 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.694 2.263 . . . . 0.0 112.497 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.27 -41.59 93.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 0.0 110.207 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.46 -33.76 76.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.248 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -65.0 -35.13 80.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.115 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -63.24 -46.27 87.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.637 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.42 -31.51 67.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.222 0.534 . . . . 0.0 110.755 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 426' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -68.62 -46.01 70.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.207 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 58.3 mt -76.42 -35.92 27.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.705 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -65.68 -35.19 80.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.932 0.396 . . . . 0.0 111.176 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 60.2 mtp . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 179.943 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 34.4 mm . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.921 0.391 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.96 HG11 HG21 ' A' ' 408' ' ' VAL . 12.6 p -125.22 140.34 48.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.686 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.8 mmt -85.55 113.75 22.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.065 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.687 HG23 ' HB2' ' A' ' 403' ' ' PHE . 34.6 t -111.03 120.08 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.851 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.73 23.25 6.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.466 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.81 21.02 37.85 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.825 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -137.11 149.67 66.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.563 0.22 . . . . 0.0 110.74 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 402' ' ' PRO . . . . . 0.426 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 18.2 Cg_exo -66.29 135.66 40.76 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.474 2.116 . . . . 0.0 112.338 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 403' ' ' PHE . . . . . 0.687 ' HB2' HG23 ' A' ' 398' ' ' VAL . 17.3 m-85 -148.42 172.13 14.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . 0.719 ' O ' HG23 ' A' ' 408' ' ' VAL . 22.3 p -97.71 135.37 39.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.431 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 405' ' ' TYR . . . . . 0.499 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 45.8 t80 -56.98 -39.57 74.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.122 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.1 m -64.44 -39.7 94.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.093 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -68.24 -28.89 67.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.96 HG21 HG11 ' A' ' 396' ' ' VAL . 24.3 t -68.25 -55.97 14.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.068 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 1.4 m -59.23 -29.99 67.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -73.74 -26.26 60.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.861 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 41.4 mtt-85 -125.04 87.47 55.41 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.817 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.97 -26.43 18.46 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.535 2.157 . . . . 0.0 112.408 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.52 -28.52 69.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.031 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.654 HD12 ' HA ' ' A' ' 408' ' ' VAL . 68.6 mt -66.56 -39.58 88.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.845 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.5 -37.07 78.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.009 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -68.41 -28.85 67.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.034 0.445 . . . . 0.0 111.158 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -80.11 -19.71 46.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.119 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 418' ' ' MET . . . . . 0.535 ' HG2' HG13 ' A' ' 398' ' ' VAL . 2.8 mtt -75.46 133.33 41.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.055 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.487 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 6.7 p -62.63 158.41 50.86 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.015 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 2.6 Cg_endo -45.65 -52.85 6.27 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.624 2.216 . . . . 0.0 112.377 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -60.09 -43.38 95.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.925 0.393 . . . . 0.0 110.168 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -65.07 -33.25 75.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.196 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.654 ' O ' HD12 ' A' ' 427' ' ' ILE . 41.2 tttt -64.66 -38.07 89.74 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.085 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -65.02 -45.24 86.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.588 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.34 -30.4 64.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.211 0.529 . . . . 0.0 110.712 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 426' ' ' TYR . . . . . 0.499 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 56.1 t80 -69.19 -47.89 63.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.248 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.654 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.0 mt -74.69 -33.72 32.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.497 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.66 -39.49 88.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.167 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 71.6 mtm . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.833 179.955 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.4 mm . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.933 0.397 . . . . 0.0 111.16 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.932 HG11 HG21 ' A' ' 408' ' ' VAL . 11.4 p -117.7 139.34 45.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.688 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . 0.434 ' HE2' ' HA ' ' A' ' 402' ' ' PRO . 2.3 mmt -86.9 113.85 23.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.95 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' A' ' 403' ' ' PHE . 39.9 t -110.03 119.58 59.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.816 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 57.2 24.82 10.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.323 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 88.44 22.07 41.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.835 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 29.4 mtt-85 -136.94 150.71 70.51 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.607 0.242 . . . . 0.0 110.813 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 402' ' ' PRO . . . . . 0.434 ' HA ' ' HE2' ' A' ' 397' ' ' MET . 17.7 Cg_exo -66.52 135.64 39.93 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.47 2.113 . . . . 0.0 112.372 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 403' ' ' PHE . . . . . 0.66 ' HB2' HG23 ' A' ' 398' ' ' VAL . 17.9 m-85 -148.82 171.99 15.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.606 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . 0.675 ' O ' HG23 ' A' ' 408' ' ' VAL . 53.6 p -100.32 134.81 42.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.559 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 405' ' ' TYR . . . . . 0.481 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 28.3 t80 -56.03 -37.36 69.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 21.7 m -66.46 -41.63 88.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.099 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -66.28 -29.71 69.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 111.256 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.932 HG21 HG11 ' A' ' 396' ' ' VAL . 44.1 t -65.81 -48.91 80.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.102 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.1 p -64.49 -29.25 70.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -77.91 -25.91 48.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.02 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -124.1 85.76 54.51 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.87 -26.81 18.9 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.569 2.179 . . . . 0.0 112.398 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.31 -28.25 69.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.034 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 408' ' ' VAL . 71.8 mt -66.48 -39.25 88.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.833 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 38.6 t -63.82 -38.15 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.78 -28.86 67.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.11 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -76.07 -22.88 55.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.053 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 418' ' ' MET . . . . . 0.601 ' HG2' HG13 ' A' ' 398' ' ' VAL . 2.8 mtt -74.21 133.68 42.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.444 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 3.8 p -66.69 171.25 4.59 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.11 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 51.1 Cg_exo -53.27 -56.06 3.08 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.247 1.965 . . . . 0.0 112.368 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.0 -41.53 87.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.072 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -65.83 -33.02 74.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.094 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . 0.694 ' O ' HD12 ' A' ' 427' ' ' ILE . 79.9 tttt -64.43 -37.21 86.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.1 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -65.4 -45.09 85.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.527 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -56.94 -30.53 64.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.21 0.528 . . . . 0.0 110.537 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 426' ' ' TYR . . . . . 0.646 ' CE1' HG11 ' A' ' 408' ' ' VAL . 64.3 t80 -68.49 -48.82 63.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.132 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 423' ' ' LYS . 3.6 mt -73.14 -35.16 46.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.3 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -71.59 -29.23 64.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.065 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 57.7 mtp . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.899 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.9 mm . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.859 0.361 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 396' ' ' VAL . . . . . 0.897 HG11 HG21 ' A' ' 408' ' ' VAL . 13.4 p -116.16 137.61 49.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.732 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 397' ' ' MET . . . . . 0.437 ' HE2' ' HA ' ' A' ' 402' ' ' PRO . 2.1 mmt -85.74 113.94 22.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.04 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 398' ' ' VAL . . . . . 0.54 HG23 ' HB2' ' A' ' 403' ' ' PHE . 33.2 t -114.92 123.87 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.928 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.66 26.88 11.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.23 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.44 22.63 56.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.647 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -137.07 153.34 75.11 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.665 0.269 . . . . 0.0 110.931 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 402' ' ' PRO . . . . . 0.437 ' HA ' ' HE2' ' A' ' 397' ' ' MET . 48.4 Cg_endo -68.88 135.97 34.08 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.518 2.145 . . . . 0.0 112.339 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 403' ' ' PHE . . . . . 0.54 ' HB2' HG23 ' A' ' 398' ' ' VAL . 14.4 m-85 -146.65 171.54 14.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 50.8 m -97.48 129.71 44.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.619 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -52.29 -40.31 61.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.027 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 41.6 t -67.61 -35.26 78.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.738 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.87 -30.8 70.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.051 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 408' ' ' VAL . . . . . 0.897 HG21 HG11 ' A' ' 396' ' ' VAL . 81.9 t -69.83 -44.55 78.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.869 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 32.9 t -62.95 -30.91 71.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.989 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -75.48 -26.59 58.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.996 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 14.6 mtt85 -125.86 84.89 60.17 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.883 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.37 -24.99 23.0 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.597 2.198 . . . . 0.0 112.371 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -61.23 -29.31 69.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.976 0.417 . . . . 0.0 111.064 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 414' ' ' LEU . . . . . 0.508 HD12 ' HA ' ' A' ' 408' ' ' VAL . 28.8 mt -66.39 -36.23 82.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.761 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.68 -37.71 80.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.4 70.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.035 0.445 . . . . 0.0 111.008 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -79.57 -21.18 45.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.0 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 418' ' ' MET . . . . . 0.443 ' HE3' HG11 ' A' ' 408' ' ' VAL . 7.3 mtt -69.19 123.72 21.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.033 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 419' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 7.0 p -61.53 167.77 3.94 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.172 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 420' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 62.4 Cg_exo -51.47 -56.07 3.36 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.288 1.992 . . . . 0.0 112.155 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -59.98 -39.84 87.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 109.882 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.11 -34.23 77.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.27 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -64.82 -36.66 85.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.197 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -64.27 -46.24 84.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.474 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.42 -30.49 66.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.167 0.508 . . . . 0.0 110.607 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 426' ' ' TYR . . . . . 0.567 ' HD1' HG21 ' A' ' 396' ' ' VAL . 75.1 t80 -69.37 -46.42 66.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.259 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 58.7 mt -77.19 -33.66 20.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.574 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -63.4 -38.38 90.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.249 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 60.0 mtm . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.935 179.951 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 52.0 t0 . . . . . 0 N--CA 1.487 1.377 0 CA-C-O 120.803 0.335 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -109.78 154.03 23.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.92 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -92.2 135.34 34.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.834 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -99.69 29.02 4.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.001 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -93.94 16.27 14.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.228 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -95.5 111.97 23.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.787 0.327 . . . . 0.0 110.834 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 92.3 mt-10 -132.6 139.89 48.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.929 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -114.29 126.51 55.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.894 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -143.66 153.96 43.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.98 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -152.13 79.94 1.25 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.915 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.2 t -137.27 128.98 41.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.054 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -175.88 147.51 0.78 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.162 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -81.16 140.82 34.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.812 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 78.2 m-20 -60.91 139.95 93.75 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -74.48 166.05 30.31 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.494 2.129 . . . . 0.0 112.418 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.5 mm -104.41 135.01 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.034 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.93 HG11 HG21 ' A' ' 408' ' ' VAL . 13.8 p -115.57 142.57 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.803 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.6 mmt -90.81 113.83 26.08 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.808 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.608 HG22 ' CE ' ' A' ' 418' ' ' MET . 38.1 t -111.75 120.92 63.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.981 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.23 27.34 9.58 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.439 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.48 23.51 46.99 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.731 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 87.0 mtt180 -137.02 152.27 73.61 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 120.669 0.271 . . . . 0.0 110.738 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.402 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 58.3 Cg_endo -71.73 135.84 26.74 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.454 2.103 . . . . 0.0 112.406 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 403' ' ' PHE . . . . . 0.493 ' HB2' HG23 ' A' ' 398' ' ' VAL . 36.2 m-85 -150.52 172.04 16.11 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.674 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . 0.668 ' O ' HG23 ' A' ' 408' ' ' VAL . 24.8 p -98.59 136.9 38.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.552 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 405' ' ' TYR . . . . . 0.484 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 35.1 t80 -56.84 -39.31 74.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.032 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.1 m -64.73 -40.68 95.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -66.61 -29.54 69.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.192 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.93 HG21 HG11 ' A' ' 396' ' ' VAL . 48.1 t -68.14 -47.68 77.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.04 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 87.1 p -61.39 -30.39 70.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.941 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -74.07 -26.88 60.63 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.893 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -125.6 94.89 41.63 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.75 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 21.7 Cg_endo -61.31 -23.1 76.36 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.462 2.108 . . . . 0.0 112.367 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -62.71 -29.05 70.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.885 0.374 . . . . 0.0 110.89 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.701 HD12 ' HA ' ' A' ' 408' ' ' VAL . 30.2 mt -65.09 -38.48 90.88 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.721 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.4 t -62.61 -39.85 86.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.965 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.1 -27.57 67.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.128 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -80.87 -20.5 42.16 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.165 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 418' ' ' MET . . . . . 0.608 ' CE ' HG22 ' A' ' 398' ' ' VAL . 3.0 mtt -73.64 131.85 42.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.955 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.443 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 6.4 p -63.13 167.37 6.43 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.356 179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 53.5 Cg_exo -52.4 -56.07 3.22 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.31 2.007 . . . . 0.0 112.187 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 54.4 mp0 -59.67 -40.17 86.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.01 0.433 . . . . 0.0 109.946 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -65.3 -33.78 76.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.183 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.612 ' O ' HD12 ' A' ' 427' ' ' ILE . 85.0 tttt -65.16 -36.75 85.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.199 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -65.0 -45.45 85.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.528 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.31 -30.37 64.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.147 0.499 . . . . 0.0 110.567 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 426' ' ' TYR . . . . . 0.541 ' CE1' HG11 ' A' ' 408' ' ' VAL . 58.4 t80 -68.87 -48.05 64.39 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.223 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.2 mt -75.13 -33.54 29.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.05 -0.977 . . . . 0.0 111.512 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.65 -43.0 99.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.208 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 68.9 mtm -60.43 -37.75 81.92 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.948 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.66 -44.9 96.49 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.527 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -64.64 -38.6 91.54 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.777 0.322 . . . . 0.0 110.927 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 56.8 mtp180 -60.48 -39.01 86.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.019 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 70.2 mtm -75.08 -25.94 58.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.237 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 434' ' ' PHE . . . . . 0.702 ' HA ' HD13 ' A' ' 437' ' ' LEU . 6.1 t80 -99.9 29.8 4.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.017 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -79.87 -21.21 44.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.263 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . 0.507 ' C ' HD12 ' A' ' 437' ' ' LEU . 52.1 t0 -145.06 80.51 1.62 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.965 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.702 HD13 ' HA ' ' A' ' 434' ' ' PHE . 3.8 mp -148.51 80.6 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.91 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -104.07 132.77 49.98 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.961 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.939 -179.925 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.777 0.322 . . . . 0.0 111.251 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -103.15 136.38 43.05 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.958 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -111.55 143.33 42.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.966 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -97.49 142.39 29.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.885 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -59.69 -38.81 82.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.91 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . 0.407 ' HB3' ' CE2' ' A' ' 387' ' ' PHE . 89.6 m-20 -135.17 164.35 27.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.838 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -133.09 80.01 1.86 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.916 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.407 ' CE2' ' HB3' ' A' ' 385' ' ' ASP . 99.1 m-85 -121.84 152.3 39.71 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.821 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -150.82 -65.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.856 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -108.39 135.32 49.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.952 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.1 t -125.77 135.07 65.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.135 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -147.65 150.99 35.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.123 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -105.13 154.32 20.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -109.97 149.86 40.61 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -70.07 160.75 48.51 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.565 2.177 . . . . 0.0 112.351 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.9 mm -84.83 148.7 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.111 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.937 HG11 HG21 ' A' ' 408' ' ' VAL . 12.0 p -127.48 141.07 47.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.742 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 16.1 mmt -84.26 113.68 21.29 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.825 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.501 HG13 ' HG2' ' A' ' 418' ' ' MET . 32.8 t -111.76 108.6 25.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.808 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.76 22.54 7.02 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.256 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 103.83 -17.48 49.16 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.931 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 72.5 mtm-85 -100.21 146.04 31.27 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 120.678 0.275 . . . . 0.0 111.047 -179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -74.79 135.92 20.16 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.649 2.233 . . . . 0.0 112.494 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 403' ' ' PHE . . . . . 0.544 ' O ' HG12 ' A' ' 396' ' ' VAL . 57.4 m-85 -148.33 158.75 44.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.751 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 408' ' ' VAL . 18.0 p -76.92 137.8 39.32 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.646 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 405' ' ' TYR . . . . . 0.493 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 57.6 t80 -57.58 -40.57 79.33 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.948 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.0 m -63.49 -39.02 93.34 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.94 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -66.11 -29.39 69.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.061 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.937 HG21 HG11 ' A' ' 396' ' ' VAL . 57.1 t -67.41 -46.94 82.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.963 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.8 p -64.22 -29.3 70.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.026 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -75.89 -26.2 56.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.919 179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 35.9 mtt-85 -124.0 97.2 41.24 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.824 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -61.72 -25.59 78.95 Favored 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.345 2.03 . . . . 0.0 112.272 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 -62.84 -28.47 70.04 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.92 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' A' ' 408' ' ' VAL . 68.7 mt -66.05 -40.24 90.79 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.846 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 22.0 t -63.4 -38.38 82.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.969 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -68.05 -28.88 67.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.073 179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -79.07 -19.1 52.17 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.114 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 418' ' ' MET . . . . . 0.501 ' HG2' HG13 ' A' ' 398' ' ' VAL . 3.5 mtt -74.41 129.3 37.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.067 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.476 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 8.7 p -61.69 158.07 43.85 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.208 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 3.0 Cg_endo -45.79 -56.07 3.11 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.661 2.241 . . . . 0.0 112.244 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.1 -38.42 82.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.97 0.414 . . . . 0.0 109.937 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . 0.414 ' OE1' HG23 ' A' ' 419' ' ' THR . 96.0 mt-10 -66.05 -34.53 78.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.159 179.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 12.1 tptm -63.23 -36.22 82.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.116 179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -64.84 -43.12 94.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.474 179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -59.5 -31.69 69.59 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.193 0.52 . . . . 0.0 110.473 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 426' ' ' TYR . . . . . 0.523 ' HD1' HG21 ' A' ' 396' ' ' VAL . 57.2 t80 -67.78 -45.1 75.81 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.282 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 61.9 mt -79.46 -33.76 15.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.043 -0.98 . . . . 0.0 111.794 -179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -68.39 -43.26 77.69 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.336 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 429' ' ' MET . . . . . 0.526 ' HE1' HG23 ' A' ' 396' ' ' VAL . 49.4 mtm -56.31 -35.0 67.04 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.14 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.38 -46.8 93.3 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.489 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 55.9 mt-30 -71.13 -36.64 72.17 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.772 0.32 . . . . 0.0 110.936 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -56.23 -32.46 64.48 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.13 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 433' ' ' MET . . . . . 0.743 ' O ' HD12 ' A' ' 437' ' ' LEU . 73.3 mtm -59.27 -25.37 64.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.167 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -117.42 14.73 14.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.423 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -80.01 -23.99 41.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.744 0.307 . . . . 0.0 111.151 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -157.84 86.1 0.91 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.034 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.743 HD12 ' O ' ' A' ' 433' ' ' MET . 20.5 mt -158.08 87.07 0.91 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -103.24 131.73 50.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.883 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 . . . . . 0 C--O 1.25 1.109 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.909 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 47.1 p30 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.826 0.346 . . . . 0.0 111.198 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -101.69 142.26 33.29 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.862 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -79.98 150.54 30.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.892 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -79.81 -37.55 34.93 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.961 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -175.87 -46.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.984 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -158.02 163.61 37.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.919 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 49.6 mp0 -100.64 163.33 12.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 69.6 t80 -89.6 132.67 35.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.901 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -105.13 142.13 35.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -103.16 146.07 28.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.951 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 p -126.86 142.17 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.08 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -110.46 156.73 20.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.123 -179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -80.02 162.11 25.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.813 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -60.92 142.72 92.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.918 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -73.33 165.19 33.21 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.599 2.199 . . . . 0.0 112.366 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.0 mm -99.66 148.64 6.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.977 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.931 HG11 HG21 ' A' ' 408' ' ' VAL . 14.7 p -124.92 142.48 41.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.86 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 15.2 mmt -85.83 113.81 22.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.647 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.414 ' HA ' ' HG2' ' A' ' 418' ' ' MET . 12.6 t -118.75 114.56 45.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.95 179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.41 22.67 6.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.268 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.33 -17.36 57.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.872 179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 4.1 mmt180 -100.69 146.24 31.73 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 120.722 0.296 . . . . 0.0 111.032 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -76.77 135.98 16.47 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.661 2.241 . . . . 0.0 112.525 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 403' ' ' PHE . . . . . 0.624 ' O ' HG12 ' A' ' 396' ' ' VAL . 86.1 m-85 -148.18 157.73 43.67 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.771 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . 0.51 ' O ' HG23 ' A' ' 408' ' ' VAL . 49.4 m -71.38 139.98 49.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.527 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -58.01 -40.95 82.05 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.994 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.3 t -65.86 -38.81 89.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.964 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.64 -29.9 70.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.093 -179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.931 HG21 HG11 ' A' ' 396' ' ' VAL . 60.3 t -68.76 -46.3 79.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.004 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.5 p -63.14 -28.94 70.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.992 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 56.5 mt-30 -74.31 -26.25 60.06 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.019 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 86.0 mtt-85 -124.35 87.18 54.19 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.859 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_exo -51.8 -27.21 26.33 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.6 2.2 . . . . 0.0 112.36 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.24 -28.29 69.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.971 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.539 HD12 ' HA ' ' A' ' 408' ' ' VAL . 69.5 mt -66.57 -38.75 87.75 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.788 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.4 t -63.25 -37.72 80.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.861 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.02 -28.57 68.97 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.014 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -79.68 -17.63 53.21 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.141 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 418' ' ' MET . . . . . 0.419 ' HE3' HG11 ' A' ' 408' ' ' VAL . 7.6 mtt -72.64 132.21 43.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.199 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.467 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 2.9 p -74.6 173.08 7.27 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.066 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.467 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.4 Cg_exo -52.94 -55.98 3.23 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.169 1.912 . . . . 0.0 112.264 -179.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -59.83 -40.19 87.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.01 0.433 . . . . 0.0 109.931 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -65.29 -34.23 77.84 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.229 179.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 19.9 tptm -64.49 -36.84 85.51 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.148 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -63.63 -47.18 82.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.615 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -59.59 -29.71 68.16 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.12 0.486 . . . . 0.0 110.578 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 426' ' ' TYR . . . . . 0.405 ' CE1' HG11 ' A' ' 408' ' ' VAL . 85.1 t80 -70.11 -45.14 67.53 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.498 -0.773 . . . . 0.0 110.162 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 57.7 mt -77.92 -35.55 20.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.695 -179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -67.35 -37.76 83.74 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.827 0.346 . . . . 0.0 111.082 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 76.3 mtp -61.86 -37.29 83.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.921 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.22 -36.78 90.24 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.42 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.92 -38.83 83.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.797 0.332 . . . . 0.0 110.874 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 93.9 mtt-85 -64.99 -32.88 74.82 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.948 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 87.5 mtp -59.02 -25.59 63.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.135 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -79.91 -6.95 58.42 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.432 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -79.85 -21.97 43.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.709 0.29 . . . . 0.0 111.119 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -153.41 84.72 1.19 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.942 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -151.25 83.69 1.32 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.832 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -109.19 135.98 49.41 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.886 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.887 -179.942 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.809 0.337 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -80.05 141.07 36.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.879 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -117.98 150.44 39.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.85 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -102.63 -72.66 0.68 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.009 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -60.33 -41.3 93.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -92.75 118.02 30.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.914 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -124.52 136.21 53.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.838 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -122.61 154.33 38.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.904 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -107.16 139.34 41.74 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.903 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 49.7 mp0 -116.31 153.81 31.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.914 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.7 p -131.78 141.9 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.07 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -63.75 147.65 51.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.091 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 89.5 m-20 -79.94 135.82 36.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.899 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -74.05 157.06 87.41 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -66.96 163.66 32.88 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.604 2.203 . . . . 0.0 112.284 179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.8 mm -95.37 147.65 5.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.089 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.959 HG11 HG21 ' A' ' 408' ' ' VAL . 12.4 p -129.59 141.94 45.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.906 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 17.8 mmt -82.58 113.76 20.51 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.817 0.341 . . . . 0.0 110.629 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.686 HG13 ' HG2' ' A' ' 418' ' ' MET . 22.0 t -117.87 112.73 39.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.965 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.36 23.46 5.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.283 -179.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.11 -15.63 59.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.801 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 16.8 mtm-85 -103.55 145.82 31.32 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.735 0.303 . . . . 0.0 111.046 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.4 136.03 19.1 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.628 2.219 . . . . 0.0 112.455 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 403' ' ' PHE . . . . . 0.651 ' O ' HG12 ' A' ' 396' ' ' VAL . 64.0 m-85 -147.1 156.9 43.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.751 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . 0.53 ' O ' HG23 ' A' ' 408' ' ' VAL . 50.0 m -69.04 137.75 53.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.645 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -58.16 -43.3 87.32 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.958 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.0 t -64.89 -37.44 87.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.827 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.19 -29.46 70.8 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.146 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.959 HG21 HG11 ' A' ' 396' ' ' VAL . 53.2 t -69.8 -47.36 70.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.999 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.2 p -64.49 -29.04 70.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.022 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.3 mt-30 -76.76 -26.35 54.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.974 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 3.4 mtt-85 -124.16 85.29 55.03 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.887 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -51.58 -26.77 23.35 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.595 2.197 . . . . 0.0 112.344 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.0 -28.36 69.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.038 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 408' ' ' VAL . 70.0 mt -66.11 -36.75 83.98 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.797 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 39.7 t -63.92 -38.88 83.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.961 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.76 -28.86 68.74 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.113 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 56.0 mt-30 -76.56 -22.08 54.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.094 179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 418' ' ' MET . . . . . 0.686 ' HG2' HG13 ' A' ' 398' ' ' VAL . 4.1 mtt -72.72 130.08 39.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.939 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 3.9 p -65.76 171.49 3.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.072 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 50.2 Cg_exo -53.36 -56.07 3.05 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.196 1.93 . . . . 0.0 112.154 -179.796 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.01 -37.82 83.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.018 0.437 . . . . 0.0 109.842 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -66.94 -33.38 75.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.249 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.852 ' O ' HD12 ' A' ' 427' ' ' ILE . 0.0 OUTLIER -65.73 -34.08 77.37 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.203 179.509 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -64.5 -45.62 86.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.65 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.07 -30.92 64.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.145 0.498 . . . . 0.0 110.653 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 426' ' ' TYR . . . . . 0.544 ' CE1' HG11 ' A' ' 408' ' ' VAL . 63.8 t80 -68.51 -48.37 64.56 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.088 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.852 HD12 ' O ' ' A' ' 423' ' ' LYS . 3.2 mt -73.2 -35.44 47.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.565 -179.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -65.42 -49.14 70.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.173 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 429' ' ' MET . . . . . 0.683 ' CE ' HG23 ' A' ' 396' ' ' VAL . 71.5 mtm -62.12 -36.93 83.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.844 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.43 -35.92 87.12 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.445 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 -60.02 -40.37 89.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.794 0.331 . . . . 0.0 110.843 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -66.24 -32.02 73.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.884 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 94.2 mmm -58.52 -24.2 59.99 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.139 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 434' ' ' PHE . . . . . 0.402 ' CD2' ' O ' ' A' ' 434' ' ' PHE . 68.2 t80 -94.56 20.58 8.27 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.197 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -79.98 -23.51 41.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.802 0.334 . . . . 0.0 111.023 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -143.21 80.03 1.66 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.787 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.87 82.1 1.5 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.823 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -124.69 161.36 26.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.9 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 50.2 mp0 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.302 -0.856 . . . . 0.0 110.9 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.804 0.335 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -110.77 158.72 18.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -97.57 154.37 17.57 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 50.2 mp0 -79.98 85.13 5.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -135.76 160.93 37.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -103.86 154.27 19.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.916 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -122.23 153.43 38.85 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.897 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -101.64 125.9 48.38 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.843 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -132.03 141.15 49.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.899 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -99.12 130.61 45.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.926 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.0 t -122.2 133.85 67.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.157 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -109.75 151.55 26.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.993 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -79.99 89.44 5.34 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.925 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.08 163.79 27.71 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.88 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -67.38 152.59 78.75 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.591 2.194 . . . . 0.0 112.284 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.3 mm -71.71 152.27 8.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.11 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.956 HG11 HG21 ' A' ' 408' ' ' VAL . 13.9 p -131.43 142.11 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.893 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 17.2 mmt -84.47 113.7 21.4 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.597 179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.627 HG13 ' HG2' ' A' ' 418' ' ' MET . 22.3 t -118.18 113.6 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.977 179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.62 23.17 5.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.295 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 99.43 -13.82 61.17 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.956 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 6.8 mtt85 -104.75 146.3 32.37 Favored Pre-proline 0 C--N 1.331 -0.213 0 CA-C-O 120.722 0.296 . . . . 0.0 110.991 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -76.04 136.0 17.85 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.667 2.245 . . . . 0.0 112.526 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 403' ' ' PHE . . . . . 0.651 ' O ' HG12 ' A' ' 396' ' ' VAL . 71.0 m-85 -147.65 158.92 44.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.738 179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . 0.544 ' O ' HG23 ' A' ' 408' ' ' VAL . 63.6 m -71.34 138.76 49.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.694 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -58.25 -43.72 88.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.913 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 m -64.69 -38.06 89.7 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.919 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.73 -29.31 70.58 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.956 HG21 HG11 ' A' ' 396' ' ' VAL . 60.4 t -70.65 -46.79 67.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.012 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.8 t -63.09 -31.28 72.39 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.026 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.4 mt-30 -73.87 -26.72 60.7 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.001 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 55.2 mtt-85 -123.77 96.75 42.55 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.785 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -62.22 -25.94 77.21 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.393 2.062 . . . . 0.0 112.299 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -62.75 -28.61 70.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.911 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 63.0 mt -66.95 -38.11 85.52 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.731 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 35.7 t -63.65 -37.81 80.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.847 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.88 -29.05 68.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.993 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -76.24 -22.06 55.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.063 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 418' ' ' MET . . . . . 0.627 ' HG2' HG13 ' A' ' 398' ' ' VAL . 3.8 mtt -71.88 129.56 38.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.446 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.9 p -64.3 169.95 4.2 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.145 179.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 51.0 Cg_exo -53.14 -56.05 3.12 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.155 1.904 . . . . 0.0 112.161 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 54.2 mp0 -60.69 -38.31 84.56 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 69.5 mm-40 -65.99 -34.61 78.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.288 179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -65.26 -34.76 79.11 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.226 179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -64.76 -44.7 89.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.641 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.76 -30.4 67.51 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.222 0.534 . . . . 0.0 110.631 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 426' ' ' TYR . . . . . 0.541 ' CE1' HG11 ' A' ' 408' ' ' VAL . 76.4 t80 -69.38 -45.95 68.09 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.441 -0.8 . . . . 0.0 110.294 179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 61.9 mt -77.8 -33.77 19.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.076 -0.965 . . . . 0.0 111.751 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.43 -36.16 77.53 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.817 0.341 . . . . 0.0 111.227 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 67.4 mtm -59.61 -35.27 74.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.942 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.14 -43.51 95.26 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.428 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -65.39 -36.98 85.61 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.881 0.372 . . . . 0.0 110.801 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 26.1 mmt85 -61.95 -30.43 70.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.935 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 433' ' ' MET . . . . . 0.48 ' O ' HD12 ' A' ' 437' ' ' LEU . 95.9 mmm -57.51 -27.82 62.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.1 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -79.97 -17.97 51.55 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.172 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -79.89 -18.06 51.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.266 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -143.27 79.95 1.66 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.859 0.362 . . . . 0.0 110.948 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.48 HD12 ' O ' ' A' ' 433' ' ' MET . 8.1 mt -148.26 79.91 1.46 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.902 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -123.76 146.29 48.41 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.866 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.299 -0.857 . . . . 0.0 110.881 -179.996 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.806 0.336 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -110.74 145.7 37.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.942 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -113.53 135.89 53.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -122.56 139.89 53.4 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.91 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -133.15 27.38 4.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.047 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -159.19 162.44 36.28 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.871 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -82.54 122.06 27.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -107.9 132.4 53.51 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.927 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -111.23 148.75 32.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.893 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -113.12 155.64 24.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.934 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.624 HG13 ' O ' ' A' ' 390' ' ' VAL . 7.7 p -107.13 79.88 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.043 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . 58.4 164.5 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 48.2 p30 -102.24 173.66 6.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.919 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.01 144.63 90.51 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.897 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . 0.415 ' HG3' ' HE2' ' A' ' 433' ' ' MET . 53.2 Cg_endo -69.26 161.68 44.87 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.574 2.182 . . . . 0.0 112.307 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.3 mm -98.84 137.27 26.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.088 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.895 HG11 HG21 ' A' ' 408' ' ' VAL . 13.6 p -114.02 135.52 53.46 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.751 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . 0.432 ' HE2' ' HA ' ' A' ' 402' ' ' PRO . 16.8 mmt -83.77 113.86 21.2 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.845 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.585 HG11 ' HB3' ' A' ' 414' ' ' LEU . 15.1 t -117.61 118.21 57.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.943 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.4 22.7 6.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.259 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 96.59 -14.01 64.7 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.905 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 40.7 mtm180 -100.82 147.79 34.15 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-O 120.788 0.328 . . . . 0.0 111.011 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.432 ' HA ' ' HE2' ' A' ' 397' ' ' MET . 74.1 Cg_endo -75.22 136.01 19.42 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.67 2.247 . . . . 0.0 112.375 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 403' ' ' PHE . . . . . 0.436 ' CD2' ' HB ' ' A' ' 398' ' ' VAL . 77.4 m-85 -147.14 168.41 21.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.72 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 55.5 m -88.66 136.82 32.8 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.675 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 405' ' ' TYR . . . . . 0.445 ' CD2' ' CE ' ' A' ' 433' ' ' MET . 42.2 t80 -53.55 -41.67 66.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.843 0.354 . . . . 0.0 110.988 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 26.4 m -67.96 -34.17 76.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.811 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -67.18 -31.25 71.53 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.051 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.895 HG21 HG11 ' A' ' 396' ' ' VAL . 84.9 t -67.8 -43.19 86.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.829 179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.9 p -63.39 -29.79 71.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.073 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -74.44 -27.96 60.84 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.934 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 11.3 mtt-85 -124.57 92.99 47.08 Favored Pre-proline 0 C--N 1.326 -0.456 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.823 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.13 -23.1 75.25 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.451 2.101 . . . . 0.0 112.411 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -62.47 -29.25 70.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.938 0.399 . . . . 0.0 110.982 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.585 ' HB3' HG11 ' A' ' 398' ' ' VAL . 25.7 mt -66.47 -35.98 81.64 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.722 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.9 t -62.89 -36.23 74.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -64.4 -29.13 70.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.944 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -81.1 -19.76 42.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.076 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 418' ' ' MET . . . . . 0.46 ' HG3' HG13 ' A' ' 398' ' ' VAL . 6.3 mtt -70.36 124.41 24.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.025 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.429 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 5.3 p -63.65 171.01 2.54 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.115 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.1 Cg_exo -54.5 -56.14 2.74 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.109 1.872 . . . . 0.0 112.118 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.77 -39.79 90.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.018 0.437 . . . . 0.0 109.844 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -65.49 -33.41 75.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.234 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.617 ' O ' HD12 ' A' ' 427' ' ' ILE . 54.9 tttm -65.18 -36.68 84.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.24 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -64.89 -45.87 84.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.597 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.08 -30.18 64.1 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.151 0.5 . . . . 0.0 110.647 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 426' ' ' TYR . . . . . 0.539 ' HD1' HG21 ' A' ' 396' ' ' VAL . 46.8 t80 -69.17 -48.31 62.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.165 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.617 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.2 mt -74.52 -33.69 33.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.434 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -61.27 -43.97 98.0 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.121 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 69.8 mtm -62.94 -37.25 86.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.932 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.99 -39.68 94.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.619 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -61.66 -40.72 95.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.873 0.368 . . . . 0.0 110.961 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 90.6 mtt-85 -64.44 -38.35 90.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.002 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 433' ' ' MET . . . . . 0.526 ' O ' HD11 ' A' ' 437' ' ' LEU . 65.4 mtt -61.36 -29.01 69.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.066 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 434' ' ' PHE . . . . . 0.4 ' O ' ' CD2' ' A' ' 434' ' ' PHE . 58.2 t80 -99.02 25.02 7.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.044 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -79.93 -23.93 41.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.116 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . 0.609 ' O ' HD23 ' A' ' 437' ' ' LEU . 52.7 t0 -159.89 87.81 0.81 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.927 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.609 HD23 ' O ' ' A' ' 436' ' ' ASP . 88.8 mt -143.85 79.97 1.64 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.931 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 71.5 t80 -113.95 139.35 49.3 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.877 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.905 179.919 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 . . . . . 0 N--CA 1.486 1.375 0 CA-C-O 120.764 0.316 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 50.1 mp0 -108.19 147.13 31.76 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.925 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -153.04 -72.04 0.14 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -154.81 54.05 0.66 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 50.7 p30 -96.15 21.14 9.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.155 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -104.35 154.2 20.11 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.904 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 51.5 mp0 -79.88 150.75 30.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 51.1 p90 -119.45 152.21 37.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.829 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 51.6 mp0 -127.34 155.95 42.75 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.902 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -108.99 155.47 20.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.9 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 30.6 t -111.24 136.18 48.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.089 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -136.88 158.19 45.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -80.65 115.61 20.25 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.909 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -79.89 163.65 57.0 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.916 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -64.86 155.26 68.67 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.573 2.182 . . . . 0.0 112.302 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.9 mm -76.25 145.12 10.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.162 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.956 HG11 HG21 ' A' ' 408' ' ' VAL . 14.6 p -125.75 141.07 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.69 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 17.9 mmt -82.21 113.89 20.34 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.88 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.449 ' HA ' ' HG2' ' A' ' 418' ' ' MET . 21.5 t -116.16 111.42 35.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.971 179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.94 23.92 5.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.288 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.4 -19.25 51.69 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.752 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 13.7 mtp180 -99.61 145.32 29.91 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 0.0 111.012 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -75.06 135.93 19.61 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.679 2.253 . . . . 0.0 112.425 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 403' ' ' PHE . . . . . 0.645 ' O ' HG12 ' A' ' 396' ' ' VAL . 59.1 m-85 -147.04 155.65 42.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.79 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 10.9 p -75.97 137.37 40.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.51 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 405' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 55.2 t80 -55.21 -34.63 64.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.018 -179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 21.8 m -63.88 -38.13 89.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.985 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -69.84 -29.73 67.06 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.063 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.956 HG21 HG11 ' A' ' 396' ' ' VAL . 43.4 t -68.97 -49.33 64.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.02 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.9 p -66.86 -28.99 68.79 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.98 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -82.14 -23.58 35.54 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.106 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 21.7 mtt-85 -123.49 84.71 52.72 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_exo -51.76 -25.51 20.97 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.626 2.217 . . . . 0.0 112.33 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 20.1 pt-20 -60.98 -36.21 78.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.137 0.494 . . . . 0.0 110.869 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 72.1 mt -60.84 -40.75 94.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.888 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 36.0 t -62.46 -35.95 72.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.808 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.87 -29.47 69.92 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.955 179.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -81.59 -16.72 50.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.044 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 418' ' ' MET . . . . . 0.449 ' HG2' ' HA ' ' A' ' 398' ' ' VAL . 3.7 mtt -72.01 127.1 31.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.162 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.451 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 1.3 p -66.75 166.7 17.0 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.173 179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.451 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 65.9 Cg_exo -50.79 -56.24 3.28 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.26 1.974 . . . . 0.0 112.324 -179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.25 -39.84 88.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.971 0.415 . . . . 0.0 109.975 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -65.8 -33.4 75.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.217 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.57 ' O ' HD12 ' A' ' 427' ' ' ILE . 77.4 tttt -64.92 -36.42 84.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.142 179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -64.72 -46.22 83.24 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.512 179.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.55 -30.29 65.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.137 0.494 . . . . 0.0 110.591 179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 426' ' ' TYR . . . . . 0.67 ' CE1' HG11 ' A' ' 408' ' ' VAL . 50.9 t80 -69.05 -47.75 64.57 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.275 179.243 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.57 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.6 mt -75.33 -33.64 28.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.464 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.38 -43.16 96.86 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.073 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 429' ' ' MET . . . . . 0.488 ' HE1' ' HB ' ' A' ' 396' ' ' VAL . 71.2 mtm -62.85 -37.66 87.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.833 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -60.34 -39.33 95.99 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.447 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.34 -37.94 82.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.84 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 42.0 mmt180 -62.14 -35.09 77.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.969 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 433' ' ' MET . . . . . 0.44 ' O ' HD12 ' A' ' 437' ' ' LEU . 65.0 mtt -59.64 -27.61 66.5 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.061 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -81.0 -2.37 47.68 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.414 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -79.96 -23.74 41.44 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.742 0.306 . . . . 0.0 111.195 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -150.4 81.55 1.36 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.923 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 433' ' ' MET . 21.7 mt -156.89 86.58 0.98 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.926 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 48.8 p90 -129.59 161.89 29.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.857 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.284 -0.865 . . . . 0.0 110.884 179.989 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 . . . . . 0 N--CA 1.486 1.359 0 CA-C-O 120.827 0.346 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -111.58 147.56 35.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.895 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 21.1 pt-20 -99.81 28.39 4.78 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.961 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -99.23 -59.11 1.79 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.023 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -104.09 22.94 13.78 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.104 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -90.21 118.47 29.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.904 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -96.07 150.11 20.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 49.2 p90 -129.28 157.11 42.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.908 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -124.43 138.89 54.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.826 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -130.83 132.58 45.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.857 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.9 p -137.05 143.29 35.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.175 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -100.52 141.24 33.65 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.026 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -82.45 113.51 20.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.952 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 41.0 m-20 -71.73 147.52 91.94 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.948 179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -68.27 155.02 70.84 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.553 2.169 . . . . 0.0 112.292 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.4 mm -97.12 148.82 5.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.066 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.954 HG11 HG21 ' A' ' 408' ' ' VAL . 12.4 p -132.75 142.52 42.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.771 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 5.3 mmt -86.65 113.83 22.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.772 0.32 . . . . 0.0 110.889 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.64 HG11 ' HB3' ' A' ' 414' ' ' LEU . 29.5 t -112.8 118.73 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.95 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.07 23.53 5.31 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.435 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 91.33 19.58 41.43 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.853 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 -136.97 146.45 54.89 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.668 0.234 . . . . 0.0 110.89 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.441 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 17.1 Cg_exo -66.81 135.62 38.89 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.439 2.093 . . . . 0.0 112.319 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 403' ' ' PHE . . . . . 0.582 ' HB2' HG23 ' A' ' 398' ' ' VAL . 20.6 m-85 -149.44 156.04 41.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.64 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . 0.503 ' O ' HG23 ' A' ' 408' ' ' VAL . 56.2 m -76.27 133.79 39.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.704 0.288 . . . . 0.0 110.572 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -56.23 -41.56 75.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.006 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.9 m -64.57 -36.13 83.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.799 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -67.45 -29.13 68.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.144 -179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.954 HG21 HG11 ' A' ' 396' ' ' VAL . 48.7 t -66.49 -47.89 82.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.013 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.1 p -64.14 -29.2 70.33 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.005 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.6 mt-30 -81.71 -25.3 35.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.966 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 12.7 mmt85 -122.94 91.33 49.87 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.813 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -62.36 -22.42 74.07 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.5 2.133 . . . . 0.0 112.419 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -61.9 -30.23 70.74 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.983 0.421 . . . . 0.0 110.919 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.64 ' HB3' HG11 ' A' ' 398' ' ' VAL . 20.7 mt -68.67 -36.77 78.97 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.597 179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 22.5 t -64.94 -35.97 76.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.777 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.35 -26.0 66.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.083 179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -92.16 -0.5 57.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.358 179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 418' ' ' MET . . . . . 0.511 ' HG2' HG13 ' A' ' 398' ' ' VAL . 1.0 OUTLIER -87.47 125.9 34.57 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.74 0.305 . . . . 0.0 111.179 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 14.5 p -61.38 160.64 22.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.321 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 6.9 Cg_endo -49.11 -53.16 7.45 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.55 2.167 . . . . 0.0 112.246 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 73.9 mm-40 -60.02 -42.76 95.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.917 0.389 . . . . 0.0 110.159 179.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -65.57 -32.91 74.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.162 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.553 ' O ' HD12 ' A' ' 427' ' ' ILE . 16.9 tptm -65.03 -37.21 86.88 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.175 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 37.8 mm-40 -64.6 -46.26 83.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.546 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.54 -30.22 65.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.17 0.51 . . . . 0.0 110.585 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 426' ' ' TYR . . . . . 0.626 ' CE1' HG11 ' A' ' 408' ' ' VAL . 46.9 t80 -69.0 -47.95 64.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.259 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.553 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.7 mt -75.13 -33.67 29.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.065 -0.971 . . . . 0.0 111.452 -179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -59.75 -42.87 94.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.132 -179.851 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 69.1 mtm -62.03 -38.2 87.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.928 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.93 -36.73 91.1 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.479 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -60.31 -37.07 79.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.792 0.33 . . . . 0.0 110.952 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 91.7 mtt-85 -60.38 -40.09 89.6 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.875 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 65.0 mtt -62.96 -28.47 70.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.014 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -116.91 30.56 7.26 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.957 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -79.78 -23.96 41.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.073 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -143.62 79.93 1.65 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -159.56 87.46 0.82 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.907 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -106.61 132.39 52.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.917 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.224 -0.894 . . . . 0.0 110.919 179.987 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 120.867 0.365 . . . . 0.0 111.219 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 76.5 tt0 -104.2 147.16 27.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -97.35 28.65 3.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.05 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -79.96 -36.06 36.74 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.884 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -59.09 -38.06 78.6 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.951 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -85.3 112.73 21.06 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.944 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 11.6 tm-20 -126.84 143.59 51.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.921 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.48 135.51 47.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.848 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -80.01 -37.57 33.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.918 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -128.62 124.75 36.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.936 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.4 t -133.2 133.01 58.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -152.12 148.0 27.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.105 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -109.53 152.09 25.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.885 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -65.51 146.46 98.96 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.86 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -68.02 151.8 77.3 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.548 2.166 . . . . 0.0 112.182 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 41.0 mm -95.49 144.73 9.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.061 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.97 HG11 HG21 ' A' ' 408' ' ' VAL . 14.8 p -130.24 143.26 41.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.915 -179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 18.3 mmt -87.18 113.83 23.26 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.704 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.811 HG11 ' HB3' ' A' ' 414' ' ' LEU . 21.3 t -117.25 118.66 59.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.136 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 51.41 26.41 3.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.478 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 89.15 20.49 45.69 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.823 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 13.3 mtp180 -137.06 143.22 41.24 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 120.681 0.277 . . . . 0.0 110.693 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -73.17 135.92 23.61 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.439 2.093 . . . . 0.0 112.611 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 403' ' ' PHE . . . . . 0.707 ' O ' HG12 ' A' ' 396' ' ' VAL . 46.8 m-85 -150.49 154.26 37.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.687 179.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 13.3 p -69.72 136.02 50.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.59 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -56.2 -39.77 72.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.062 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.6 m -64.3 -36.43 84.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.979 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -66.11 -30.95 71.55 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.095 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.97 HG21 HG11 ' A' ' 396' ' ' VAL . 44.6 t -70.9 -48.93 53.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.059 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.9 t -62.56 -31.77 72.63 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.998 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -81.66 -25.7 35.37 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.053 179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . 0.445 ' O ' HD12 ' A' ' 414' ' ' LEU . 21.4 mtt180 -127.49 99.53 27.0 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.87 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -68.29 -15.37 42.29 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.446 2.097 . . . . 0.0 112.606 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -58.4 -33.34 69.54 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.019 0.438 . . . . 0.0 111.206 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.811 ' HB3' HG11 ' A' ' 398' ' ' VAL . 1.1 mt -72.11 -34.11 68.35 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.494 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 23.4 t -67.28 -32.98 59.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.612 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -69.45 -25.6 64.18 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.029 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 -90.75 -13.17 34.53 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.282 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 418' ' ' MET . . . . . 0.637 ' HG2' HG13 ' A' ' 398' ' ' VAL . 1.7 mtt -74.61 124.54 26.87 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.802 0.334 . . . . 0.0 111.088 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.475 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 10.2 p -61.29 158.25 38.63 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.107 179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 2.5 Cg_endo -45.52 -56.0 3.11 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.547 2.165 . . . . 0.0 112.346 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -60.2 -38.89 84.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.004 0.43 . . . . 0.0 110.002 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -66.41 -33.85 76.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.222 179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.548 ' O ' HD12 ' A' ' 427' ' ' ILE . 82.4 tttt -64.85 -35.07 79.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.214 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -64.22 -46.36 84.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.61 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.04 -30.69 64.46 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.23 0.538 . . . . 0.0 110.603 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 426' ' ' TYR . . . . . 0.552 ' CE1' HG11 ' A' ' 408' ' ' VAL . 42.4 t80 -68.62 -48.37 64.25 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.254 179.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.6 mt -74.44 -33.56 33.6 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.473 -179.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -58.91 -39.81 82.64 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.129 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 66.9 mtm -63.39 -38.29 90.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.992 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.66 -40.06 94.26 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.645 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -61.35 -39.34 90.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.744 0.307 . . . . 0.0 110.909 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 26.8 mmt85 -64.18 -36.91 85.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.006 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 97.0 mmm -61.58 -27.54 68.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.146 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 434' ' ' PHE . . . . . 0.425 ' CD2' HD12 ' A' ' 437' ' ' LEU . 2.2 t80 -122.74 31.27 6.13 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.903 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -79.86 -24.35 41.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.176 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . 0.594 ' O ' HD23 ' A' ' 437' ' ' LEU . 78.6 m-20 -144.78 80.17 1.62 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.977 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.594 HD23 ' O ' ' A' ' 436' ' ' ASP . 93.9 mt -146.65 80.0 1.54 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.894 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -127.08 155.91 42.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.934 -179.923 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 23.9 t70 . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.838 0.351 . . . . 0.0 111.261 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -104.55 135.81 45.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -117.33 135.94 53.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.866 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -138.71 154.68 48.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.915 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -129.59 -66.22 0.81 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -80.0 134.8 36.26 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.921 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -129.68 148.61 51.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.909 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.465 ' CE2' HG22 ' A' ' 390' ' ' VAL . 55.5 p90 -136.03 157.85 45.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.919 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -101.24 -53.46 3.01 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.88 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -112.92 154.86 25.72 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.93 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.465 HG22 ' CE2' ' A' ' 387' ' ' PHE . 31.1 t -110.58 130.38 64.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.051 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -111.2 147.83 34.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.14 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -80.0 131.61 35.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.877 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -121.03 150.38 53.2 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.926 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.4 164.63 34.47 Favored 'Trans proline' 0 C--N 1.343 0.269 0 C-N-CA 122.59 2.193 . . . . 0.0 112.352 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.4 mm -100.32 143.17 14.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.103 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.943 HG11 HG21 ' A' ' 408' ' ' VAL . 11.6 p -121.16 140.1 46.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.719 179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 22.3 mmt -83.19 113.81 20.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.748 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.551 HG13 ' HG2' ' A' ' 418' ' ' MET . 31.4 t -110.61 107.17 22.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.868 179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.27 22.9 6.62 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.254 -179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 104.99 -20.33 38.68 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.919 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -97.18 145.29 29.37 Favored Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 120.612 0.244 . . . . 0.0 111.096 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -75.79 135.98 18.31 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.677 2.252 . . . . 0.0 112.503 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 403' ' ' PHE . . . . . 0.517 ' O ' HG12 ' A' ' 396' ' ' VAL . 61.8 m-85 -148.52 156.98 43.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.687 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . 0.55 ' O ' HG23 ' A' ' 408' ' ' VAL . 51.3 m -73.49 138.46 45.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.605 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -58.04 -42.27 85.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.934 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.8 t -64.76 -37.37 87.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.85 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -64.69 -29.33 70.33 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.033 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.943 HG21 HG11 ' A' ' 396' ' ' VAL . 49.0 t -68.48 -47.67 76.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.054 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 24.4 t -62.89 -31.04 72.0 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.997 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -74.01 -27.07 60.77 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.977 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 13.3 mtm180 -124.41 85.34 55.87 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.787 -179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_exo -51.68 -26.82 24.21 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.585 2.19 . . . . 0.0 112.338 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.2 -29.14 70.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.976 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 59.2 mt -65.98 -37.21 85.36 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.728 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 25.7 t -63.45 -37.78 80.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.951 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.41 -30.77 71.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.077 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -74.13 -23.61 59.31 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.87 -0.604 . . . . 0.0 111.074 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 418' ' ' MET . . . . . 0.551 ' HG2' HG13 ' A' ' 398' ' ' VAL . 3.5 mtt -72.65 129.08 37.42 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.986 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.466 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.5 p -64.08 170.74 3.11 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.258 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 65.5 Cg_exo -51.65 -55.96 3.45 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.256 1.971 . . . . 0.0 112.386 -179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -58.84 -40.54 84.54 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.429 . . . . 0.0 110.092 179.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -65.42 -34.41 78.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.237 179.152 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 11.8 tptm -64.26 -36.58 84.54 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.187 179.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 53.7 mm-40 -64.92 -45.24 86.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.557 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.88 -30.53 65.92 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.167 0.508 . . . . 0.0 110.633 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 426' ' ' TYR . . . . . 0.516 ' CE1' HG11 ' A' ' 408' ' ' VAL . 79.0 t80 -69.15 -47.01 66.17 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.32 179.231 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 60.4 mt -76.28 -33.82 24.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 114.999 -1.0 . . . . 0.0 111.62 -179.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.69 -43.13 94.51 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.143 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 429' ' ' MET . . . . . 0.537 ' HE1' HG23 ' A' ' 396' ' ' VAL . 71.5 mtm -62.27 -40.86 97.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.972 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.83 -42.59 98.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.573 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -62.5 -32.55 73.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.862 0.363 . . . . 0.0 110.958 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.8 ttm180 -75.23 -28.61 59.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.791 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 62.7 mtt -59.11 -25.47 63.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.219 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -133.74 27.6 3.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.095 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -80.07 -26.45 39.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.918 0.389 . . . . 0.0 111.168 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . 0.422 ' O ' HD23 ' A' ' 437' ' ' LEU . 34.1 m-20 -160.04 87.82 0.8 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.06 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.422 HD23 ' O ' ' A' ' 436' ' ' ASP . 58.7 mt -143.61 79.87 1.64 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.899 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -125.31 154.41 41.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 48.0 tp10 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.308 -0.854 . . . . 0.0 110.876 179.932 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 51.8 t0 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.882 0.372 . . . . 0.0 111.188 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 47.9 mp0 -108.75 150.26 27.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.892 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -111.39 149.83 30.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.91 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -116.11 49.74 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.79 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -97.8 25.34 5.98 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.976 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -135.61 160.45 38.48 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.843 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -112.32 139.79 47.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.877 179.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -117.71 142.22 47.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.868 179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -120.02 142.51 48.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.877 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -119.24 145.5 46.02 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.511 HG13 ' O ' ' A' ' 390' ' ' VAL . 11.9 p -92.71 118.25 37.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.147 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -175.63 150.39 1.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.103 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 38.0 p-10 -94.52 117.91 30.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.867 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -117.09 146.65 38.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.871 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -71.9 159.39 50.56 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.516 2.144 . . . . 0.0 112.321 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.5 mm -99.11 140.64 18.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.024 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.938 HG11 HG21 ' A' ' 408' ' ' VAL . 14.7 p -120.46 143.34 32.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.733 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.4 mmt -89.5 113.79 25.23 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.774 0.321 . . . . 0.0 110.68 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.53 HG23 ' HB2' ' A' ' 403' ' ' PHE . 27.3 t -114.8 125.68 72.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.915 179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.94 24.37 5.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.349 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 86.81 19.89 55.08 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.767 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 22.4 mtt180 -137.05 154.99 76.36 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 120.601 0.238 . . . . 0.0 110.843 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.413 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 12.8 Cg_exo -69.86 135.77 31.07 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.6 2.2 . . . . 0.0 112.309 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 403' ' ' PHE . . . . . 0.53 ' HB2' HG23 ' A' ' 398' ' ' VAL . 31.7 m-85 -150.56 155.71 39.98 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.461 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . 0.48 ' O ' HG23 ' A' ' 408' ' ' VAL . 17.2 p -80.32 135.2 36.16 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.731 0.301 . . . . 0.0 110.588 179.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 405' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 61.3 t80 -56.0 -39.62 72.16 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.007 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 23.3 m -64.02 -38.3 90.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.871 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.9 tp10 -66.82 -29.52 69.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.14 -179.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.938 HG21 HG11 ' A' ' 396' ' ' VAL . 50.7 t -67.25 -47.51 81.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.991 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.7 t -63.04 -31.93 73.19 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.915 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.8 mt-30 -73.76 -26.67 60.77 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.969 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -124.1 95.26 44.15 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.789 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_endo -61.2 -25.46 80.82 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.484 2.122 . . . . 0.0 112.21 -179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -62.95 -28.36 70.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.922 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 62.5 mt -67.07 -40.56 87.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.795 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 39.1 t -62.88 -36.27 74.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.722 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.79 -29.28 69.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.929 179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -80.35 -19.38 46.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.052 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 418' ' ' MET . . . . . 0.43 ' HE3' HG11 ' A' ' 408' ' ' VAL . 6.0 mtt -70.35 128.12 35.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.046 -179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.454 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 3.2 p -68.65 172.02 5.29 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.143 179.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.454 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.4 Cg_exo -53.04 -56.02 3.17 Favored 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.188 1.925 . . . . 0.0 112.233 -179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.23 -41.55 88.96 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.0 0.428 . . . . 0.0 109.973 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.77 -33.68 76.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.139 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.609 ' O ' HD12 ' A' ' 427' ' ' ILE . 23.6 tptm -64.26 -38.29 90.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.16 179.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 78.1 mt-10 -65.51 -44.76 85.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.577 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.19 -29.92 66.03 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.136 0.493 . . . . 0.0 110.528 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 426' ' ' TYR . . . . . 0.494 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 49.8 t80 -69.44 -47.12 65.05 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.202 179.275 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.609 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.4 mt -76.42 -33.81 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.53 -179.362 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -65.86 -45.89 80.45 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.25 -179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 429' ' ' MET . . . . . 0.406 ' HE1' HG23 ' A' ' 396' ' ' VAL . 69.0 mtm -59.78 -35.42 74.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.929 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.24 -45.48 94.08 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.535 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -66.8 -36.85 83.34 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.873 0.368 . . . . 0.0 110.892 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -60.28 -36.49 77.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.957 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 73.0 mtm -59.72 -27.26 66.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.049 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 434' ' ' PHE . . . . . 0.401 ' CD2' ' O ' ' A' ' 434' ' ' PHE . 39.5 t80 -101.74 25.28 8.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.998 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -79.98 -22.13 42.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.159 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 37.8 p30 -143.61 79.94 1.65 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.904 -179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.64 79.98 1.65 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.805 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 50.5 p90 -133.3 162.39 31.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.222 -0.894 . . . . 0.0 110.911 179.965 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 . . . . . 0 N--CA 1.487 1.407 0 CA-C-O 120.856 0.36 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -110.02 153.71 24.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.937 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -100.39 139.14 36.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.909 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -80.01 140.8 36.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.911 -179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -167.62 95.54 0.45 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.886 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -84.15 112.34 20.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.796 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -125.21 149.12 48.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.823 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -117.19 144.54 44.64 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.871 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -108.24 129.93 55.18 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.967 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -133.09 152.79 51.93 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.87 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.1 t -118.27 130.03 73.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.104 -179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -158.92 152.22 22.63 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.051 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -80.43 122.12 26.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.909 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -120.97 149.34 50.82 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.972 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -69.47 160.45 49.73 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.558 2.172 . . . . 0.0 112.131 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 34.5 mm -97.13 134.62 34.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.028 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.965 HG11 HG21 ' A' ' 408' ' ' VAL . 12.5 p -113.96 139.71 38.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.591 179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 21.7 mmt -84.11 113.85 21.34 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.825 0.345 . . . . 0.0 110.815 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.451 HG23 ' HB2' ' A' ' 403' ' ' PHE . 22.0 t -112.23 112.46 40.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.838 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.28 22.86 6.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.304 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.97 -16.0 57.67 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.826 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 12.7 mmt180 -100.58 148.23 34.69 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.691 0.281 . . . . 0.0 111.052 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.78 136.01 20.3 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.641 2.227 . . . . 0.0 112.472 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 403' ' ' PHE . . . . . 0.483 ' O ' HG12 ' A' ' 396' ' ' VAL . 57.8 m-85 -149.23 156.34 41.98 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.68 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . 0.433 ' O ' HG23 ' A' ' 408' ' ' VAL . 15.7 p -79.98 137.6 36.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.504 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 405' ' ' TYR . . . . . 0.498 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 57.5 t80 -55.33 -34.83 64.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.126 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 93.4 p -64.2 -40.67 96.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.105 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -67.63 -30.32 69.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.178 -179.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.965 HG21 HG11 ' A' ' 396' ' ' VAL . 45.7 t -66.08 -48.92 79.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.92 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.6 t -64.84 -30.57 71.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.008 0.432 . . . . 0.0 110.978 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -77.46 -26.13 51.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.061 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 7.1 mtp85 -124.4 84.16 56.79 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.816 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -51.69 -24.91 18.92 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.65 2.233 . . . . 0.0 112.38 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -61.78 -29.81 70.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.002 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 32.3 mt -67.95 -37.76 81.99 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.728 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 38.9 t -64.36 -35.6 74.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.765 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.74 -29.97 70.56 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.879 179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.5 mt-30 -80.21 -19.41 47.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.935 179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 418' ' ' MET . . . . . 0.447 ' HG2' ' HA ' ' A' ' 398' ' ' VAL . 4.3 mtt -70.45 124.95 25.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.037 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.453 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 17.3 p -61.04 163.18 10.65 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.348 179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 76.7 Cg_exo -48.07 -56.06 3.46 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.363 2.042 . . . . 0.0 112.382 -179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -59.49 -40.03 85.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.008 0.432 . . . . 0.0 110.0 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 56.9 mm-40 -65.11 -33.99 77.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.176 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.584 ' O ' HD12 ' A' ' 427' ' ' ILE . 20.9 tptm -63.58 -37.96 89.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.158 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 71.4 mt-10 -64.93 -46.18 82.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.569 179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.78 -29.5 64.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.16 0.505 . . . . 0.0 110.655 179.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 426' ' ' TYR . . . . . 0.622 ' CE1' HG11 ' A' ' 408' ' ' VAL . 63.3 t80 -69.72 -47.67 62.28 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.217 179.229 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.584 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.5 mt -75.23 -33.98 29.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.416 -179.468 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.6 -33.94 76.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.103 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 59.4 mtp -59.98 -37.55 79.97 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.899 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.16 -39.7 92.65 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.482 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 58.5 mt-30 -61.62 -31.93 72.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.861 0.362 . . . . 0.0 110.884 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.9 ttm180 -78.21 -29.8 48.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.686 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 96.6 mmm -58.87 -22.69 59.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.217 -179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -90.96 12.65 18.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.459 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -79.96 -24.99 40.59 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.762 0.315 . . . . 0.0 111.077 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 72.8 m-20 -147.93 82.01 1.5 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.914 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -150.27 83.06 1.37 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.883 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -109.47 138.32 46.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.964 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.238 -0.887 . . . . 0.0 110.912 179.996 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 90.0 m-20 . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.86 0.362 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -109.35 151.27 26.84 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -111.8 155.77 23.03 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.882 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -79.84 -35.45 38.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.917 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -89.05 123.67 33.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.845 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -81.96 116.99 21.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.9 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -79.98 137.69 36.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.97 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 69.2 t80 -124.27 154.6 39.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.83 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -79.89 115.83 19.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.877 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -136.85 159.76 40.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.3 t -113.72 130.5 67.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.135 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -109.49 140.67 42.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -88.99 130.93 35.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.982 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -97.47 149.19 35.45 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.802 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -65.8 150.56 85.88 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.498 2.132 . . . . 0.0 112.274 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.9 mm -96.71 139.93 18.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.062 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.941 HG11 HG21 ' A' ' 408' ' ' VAL . 12.4 p -124.05 141.47 44.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.95 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 18.6 mmt -83.36 114.95 21.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.825 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.634 HG23 ' HB2' ' A' ' 403' ' ' PHE . 60.0 t -114.25 106.54 20.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.591 179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 63.95 16.55 9.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.342 -179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 109.57 -22.39 24.31 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 120.622 -0.799 . . . . 0.0 113.073 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . 0.414 ' HG2' ' O ' ' A' ' 398' ' ' VAL . 11.7 ptm180 -99.0 149.76 36.04 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 120.85 0.357 . . . . 0.0 111.129 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -69.25 135.93 32.99 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.806 2.337 . . . . 0.0 113.012 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 403' ' ' PHE . . . . . 0.634 ' HB2' HG23 ' A' ' 398' ' ' VAL . 4.2 m-85 -139.32 172.17 13.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.696 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . 0.528 ' O ' HG23 ' A' ' 408' ' ' VAL . 0.7 OUTLIER -93.89 130.45 39.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.457 179.432 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -54.24 -42.93 70.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.172 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 31.1 m -66.75 -34.85 78.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.862 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.3 tp10 -67.62 -29.72 69.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.159 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.941 HG21 HG11 ' A' ' 396' ' ' VAL . 55.1 t -70.29 -47.46 66.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.058 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 20.9 t -61.6 -31.45 71.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.007 0.432 . . . . 0.0 111.036 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.8 mt-30 -75.9 -27.49 57.71 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.948 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 21.4 mtt180 -125.87 96.35 37.84 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.832 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 27.9 Cg_endo -62.79 -23.94 74.49 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.465 2.11 . . . . 0.0 112.373 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -61.4 -29.25 69.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.992 0.425 . . . . 0.0 110.954 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.519 HD12 ' HA ' ' A' ' 408' ' ' VAL . 16.4 mt -67.38 -36.42 81.3 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.708 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.2 -37.03 78.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.865 179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.86 -28.58 68.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.015 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -76.7 -22.88 53.31 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.053 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 418' ' ' MET . . . . . 0.46 ' CE ' HG22 ' A' ' 398' ' ' VAL . 5.0 mtt -71.11 129.29 38.58 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.944 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.464 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.3 p -63.91 171.18 2.61 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.206 179.53 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 52.4 Cg_exo -52.66 -56.09 3.16 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.179 1.919 . . . . 0.0 112.188 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -60.48 -38.69 85.06 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -65.45 -34.23 77.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.133 179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.6 ' O ' HD12 ' A' ' 427' ' ' ILE . 11.3 tptm -64.34 -36.63 84.74 Favored 'General case' 0 N--CA 1.456 -0.15 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.288 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -65.32 -44.36 88.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.597 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.76 -30.45 65.63 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.181 0.515 . . . . 0.0 110.528 179.445 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 426' ' ' TYR . . . . . 0.664 ' CE1' HG11 ' A' ' 408' ' ' VAL . 68.5 t80 -68.78 -47.57 65.84 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.31 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.2 mt -75.37 -34.03 29.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.532 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -66.77 -30.1 70.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.239 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 64.0 mtp -57.84 -35.14 70.5 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.04 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . 0.412 ' O ' ' CE1' ' A' ' 434' ' ' PHE . . . -59.21 -48.04 87.89 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.477 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . 0.451 ' HA ' ' CE1' ' A' ' 434' ' ' PHE . 95.1 mt-30 -63.34 -38.46 91.26 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.782 0.325 . . . . 0.0 110.89 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -50.62 -31.59 16.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 86.1 mtp -72.99 -29.37 63.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.903 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 434' ' ' PHE . . . . . 0.451 ' CE1' ' HA ' ' A' ' 431' ' ' GLN . 49.9 p90 -131.58 45.37 2.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.164 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 86.4 tt0 -111.64 -18.79 12.7 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.342 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -154.07 85.31 1.15 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.84 0.352 . . . . 0.0 110.958 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 2.4 mp -143.02 79.86 1.66 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.76 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -120.27 156.26 31.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.952 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 50.7 mp0 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.849 179.993 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 23.0 t70 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.796 0.331 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -107.31 145.54 32.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.884 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 49.2 mp0 -126.52 147.45 49.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.91 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -146.79 141.71 26.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.891 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -59.73 -37.47 79.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.885 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 48.3 p30 -145.76 164.27 32.38 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.965 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 50.2 mp0 -121.31 132.36 54.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.914 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -111.67 129.78 55.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.817 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -160.09 -47.06 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.884 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -125.13 163.77 21.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.921 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 11.6 p -126.43 137.41 57.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.08 -179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -174.28 145.3 1.0 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.052 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -79.99 136.57 36.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.89 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -117.69 146.26 38.33 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.852 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -72.25 164.54 35.32 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.576 2.184 . . . . 0.0 112.357 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.7 mm -99.01 143.2 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.028 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.921 HG11 HG21 ' A' ' 408' ' ' VAL . 14.4 p -119.97 141.94 37.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.759 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 15.1 mmt -84.76 113.85 21.63 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.855 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.443 ' HA ' ' HG2' ' A' ' 418' ' ' MET . 18.7 t -114.81 113.01 42.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.944 179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.86 23.9 5.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.306 -179.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 100.16 -17.85 56.44 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.804 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -99.61 146.38 31.73 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 120.732 0.301 . . . . 0.0 111.05 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -75.13 135.98 19.54 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.669 2.246 . . . . 0.0 112.529 -179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 403' ' ' PHE . . . . . 0.576 ' O ' HG12 ' A' ' 396' ' ' VAL . 62.1 m-85 -148.12 156.26 42.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.682 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . 0.476 ' O ' HG23 ' A' ' 408' ' ' VAL . 17.3 p -74.82 138.59 42.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.58 179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 60.8 t80 -56.88 -39.91 75.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.003 -179.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.3 m -64.55 -38.21 90.21 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.923 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -65.87 -29.72 70.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.182 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.921 HG21 HG11 ' A' ' 396' ' ' VAL . 59.8 t -67.12 -46.3 84.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.946 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 85.7 p -65.02 -29.33 70.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.98 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -76.83 -26.14 53.99 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.947 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 34.9 mtt180 -123.7 95.03 45.31 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.801 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -62.02 -25.51 77.72 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.389 2.059 . . . . 0.0 112.252 -179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.34 -28.47 69.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.951 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 65.7 mt -66.57 -38.84 87.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.703 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 21.8 t -62.41 -36.17 73.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.735 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -64.62 -29.97 70.99 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.936 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -80.77 -18.25 48.26 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.974 179.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 418' ' ' MET . . . . . 0.443 ' HG2' ' HA ' ' A' ' 398' ' ' VAL . 5.3 mtt -72.71 126.44 29.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.176 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.446 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 2.8 p -69.14 172.57 4.83 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.049 179.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.446 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 50.5 Cg_exo -53.71 -56.09 2.96 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.188 1.925 . . . . 0.0 112.226 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.33 -41.92 90.24 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.923 0.392 . . . . 0.0 110.028 179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -65.05 -33.35 75.83 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.34 179.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.579 ' O ' HD12 ' A' ' 427' ' ' ILE . 48.6 tttm -65.97 -36.62 83.82 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.308 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 80.5 mt-10 -65.03 -45.8 83.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.639 179.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.2 -29.48 65.71 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.11 0.481 . . . . 0.0 110.57 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 426' ' ' TYR . . . . . 0.531 ' CE1' HG11 ' A' ' 408' ' ' VAL . 43.9 t80 -69.82 -47.05 64.23 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.263 179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.579 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.7 mt -76.44 -33.84 23.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.443 -179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -63.59 -45.88 88.36 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.127 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 429' ' ' MET . . . . . 0.467 ' HE1' HG23 ' A' ' 396' ' ' VAL . 66.9 mtm -62.34 -37.29 85.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.872 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.5 -37.24 87.93 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.458 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -60.91 -32.11 71.6 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.802 0.334 . . . . 0.0 110.891 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 3.8 ttm105 -80.5 -29.4 37.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.734 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 95.5 mmm -58.32 -27.61 64.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.089 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -102.27 24.37 10.34 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.997 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -79.87 -22.9 42.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.189 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . 0.621 ' O ' HD23 ' A' ' 437' ' ' LEU . 34.7 p30 -152.14 83.96 1.26 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.038 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.621 HD23 ' O ' ' A' ' 436' ' ' ASP . 87.4 mt -142.95 79.91 1.67 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.843 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -120.68 152.72 37.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.886 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 50.7 mp0 . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.227 -0.892 . . . . 0.0 110.922 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 47.5 p30 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.84 0.352 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -99.66 136.63 39.29 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.89 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -79.83 -36.0 37.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.846 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 49.5 mp0 -113.71 150.75 32.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -130.93 -45.63 1.04 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.046 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 33.0 m-20 -160.03 95.49 1.17 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.043 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -114.31 141.66 47.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.89 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.596 ' CE2' HG22 ' A' ' 390' ' ' VAL . 0.1 OUTLIER -160.04 85.99 0.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.903 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -79.86 -37.91 33.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.999 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -128.58 148.57 50.79 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.924 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . 0.596 HG22 ' CE2' ' A' ' 387' ' ' PHE . 26.9 t -124.29 132.28 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.979 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -156.08 148.46 23.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.167 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -90.47 120.23 31.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.886 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -117.87 150.89 48.0 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.915 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -68.75 163.45 37.12 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.613 2.209 . . . . 0.0 112.269 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.4 mm -101.57 146.37 9.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.174 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.95 HG11 HG21 ' A' ' 408' ' ' VAL . 11.7 p -129.0 140.48 49.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.725 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 18.2 mmt -81.04 113.72 19.43 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.669 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.62 HG13 ' HG2' ' A' ' 418' ' ' MET . 23.2 t -115.68 110.44 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.913 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.57 23.31 5.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.295 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 102.19 -17.74 53.27 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.862 179.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 35.9 mtp85 -101.54 145.15 29.95 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.737 0.268 . . . . 0.0 111.095 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.29 135.92 19.16 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.689 2.259 . . . . 0.0 112.412 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 403' ' ' PHE . . . . . 0.608 ' O ' HG12 ' A' ' 396' ' ' VAL . 62.0 m-85 -147.4 157.52 43.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.787 179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . 0.586 ' O ' HG23 ' A' ' 408' ' ' VAL . 49.0 m -69.88 138.2 52.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.611 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 68.2 t80 -58.49 -41.59 85.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.979 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 95.4 p -66.25 -39.89 89.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.889 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.14 -29.22 69.65 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.131 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.95 HG21 HG11 ' A' ' 396' ' ' VAL . 49.4 t -68.46 -47.67 76.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.994 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 22.7 t -64.08 -30.12 71.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 179.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -75.71 -26.31 57.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.025 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -124.35 85.09 55.84 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.874 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.08 -27.25 28.42 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.611 2.207 . . . . 0.0 112.291 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -61.07 -29.27 69.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.932 0.396 . . . . 0.0 110.989 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 63.3 mt -66.17 -37.54 85.88 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.761 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 37.5 t -63.68 -38.06 81.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.924 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -66.11 -28.48 68.84 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.066 179.768 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -80.05 -17.73 51.97 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.116 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 418' ' ' MET . . . . . 0.62 ' HG2' HG13 ' A' ' 398' ' ' VAL . 3.0 mtt -76.35 132.2 39.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.153 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.477 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 8.3 p -63.79 158.61 59.8 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.065 179.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 2.0 Cg_endo -45.05 -56.03 3.0 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.617 2.211 . . . . 0.0 112.257 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -60.25 -38.55 83.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.969 0.414 . . . . 0.0 109.956 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -66.0 -34.25 77.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.158 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.61 ' O ' HD12 ' A' ' 427' ' ' ILE . 74.9 tttt -63.52 -36.16 82.84 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.205 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 24.1 mt-10 -64.57 -45.46 86.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.634 179.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -56.87 -31.04 64.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.131 0.491 . . . . 0.0 110.594 179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 426' ' ' TYR . . . . . 0.512 ' CE1' HG11 ' A' ' 408' ' ' VAL . 47.4 t80 -68.45 -48.23 65.08 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.218 179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.61 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.1 mt -74.05 -34.03 37.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.0 -1.0 . . . . 0.0 111.519 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -64.04 -46.63 83.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.061 -179.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 65.1 mtm -62.69 -36.99 84.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.826 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.99 -35.99 86.22 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.464 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -59.97 -40.01 87.62 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.797 0.332 . . . . 0.0 110.828 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -69.53 -29.83 67.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.942 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 16.3 mmt -57.48 -22.82 46.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.209 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 434' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 434' ' ' PHE . 55.7 t80 -91.9 45.98 1.25 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.076 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -109.31 -21.14 12.68 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.12 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . 0.832 ' O ' HD22 ' A' ' 437' ' ' LEU . 82.7 m-20 -142.9 79.96 1.67 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.854 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.832 HD22 ' O ' ' A' ' 436' ' ' ASP . 1.3 mm? -142.58 79.88 1.67 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.724 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -90.98 133.39 35.32 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.881 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.169 -0.92 . . . . 0.0 110.83 179.977 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 . . . . . 0 N--CA 1.486 1.345 0 CA-C-O 120.826 0.345 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -100.47 131.96 46.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.777 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -108.67 -75.84 0.62 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.998 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 49.7 tp10 -108.62 -57.17 2.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.978 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 50.2 p30 -62.06 174.61 0.84 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.95 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -135.38 100.68 4.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.925 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -112.61 147.45 36.66 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.895 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 69.5 t80 -92.9 122.38 35.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -148.53 156.64 42.7 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.956 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -108.16 137.91 45.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.961 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.0 t -119.02 132.84 67.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.11 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -158.62 168.66 26.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -79.87 146.31 32.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -60.98 143.19 92.18 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.944 -179.959 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -73.7 165.94 31.02 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.587 2.191 . . . . 0.0 112.384 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.6 mm -94.47 135.82 27.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.03 179.882 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.937 HG11 HG21 ' A' ' 408' ' ' VAL . 12.7 p -115.9 142.24 30.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.769 179.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . 0.432 ' HE2' ' HA ' ' A' ' 402' ' ' PRO . 2.8 mmt -90.13 113.86 25.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.866 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.619 HG13 ' HG2' ' A' ' 418' ' ' MET . 39.2 t -110.63 119.09 58.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.011 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.95 27.68 11.53 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.363 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 85.88 23.51 45.43 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.785 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 75.8 mtm-85 -137.01 151.68 72.53 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 120.602 0.239 . . . . 0.0 110.688 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.432 ' HA ' ' HE2' ' A' ' 397' ' ' MET . 57.7 Cg_endo -71.28 135.72 27.48 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.406 2.071 . . . . 0.0 112.411 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 403' ' ' PHE . . . . . 0.523 ' HB2' HG23 ' A' ' 398' ' ' VAL . 35.1 m-85 -150.67 172.09 16.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.668 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . 0.728 ' O ' HG23 ' A' ' 408' ' ' VAL . 49.4 m -97.84 136.87 37.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.569 179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 405' ' ' TYR . . . . . 0.428 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 41.3 t80 -57.11 -41.71 79.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.913 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.4 t -64.4 -39.57 94.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.843 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -66.86 -29.22 69.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.109 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.937 HG21 HG11 ' A' ' 396' ' ' VAL . 51.5 t -66.59 -47.49 83.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.901 -0.591 . . . . 0.0 111.016 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.0 p -64.45 -29.03 70.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.983 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -76.78 -25.65 53.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.01 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 38.7 mtt85 -124.76 85.57 56.89 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.794 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_exo -51.79 -26.7 24.64 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.623 2.215 . . . . 0.0 112.295 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -61.61 -29.79 70.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.945 0.403 . . . . 0.0 111.009 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . . . . . . . . . 67.7 mt -66.83 -36.86 83.34 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.74 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . 0.651 HG13 ' NZ ' ' A' ' 423' ' ' LYS . 43.2 t -64.71 -37.95 81.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.948 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -68.09 -28.39 67.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.107 179.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 57.5 mt-30 -77.3 -22.46 51.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.121 179.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 418' ' ' MET . . . . . 0.619 ' HG2' HG13 ' A' ' 398' ' ' VAL . 2.6 mtt -73.47 130.28 39.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.95 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.439 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.1 p -65.97 171.18 4.08 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.259 179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.439 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 50.6 Cg_exo -53.91 -56.2 2.81 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.334 2.023 . . . . 0.0 112.418 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -58.33 -42.66 87.27 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.857 0.36 . . . . 0.0 110.216 179.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 63.5 mm-40 -65.96 -32.82 74.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.079 179.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.651 ' NZ ' HG13 ' A' ' 415' ' ' VAL . 0.5 OUTLIER -65.21 -36.69 84.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.168 179.371 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -64.6 -45.82 85.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.59 179.554 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.11 -30.81 64.69 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.119 0.485 . . . . 0.0 110.536 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 426' ' ' TYR . . . . . 0.552 ' CE1' HG11 ' A' ' 408' ' ' VAL . 63.5 t80 -68.46 -48.27 64.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.273 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.566 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.4 mt -74.47 -33.82 34.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.022 -0.99 . . . . 0.0 111.434 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.03 -40.05 87.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.144 -179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 68.8 mtm -61.55 -35.81 78.82 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.891 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -58.94 -41.57 96.35 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.458 180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -62.71 -36.59 83.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.781 0.324 . . . . 0.0 110.891 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 48.4 mmm-85 -60.87 -36.23 78.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.912 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 65.0 mtt -59.78 -27.67 66.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.029 -179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -156.71 79.55 0.94 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.891 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 21.7 pt-20 -80.06 -37.33 34.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.13 0.49 . . . . 0.0 110.847 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . 0.715 ' O ' HD23 ' A' ' 437' ' ' LEU . 52.2 t0 -159.07 82.92 0.78 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.866 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.715 HD23 ' O ' ' A' ' 436' ' ' ASP . 47.2 mt -146.01 80.8 1.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.901 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -122.0 152.55 39.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.834 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.93 179.969 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.847 0.356 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -106.94 150.0 26.9 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.884 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -114.31 153.13 30.29 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.902 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -98.21 35.19 1.8 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.905 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 85.7 m-20 61.4 44.95 8.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.833 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -131.44 133.18 44.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -102.62 145.3 29.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -128.08 159.99 33.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.904 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -117.78 147.47 42.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.92 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -123.85 155.9 37.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.84 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.6 t -114.18 131.75 65.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.089 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . 58.52 163.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.173 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -130.96 106.21 8.26 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -74.56 148.07 85.23 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.927 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_endo -69.36 158.37 57.74 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.535 2.157 . . . . 0.0 112.265 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.4 mm -80.02 148.28 5.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.106 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.959 HG11 HG21 ' A' ' 408' ' ' VAL . 11.8 p -127.44 139.75 51.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.763 179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 19.4 mmt -81.0 113.82 19.47 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.824 0.345 . . . . 0.0 110.82 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.577 HG13 ' HG2' ' A' ' 418' ' ' MET . 21.7 t -115.3 110.27 31.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.03 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 54.02 24.38 4.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.28 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 101.9 -19.68 48.64 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.758 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? -98.68 143.6 26.64 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-O 120.651 0.262 . . . . 0.0 110.958 -179.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.56 135.91 16.79 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.651 2.234 . . . . 0.0 112.475 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 403' ' ' PHE . . . . . 0.571 ' O ' HG12 ' A' ' 396' ' ' VAL . 48.7 m-85 -148.47 161.1 42.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.714 179.794 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . 0.619 ' O ' HG23 ' A' ' 408' ' ' VAL . 25.9 p -75.92 141.35 42.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.595 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 61.1 t80 -58.24 -40.8 82.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.908 -179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 22.7 t -63.59 -40.39 96.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.936 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 48.9 tp10 -63.97 -28.79 70.05 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.084 -179.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.959 HG21 HG11 ' A' ' 396' ' ' VAL . 37.7 t -70.32 -54.02 20.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.051 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 18.2 m -61.04 -30.17 70.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.94 -179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -76.19 -25.44 55.16 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.974 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 13.4 mtp180 -124.72 86.79 55.52 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.845 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_exo -51.77 -25.51 21.05 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.559 2.173 . . . . 0.0 112.408 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.9 mm-40 -61.67 -30.7 70.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.934 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.455 HD12 ' HA ' ' A' ' 408' ' ' VAL . 30.5 mt -68.07 -36.94 80.67 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.679 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.51 -36.49 77.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.813 179.77 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.98 -28.07 67.12 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.035 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -81.47 -17.16 49.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.227 179.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 418' ' ' MET . . . . . 0.577 ' HG2' HG13 ' A' ' 398' ' ' VAL . 2.9 mtt -77.02 130.93 38.12 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.151 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.502 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 4.6 p -67.25 159.07 79.35 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.982 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.502 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 1.2 Cg_endo -44.14 -53.35 4.8 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.694 2.263 . . . . 0.0 112.497 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -60.27 -41.59 93.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.898 0.38 . . . . 0.0 110.207 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -66.46 -33.76 76.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.248 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 72.4 tttt -65.0 -35.13 80.22 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.115 179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 35.0 mm-40 -63.24 -46.27 87.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.637 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.42 -31.51 67.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.222 0.534 . . . . 0.0 110.755 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 426' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -68.62 -46.01 70.4 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.207 179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 58.3 mt -76.42 -35.92 27.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.705 -179.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -65.68 -35.19 80.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.932 0.396 . . . . 0.0 111.176 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 60.2 mtp -61.48 -39.69 91.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.883 179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -63.1 -37.25 94.62 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.576 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -60.08 -35.86 76.11 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.836 0.351 . . . . 0.0 110.975 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -69.19 -31.0 69.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.637 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 65.1 mtt -61.22 -27.35 68.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.087 -179.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -106.58 -24.54 12.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.199 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -80.01 -20.64 44.92 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.281 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 83.2 m-20 -142.21 79.88 1.68 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.81 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -144.37 80.05 1.63 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.867 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -121.46 154.4 36.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.901 179.998 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.718 0.294 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -107.57 139.47 42.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -135.63 135.27 40.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.925 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -113.52 140.84 47.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.936 179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -158.05 93.89 1.28 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.925 -179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -145.07 79.92 1.6 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -143.62 162.5 35.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.92 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -107.2 133.25 52.06 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.799 -179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -116.67 155.92 27.98 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.918 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -102.04 146.87 27.29 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.851 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.1 t -102.56 131.52 50.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.064 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -70.67 150.32 46.1 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.145 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -81.21 116.81 21.28 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.864 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -120.96 155.79 57.33 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -67.2 157.84 59.78 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.535 2.157 . . . . 0.0 112.26 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 34.4 mm -96.59 138.73 20.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.128 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.96 HG11 HG21 ' A' ' 408' ' ' VAL . 12.6 p -125.22 140.34 48.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.686 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . . . . . . . . . 2.8 mmt -85.55 113.75 22.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.065 -179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.687 HG23 ' HB2' ' A' ' 403' ' ' PHE . 34.6 t -111.03 120.08 60.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.851 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 55.73 23.25 6.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.466 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 90.81 21.02 37.85 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.825 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 19.2 mtp180 -137.11 149.67 66.93 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 120.563 0.22 . . . . 0.0 110.74 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.426 ' O ' ' CD1' ' A' ' 403' ' ' PHE . 18.2 Cg_exo -66.29 135.66 40.76 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.474 2.116 . . . . 0.0 112.338 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 403' ' ' PHE . . . . . 0.687 ' HB2' HG23 ' A' ' 398' ' ' VAL . 17.3 m-85 -148.42 172.13 14.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.724 179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . 0.719 ' O ' HG23 ' A' ' 408' ' ' VAL . 22.3 p -97.71 135.37 39.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.431 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 405' ' ' TYR . . . . . 0.499 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 45.8 t80 -56.98 -39.57 74.9 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.122 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 24.1 m -64.44 -39.7 94.32 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.093 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -68.24 -28.89 67.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.247 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.96 HG21 HG11 ' A' ' 396' ' ' VAL . 24.3 t -68.25 -55.97 14.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.068 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 1.4 m -59.23 -29.99 67.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.874 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 30.3 mt-30 -73.74 -26.26 60.59 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.861 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 41.4 mtt-85 -125.04 87.47 55.41 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.817 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.97 -26.43 18.46 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.535 2.157 . . . . 0.0 112.408 -179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.52 -28.52 69.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.031 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.654 HD12 ' HA ' ' A' ' 408' ' ' VAL . 68.6 mt -66.56 -39.58 88.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.845 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 24.5 t -63.5 -37.07 78.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.009 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -68.41 -28.85 67.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.034 0.445 . . . . 0.0 111.158 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -80.11 -19.71 46.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.879 -0.6 . . . . 0.0 111.119 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 418' ' ' MET . . . . . 0.535 ' HG2' HG13 ' A' ' 398' ' ' VAL . 2.8 mtt -75.46 133.33 41.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.055 -179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.487 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 6.7 p -62.63 158.41 50.86 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.015 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 2.6 Cg_endo -45.65 -52.85 6.27 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.624 2.216 . . . . 0.0 112.377 -179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -60.09 -43.38 95.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.925 0.393 . . . . 0.0 110.168 179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 87.0 mt-10 -65.07 -33.25 75.59 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.196 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.654 ' O ' HD12 ' A' ' 427' ' ' ILE . 41.2 tttt -64.66 -38.07 89.74 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.085 179.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 42.4 mm-40 -65.02 -45.24 86.34 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.588 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -57.34 -30.4 64.77 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.211 0.529 . . . . 0.0 110.712 179.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 426' ' ' TYR . . . . . 0.499 ' CE1' ' CE1' ' A' ' 405' ' ' TYR . 56.1 t80 -69.19 -47.89 63.64 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.507 -0.769 . . . . 0.0 110.248 179.247 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.654 HD12 ' O ' ' A' ' 423' ' ' LYS . 4.0 mt -74.69 -33.72 32.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.497 -179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -60.66 -39.49 88.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.167 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 71.6 mtm -60.53 -39.25 87.16 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.833 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -61.4 -39.84 97.83 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.49 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 99.4 mm-40 -61.49 -33.54 73.95 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.873 0.368 . . . . 0.0 110.93 179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -70.75 -29.57 65.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.662 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 96.5 mmm -60.02 -26.7 66.29 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.118 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 434' ' ' PHE . . . . . 0.511 ' HA ' HD12 ' A' ' 437' ' ' LEU . 98.0 m-85 -116.08 23.25 12.34 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.273 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -79.99 -19.45 47.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.252 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -143.13 79.89 1.66 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.889 0.376 . . . . 0.0 110.888 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.511 HD12 ' HA ' ' A' ' 434' ' ' PHE . 98.3 mt -148.65 82.2 1.46 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.833 179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -107.75 135.53 49.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.252 -0.88 . . . . 0.0 110.903 -179.985 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 . . . . . 0 N--CA 1.486 1.339 0 CA-C-O 120.798 0.333 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -119.69 80.11 1.53 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.841 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.93 -34.08 39.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.924 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -132.24 -62.09 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.927 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -71.19 132.43 45.0 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -103.48 113.98 27.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.938 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -122.9 134.4 54.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.878 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -108.21 124.78 50.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.904 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -129.19 151.79 49.47 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.906 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -114.67 136.77 52.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.947 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.76 134.67 62.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.039 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -146.89 150.29 34.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.122 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -112.92 166.61 11.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.978 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -92.93 155.56 41.34 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.923 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -66.74 158.72 54.74 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.526 2.15 . . . . 0.0 112.194 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 33.4 mm -98.85 131.98 45.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.16 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.932 HG11 HG21 ' A' ' 408' ' ' VAL . 11.4 p -117.7 139.34 45.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.688 179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . 0.434 ' HE2' ' HA ' ' A' ' 402' ' ' PRO . 2.3 mmt -86.9 113.85 23.04 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.95 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.66 HG23 ' HB2' ' A' ' 403' ' ' PHE . 39.9 t -110.03 119.58 59.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.816 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 57.2 24.82 10.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.323 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 88.44 22.07 41.95 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.835 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 29.4 mtt-85 -136.94 150.71 70.51 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 120.607 0.242 . . . . 0.0 110.813 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.434 ' HA ' ' HE2' ' A' ' 397' ' ' MET . 17.7 Cg_exo -66.52 135.64 39.93 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.47 2.113 . . . . 0.0 112.372 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 403' ' ' PHE . . . . . 0.66 ' HB2' HG23 ' A' ' 398' ' ' VAL . 17.9 m-85 -148.82 171.99 15.37 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.606 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . 0.675 ' O ' HG23 ' A' ' 408' ' ' VAL . 53.6 p -100.32 134.81 42.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.559 179.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 405' ' ' TYR . . . . . 0.481 ' CE1' ' CE1' ' A' ' 426' ' ' TYR . 28.3 t80 -56.03 -37.36 69.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.993 -179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 21.7 m -66.46 -41.63 88.76 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.099 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -66.28 -29.71 69.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.925 0.393 . . . . 0.0 111.256 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.932 HG21 HG11 ' A' ' 396' ' ' VAL . 44.1 t -65.81 -48.91 80.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.102 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 86.1 p -64.49 -29.25 70.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -77.91 -25.91 48.71 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.02 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? -124.1 85.76 54.51 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.841 179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -50.87 -26.81 18.9 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.569 2.179 . . . . 0.0 112.398 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.31 -28.25 69.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.034 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.544 HD12 ' HA ' ' A' ' 408' ' ' VAL . 71.8 mt -66.48 -39.25 88.66 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.833 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 38.6 t -63.82 -38.15 81.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -67.78 -28.86 67.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.11 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -76.07 -22.88 55.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.053 179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 418' ' ' MET . . . . . 0.601 ' HG2' HG13 ' A' ' 398' ' ' VAL . 2.8 mtt -74.21 133.68 42.71 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.904 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.444 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 3.8 p -66.69 171.25 4.59 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.11 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 51.1 Cg_exo -53.27 -56.06 3.08 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.247 1.965 . . . . 0.0 112.368 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.0 -41.53 87.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.93 0.395 . . . . 0.0 110.072 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 58.6 mm-40 -65.83 -33.02 74.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.094 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . 0.694 ' O ' HD12 ' A' ' 427' ' ' ILE . 79.9 tttt -64.43 -37.21 86.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.1 179.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -65.4 -45.09 85.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.527 179.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -56.94 -30.53 64.1 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.21 0.528 . . . . 0.0 110.537 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 426' ' ' TYR . . . . . 0.646 ' CE1' HG11 ' A' ' 408' ' ' VAL . 64.3 t80 -68.49 -48.82 63.44 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.132 179.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . 0.694 HD12 ' O ' ' A' ' 423' ' ' LYS . 3.6 mt -73.14 -35.16 46.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.3 -179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -71.59 -29.23 64.46 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.065 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 57.7 mtp -70.52 -30.85 67.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.876 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -84.1 -42.52 7.53 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.863 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . 0.422 ' HG3' ' HD3' ' A' ' 432' ' ' ARG . 21.5 pt20 -57.84 -42.48 84.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.773 0.321 . . . . 0.0 111.07 -179.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . 0.422 ' HD3' ' HG3' ' A' ' 431' ' ' GLN . 0.1 OUTLIER -58.24 -29.93 66.13 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.0 179.933 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 94.2 mmm -58.22 -23.38 55.58 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.263 -179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 434' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -94.8 21.59 7.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.37 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 -79.91 -22.54 42.65 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.848 0.356 . . . . 0.0 111.238 179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . 0.677 ' O ' HD23 ' A' ' 437' ' ' LEU . 51.9 t0 -151.83 83.97 1.28 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.922 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 436' ' ' ASP . 83.7 mt -143.18 79.92 1.66 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.817 179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -120.96 153.72 36.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.86 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.178 -0.915 . . . . 0.0 110.914 -179.984 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 380' ' ' ASP . . . . . . . . . . . . . 57.3 p30 . . . . . 0 N--CA 1.487 1.404 0 CA-C-O 120.835 0.35 . . . . 0.0 111.208 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 381' ' ' GLU . . . . . . . . . . . . . 47.9 mp0 -98.73 152.14 19.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.881 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 382' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -79.84 -29.55 40.17 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.909 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 383' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -138.88 79.59 1.74 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.932 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 384' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -145.67 102.19 3.65 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.823 179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 385' ' ' ASP . . . . . . . . . . . . . 52.1 t0 -79.99 110.48 15.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.775 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 386' ' ' GLU . . . . . . . . . . . . . 18.6 pt-20 -123.44 154.22 39.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.113 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 387' ' ' PHE . . . . . 0.408 ' CD2' ' O ' ' A' ' 388' ' ' GLU . 66.2 t80 -111.68 155.06 24.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.86 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 388' ' ' GLU . . . . . 0.408 ' O ' ' CD2' ' A' ' 387' ' ' PHE . 96.0 mt-10 -79.84 133.29 36.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.945 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 389' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -136.83 164.49 28.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.902 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 390' ' ' VAL . . . . . . . . . . . . . 24.5 t -103.99 131.05 53.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.02 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 391' ' ' ALA . . . . . . . . . . . . . . . -104.72 149.47 25.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.138 179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 392' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -79.95 134.03 36.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.825 179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 393' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.86 151.61 97.17 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.978 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 394' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -73.64 166.07 30.73 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.692 2.261 . . . . 0.0 112.349 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 395' ' ' ILE . . . . . . . . . . . . . 32.9 mm -101.19 130.61 50.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.146 179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 396' ' ' VAL . . . . . 0.897 HG11 HG21 ' A' ' 408' ' ' VAL . 13.4 p -116.16 137.61 49.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.732 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 397' ' ' MET . . . . . 0.437 ' HE2' ' HA ' ' A' ' 402' ' ' PRO . 2.1 mmt -85.74 113.94 22.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.04 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 398' ' ' VAL . . . . . 0.54 HG23 ' HB2' ' A' ' 403' ' ' PHE . 33.2 t -114.92 123.87 71.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.928 179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 399' ' ' ALA . . . . . . . . . . . . . . . 56.66 26.88 11.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.23 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 400' ' ' GLY . . . . . . . . . . . . . . . 83.44 22.63 56.11 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.647 179.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 401' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -137.07 153.34 75.11 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 120.665 0.269 . . . . 0.0 110.931 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 402' ' ' PRO . . . . . 0.437 ' HA ' ' HE2' ' A' ' 397' ' ' MET . 48.4 Cg_endo -68.88 135.97 34.08 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.518 2.145 . . . . 0.0 112.339 -179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 403' ' ' PHE . . . . . 0.54 ' HB2' HG23 ' A' ' 398' ' ' VAL . 14.4 m-85 -146.65 171.54 14.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 404' ' ' SER . . . . . . . . . . . . . 50.8 m -97.48 129.71 44.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.619 179.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 405' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -52.29 -40.31 61.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.027 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 406' ' ' SER . . . . . . . . . . . . . 41.6 t -67.61 -35.26 78.62 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.738 179.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 407' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -67.87 -30.8 70.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.051 -179.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 408' ' ' VAL . . . . . 0.897 HG21 HG11 ' A' ' 396' ' ' VAL . 81.9 t -69.83 -44.55 78.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.869 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 409' ' ' SER . . . . . . . . . . . . . 32.9 t -62.95 -30.91 71.94 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.989 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 410' ' ' GLN . . . . . . . . . . . . . 58.1 mt-30 -75.48 -26.59 58.33 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.996 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 411' ' ' ARG . . . . . . . . . . . . . 14.6 mtt85 -125.86 84.89 60.17 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.883 -179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 412' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -52.37 -24.99 23.0 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.597 2.198 . . . . 0.0 112.371 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 413' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -61.23 -29.31 69.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.976 0.417 . . . . 0.0 111.064 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 414' ' ' LEU . . . . . 0.508 HD12 ' HA ' ' A' ' 408' ' ' VAL . 28.8 mt -66.39 -36.23 82.32 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.761 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 415' ' ' VAL . . . . . . . . . . . . . 38.8 t -63.68 -37.71 80.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.831 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 416' ' ' ALA . . . . . . . . . . . . . . . -65.09 -29.4 70.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.035 0.445 . . . . 0.0 111.008 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 417' ' ' GLN . . . . . . . . . . . . . 53.8 mt-30 -79.57 -21.18 45.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.0 179.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 418' ' ' MET . . . . . 0.443 ' HE3' HG11 ' A' ' 408' ' ' VAL . 7.3 mtt -69.19 123.72 21.87 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.033 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 419' ' ' THR . . . . . 0.456 ' HB ' ' HD2' ' A' ' 420' ' ' PRO . 7.0 p -61.53 167.77 3.94 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.172 179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 420' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 419' ' ' THR . 62.4 Cg_exo -51.47 -56.07 3.36 Favored 'Trans proline' 0 C--N 1.344 0.32 0 C-N-CA 122.288 1.992 . . . . 0.0 112.155 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 421' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -59.98 -39.84 87.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.054 0.454 . . . . 0.0 109.882 179.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 422' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.11 -34.23 77.91 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.758 -0.656 . . . . 0.0 110.27 179.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 423' ' ' LYS . . . . . . . . . . . . . 75.6 tttt -64.82 -36.66 85.06 Favored 'General case' 0 N--CA 1.455 -0.202 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.197 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 424' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -64.27 -46.24 84.56 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.474 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 425' ' ' ALA . . . . . . . . . . . . . . . -58.42 -30.49 66.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.167 0.508 . . . . 0.0 110.607 179.461 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 426' ' ' TYR . . . . . 0.567 ' HD1' HG21 ' A' ' 396' ' ' VAL . 75.1 t80 -69.37 -46.42 66.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.259 179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 427' ' ' ILE . . . . . . . . . . . . . 58.7 mt -77.19 -33.66 20.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.574 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 428' ' ' ALA . . . . . . . . . . . . . . . -63.4 -38.38 90.91 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.249 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 429' ' ' MET . . . . . . . . . . . . . 60.0 mtm -60.14 -44.63 94.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.935 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 430' ' ' GLY . . . . . . . . . . . . . . . -59.81 -40.94 97.36 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.452 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 431' ' ' GLN . . . . . . . . . . . . . 94.9 mm-40 -64.59 -34.5 78.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.763 0.316 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 432' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 -72.14 -37.31 69.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.746 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 433' ' ' MET . . . . . . . . . . . . . 88.0 mtp -58.53 -25.77 62.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.109 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 434' ' ' PHE . . . . . 0.403 ' CD2' ' O ' ' A' ' 434' ' ' PHE . 61.1 t80 -96.28 1.54 52.12 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.409 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 435' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -99.95 -19.59 16.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.711 0.291 . . . . 0.0 111.338 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 436' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -144.18 80.16 1.64 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.771 0.32 . . . . 0.0 111.011 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 437' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.6 86.91 0.94 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.888 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 438' ' ' PHE . . . . . . . . . . . . . 48.1 p90 -132.08 165.53 23.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.856 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 439' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.988 179.983 . . . . . . . . 0 0 . 1 stop_ save_